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ABSTRACT
Throughout life, we are constantly exposed to a wide variety of extrinsic and 
intrinsic agents which have the potential to damage cellular biomolecules, including 
DNA and lipids. Imperfections in cellular defence systems in combination with 
other age-related changes may contribute to ageing and the development of age- 
related pathologies such as Alzheimer’s Disease (AD).
The aim of this project was to investigate the effect of age and AD on oxidative- 
damage-related parameters and antioxidants in peripheral blood mononuclear cells 
(PBMCs) or blood plasma from three groups of volunteers: healthy individuals aged 
under 30, healthy individuals aged over 60 and patients diagnosed with AD of age 
over 60 (n = 25 in each group). Hydrogen peroxide (H2 0 2 )-induced DNA damage 
was measured in PBMCs using the comet assay and it was found to increase with 
increasing concentration of H2O2 . A higher level of DNA damage was found in the 
healthy younger group than in the healthy older group whilst AD was found to have 
no significant effect on the level of DNA damage. AD was found to have a 
significant effect whilst age was shown to have no significant effect on 
malondialdehyde (MDA) level, a biomarker for lipid peroxidation. Neither age nor 
AD had any effect on reduced glutathione level whilst oxidised glutathione level was 
found to be significantly affected by AD but not age. Neither age nor AD was 
shown to have any significant effect on the total antioxidant activity (TAA) in blood 
plasma. However, TAA measured in healthy females over 60 was found to be 
significantly higher than that in healthy females under 30. Attempts were also made 
to study the oxidative induction of heme oxygenase- 1 expression using quantitative 
and semi-quantitative RT-PCR.
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1.1 The ageing population
Although philosophers and scientists have long been interested in the ageing process, 
general interest in this topic was minimal before 1960. In recent decades, however, 
interest in the various aspects of ageing has grown due to the realisation that not only 
do the elderly form an ever-increasing percentage of the population, but they also 
utilise a disproportionately high percent of health care costs. In 1996, the population 
of the United Kingdom based on mid-year estimates was 58,801,000. Of that figure,
18.14 % (10,668,000 people) were over pensionable age (i.e. men aged 65 and over 
and women aged 60 and over). Further statistics on the ageing population in 1996 
are shown in Table 1.1.
Group Number of people
Men aged 65 and over 3,768,000
Women aged 60 and over 6,900,000
People aged 65 and over 9,250,000
People aged 75 and over 4,192,000
People aged 85 and over 1,067,000
Table 1.1 The ageing population in the United Kingdom in 1996 (Population 
Trends, Summer 1998, Table 6).
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In 1996, in the United Kingdom, almost two-thirds of people aged 75 and over were 
women and almost three-quarters of those aged 85 and over were women (Population 
Trends, Summer 1998, Table 6 ). In 1996, 5,670 women and 655 men were aged 100 
and over. In 2021, it is estimated that 22,493 women and 4,386 men will be in this 
age group. In 1996, a man of 60 could be expected to live for another 18.5 years and 
a woman of the same age for 22.4 years. The number of people of pensionable age is 
projected to increase from 10.7 million in 1996 to 11.8 million in 2010. This will 
rise to 14 million by 2021 and will peak at just over 17 million. The number of 
people aged over 75 will have doubled by the middle of the next century, while the 
number aged 90 and over will have more than tripled. All statistics shown above 
were obtained from the 1996-based National Population Projections provided by the 
Government Actuary’s Department. The projected change in the population of the 
United Kingdom is shown in Table 1.2. It is estimated that at present some 
5 % of the population aged 65 and over and 20 % of the population aged 80 and over 
suffer from dementia (House of Commons, Hansard, 30/10/95, col, 45W and PT op 
cit.).
Group Number of people
1996 2001 2011
People aged over 75 and over 4,193,000 4,383,000 4,516,000
People aged over 85 and over 1,069,000 1,158,000 1,281,000
Table 1.2 The projected change in the population of the United Kingdom (IBDI, 
Appendix 1).
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Improvements in general living conditions such as better nutrition, housing, medical 
care and advances in medical research are responsible for the rapid growth of the 
ageing population. As these factors within a population approach optimum, the 
curve of the chance of death versus age shifts towards a limit determined by 
individual ageing changes associated with the environment and disease plus those 
formed as a result of an increasing inborn process, the ageing process.
1.2 The ageing process
It is true that as people age, they become more susceptible to a variety of diseases. 
Nevertheless, it is important to recognise that ageing and disease are distinctly 
different. So, how is ageing defined? Harman defined ageing as “the progressive 
accumulation of changes with time associated with or responsible for the ever 
increasing susceptibility to disease and death which accompany age” (Harman, 1981) 
while Rothstein stated that “the changes from maturity through senescence 
constitutes the ageing process” (Rothstein, 1982). Regardless of how ageing is 
defined, it is now widely accepted that the ageing effects include the following 
(Knight, 1995):
a) a progressive decrease in efficiency of essentially all physiological functions;
b) atrophy of most organs and tissues;
c) increased vulnerability to trauma, infections, and various immune system 
malfunctions;
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d) increased susceptibility to most malignant processes; and
e) decreased capacity for the body to extract oxygen from the air and transmit it to 
the circulatory system.
There have been numerous theories to explain the ageing process (Medvedev, 1990). 
This is a natural result of the very rapid progress in our knowledge of biological 
phenomena and the application of many new approaches, methods and techniques to 
ageing research. Almost every important discovery in cellular and molecular biology 
has stimulated a new family of theories of ageing or new advanced versions of older 
versions. Many of them are either out of date, too selective or they employ 
contradictory methods of classification. Many theories co-exist because they do not 
contradict each other, or because they attempt to explain different and independent 
forms of senescence. No one theory is generally accepted but scientists are working 
towards the same goal, that is to investigate means of increasing the functional life 
span of man while continue to work towards a consensus on the cause(s) of the 
ageing process.
1.3 The ageing theories
As an organism ages, its chance of death increases, so that all individuals of a given 
species are dead by some age, characteristic of that species. The maximum life span 
is around 90-115 years for humans. For the purpose of this discussion, theories to 
explain the mechanism of ageing are grouped under three main headings -
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programmed ageing, damage accumulation ageing and the free radical theory of
ageing.
1.3.1 Programmed ageing
The programmed theory of ageing proposes a purposeful sequence of events encoded 
into the genome. This genome-based theory suggests that although everyone is 
programmed individually, an internal “clock” starts at conception and runs a specific 
period of time. Accordingly, genes carry specific instructions that control not only 
growth and maturation, but also decline and death. This theory has considerable 
support, including that obtained from both the observational studies and laboratory 
research (Knight, 1995). The studies of telomerase (Blackburn, 1991; Kim et al, 
1994; Haber, 1995; Price, 1999) have increased our understanding of programmed 
ageing. Progressive shortening of the ends of chromosomes, or telomeres, 
accompanies normal cell division and may contribute to cellular ageing. In humans, 
germ cells express telomerase and maintain their telomere length along with their 
ability to divide throughout life. In contrast, somatic cell tissues do not have 
telomerase activity, and they progressively lose telomere length (Haber, 1995). 
Patients with Hutchinson-Gilford Syndrome, the premature ageing syndrome 
(Section 1.3.1.1), have pronounced shortening of telomeres. These observations 
have led to the hypothesis that telomere length serves as a biological "clock" 
regulating the life span of normal cells. In a manner consistent with this model, 
cultured normal human fibroblasts undergo a finite number of cell divisions, after
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which they enter a state of senescence. The number of cell divisions correlates well 
with the initial length of the telomeres, and progressive loss of telomeres is observed 
in culture (Haber, 1995).
It is generally accepted that in humans there is a modest to moderate correlation in 
life expectancy between family members. That is, families in which centenarians 
exist are more likely to have other equally long-lived members than those families 
without centenarians. Furthermore, the difference in longevity i.e. the length of life 
is, on average, less in identical than with fraternal twins (Schachter et al, 1993). 
Hutchinson-Gilford Syndrome, Werner’s Syndrome and Down’s Syndrome are 
examples of disorders that are characterised by accelerated ageing and decreased life 
expectancy. They also provide some evidence that a few genes can have major 
effects on ageing.
1.3.1.1 Accelerated ageing syndromes
Hutchinson-Gilford Syndrome (Progeria) is extremely rare, affecting 1 in 4-8 million 
births. It is almost certainly genetic in origin being dominant rather than recessive 
and is considered to be a disease model of certain aspects of accelerated ageing 
(Berstein and Gensler, 1993). Sufferers appear normal at birth but within a few 
years, somatic growth slows and clinically apparent ageing features such as baldness, 
skin atrophy and atherosclerosis appear. Interestingly, the endocrine system 
apparently remains normal. They have normal to above average intelligence with a
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median age of death at 12 years. Most deaths are due to heart failure. Cultured 
progeria fibroblasts show poorer growth and generally earlier in vitro senescence 
than normal human cells (Brown et al, 1978). They also exhibit decreased ability to 
repair single-strand breaks following y-irradiation (Epstein et al, 1974).
Werner’s Syndrome, considered by some gerontologists to be a model of precocious 
ageing, is a rare autosomal-recessive mutation with some striking differences to 
Hutchinson-Gilford Syndrome. Affected individuals are usually normal during 
childhood but stop growth during their teens. Greying and whitening of the hair 
occurs at an early age, the skin appears old with a scaly appearance. The patients 
develop early cataracts, tumors, bone demineralisation, diabetes and atherosclerosis. 
They show peripheral muscular atrophy, poor wound healing and poor gonad 
development. They usually die in their 40s from atherosclerosis-related conditions. 
A report by Goto et al (1992) indicated a genetic linkage in this syndrome to five 
markers on chromosome 8 .
Individuals with Down’s Syndrome develop certain characteristics similar to 
premature ageing. It was the first condition shown to be associated with a 
chromosomal abnormality; about 85 % have 47 chromosomes (three chromosome 
21), while in the other 15 %, the extra chromosome is borne on another chromosome 
(translocation), usually Group D. The disorder is quite common, affecting one in 
every 600-800 births, increasing to one in approximately 25 if the mother is over 40 
years old. The condition is commonly characterised by a variety of dermatological
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features, mental retardation, congenital defects and a distinctly shortened life span. It 
is not understood why the life span of these individuals is shortened. However, one 
study reported an increase in their blood plasma lipoperoxides in the presence of 
increased red cell activity of superoxide dismutase and glutathione peroxidase 
(Kedziora et al, 1986). Although these findings are somewhat confusing in that the 
increased enzyme values would be expected to be protective, it suggests a possible 
relationship to the free radical theory of ageing.
These syndromes have most of the features associated with accelerated ageing, 
suggesting that normal human ageing can be greatly affected by simple mutations in 
one or both of a pair of key genes. In recent years, association studies have identified 
a number of loci, alleles associated with enhanced longevities in certain populations. 
A good example is apolipoprotein E e2 (Apo E e2), which is prevalent among 
centenarians (Schachter et al, 1994). ApoE 82 is also associated with a decreased 
susceptibility to Alzheimer’s disease, in contrast to the e4 allele, which, when 
homozygous, is associated with the appearance of Alzheimer’s disease, on average, 
about a decade earlier than that in individuals who are homozygous for the more 
prevalent e3 allele (Strittmatter and Rose, 1995).
1.3.2 Damage accumulation ageing
Proteins, lipids and nucleic acids are all known to be susceptible to damage by free 
radicals/oxidants and other endogenous reactive agents. Oxidatively damaged 
proteins and lipids are subjected to both degradation and some repair reactions while 
DNA is usually not degraded but is subjected to numerous repair processes. There 
have been very few demonstrations or documentation of the general biological 
importance of protein changes to ageing at the cellular and organ level (Garfni, 1990; 
Beckman and Ames, 1998). On the other hand, damage can accumulate in DNA, 
particularly in non-replicating cells, and lead to declining production of mRNA with 
age.
1.3.2.1 The DNA damage theory of ageing
According to the DNA damage theory of ageing, first proposed by Alexander, 
mammalian ageing is due to the accumulation of DNA damage in somatic cells 
(Alexander, 1967). The idea that damage to DNA, rather than damage to other 
biomolecules or structures, is the underlying cause of ageing is based on the 
following general considerations. DNA encodes the genetic information of the cell 
and deterioration of its ability to be transcribed will lead to a decline in cellular 
function and lethality. By contrast, other macromolecules, such as RNA or proteins, 
can be replaced, in principle, by new synthesis if the DNA remains undamaged. In 
general, cells are thought to have a considerable DNA-dependent capacity for self­
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renewal involving replacement and repair of worn-out components. DNA is 
especially vulnerable to damage because it ordinarily occurs in only two copies per 
diploid cell (compared with the numerous copies of most other macromolecules), and 
each of the many deoxyribonucleotides is a potential target of damaging agents. The 
DNA damage theory was preceded by the related theory that ageing is due to somatic 
mutation (Failla, 1958). These two theories are similar in that both attribute ageing 
to errors in DNA. However, there are important differences between DNA damage 
and mutations. DNA damage cannot be inherited over successive cell generations, 
whereas mutations can be inherited. Furthermore, DNA damage, in contrast to 
mutations, can be repaired. Because of these fundamental differences at the 
molecular level, the DNA damage theory of ageing has a logic that is substantially 
different from that of the somatic mutation theory (reviewed by Gensler and 
Bernstein, 1981). The relationship between DNA damage and ageing is 
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Figure 1.1 Hypothetical pathways by which induced DNA damage may 
contribute to the aged phenotype (Viig et al, 1985).
1.3.2.2 Sources of oxidative DNA damage in vivo
DNA damage can be caused either by intrinsic intracellular processes such as 
oxidation, hydrolysis, and alkylation or by extrinsic chemicals and radiation. Agents 
that induce chemical change in DNA have been classified in Figure 1.2 into 
endogenous agents and exogenous agents. Among these possible causes of DNA 
damage, oxidative DNA damage caused by free radicals, produced from oxygen as a 
consequence of normal respiratory metabolism, appears to be a major cause of ageing 
in mammalians. The univalent pathway of oxygen reduction generates the 
superoxide radical (0 2 *"), hydrogen peroxide (H2O2), the hydroxyl radical (#0 H) and 
water (Section 1.3.3.1). It has been concluded that approximately 50 % of oxidative 
DNA damage is due to *OH (Imlay and Linn, 1988).
Endogenous agents Exogenous agents
Endogenous alkylating agents 









Figure 1.2 Sources of DNA damage.
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1.3.2.3 Types of Oxidative DNA damage
Oxygen radicals can interact with DNA at either the deoxyribose-phosphate 
backbone or at a base (Imlay and Linn, 1988). The reaction of an oxygen radical 
with a deoxyribose leads to fragmentation of the sugar, loss of the base to which it is 
bound, and strand breakage. Some of the reaction products resulting from the 
oxidation of DNA are thymine glycol (Section 1.3.3.2.1), methyl tartronyl urea, urea, 
5-hydroxymethyluracil, 4,6-diamino-5-formamidopyrimidine and 8-hydroxy-2’- 
deoxyguanosine (8 -OHdG). These products are removed from DNA by specific 
repair enzymes and excreted in urine. Indeed, their levels in human urine can be 
used to quantify the amount of oxidative damage. Ames and Gold (1991) estimated 
the total number of all types of oxidative damage to DNA per cell per day to be about 
10,000 in humans and about 100,000 in rats. The difference in oxidative DNA 
damage incidence rates between human and rats is consistent with the proposal that 
oxidative DNA damage increases in proportion to species-specific basal metabolic 
rates (Shigenaga et al, 1989). Treatment of DNA in vitro with H2O2 produces DNA 
damages of which over 90 % are altered bases; about 2-4 % are single-strand breaks; 
about 0 . 9  % are double-strand breaks and about 0 . 8  % are inter-strand cross-links 
(Massie et al, 1972). Methods of detecting oxidative DNA damage are discussed in 
Chapter 3.
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1.3.2.4 Cellular defence mechanisms against oxidative DNA damage
DNA damage accumulates in a cell if the rate of occurrence of DNA damage exceeds 
the rate of DNA repair. There appear to be three levels of defence against the DNA 
damage caused by active oxygen species. These levels are:
a) prevention by removal of active oxygen species before they can interact with 
DNA;
b) repair of DNA damage; and
c) compensation for cell loss due to lethal DNA damage through cellular 
redundancy and/or replication.
Cellular enzymes include superoxide dismutase which converts Oo' into H2O2, and 
catalase and glutathione peroxidase which convert H2O2 into H2O. The removal of 
reactive oxygen species, however, is incomplete, allowing those that escape to 
damage cellular constituents. Repair of DNA damage provides another line of 
defence. Double-strand DNA genomes have a built-in informational redundancy 
because the coding sequences of the two strands are complementary. Consequently, 
it is possible to repair damage localised to one strand by excising the damaged 
sequence and replacing the lost information by copying from the complementary 
strand. This general process is known as excision repair (Figure 1.3). This process 
appears to be the principal mechanism for removing single-strand damage, which, if 
unrepaired, would contribute to ageing. The most well-understood pathways of
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excision repair in mammalians are those initiated by specific glycosylases which 
remove damaged bases from the deoxyribose phosphate backbone of DNA. When 
the damaged base is removed from the DNA by a glycosylase, an 
apurinic/apyrimidine (AP) site is formed. For repair to be completed, the AP sites 
must be removed and replaced by an undamaged correct base, one that is 
complementary to the pairing partner in the undamaged strand of DNA. AP sites are 
removed by a process in which the DNA strand is first cleaved, either at the 3’ side 
or the 5’ side, by an AP endonuclease. Class I AP endonucleases cleave at the 3’ 
side and Class II AP endonucleases cleave at the 5’ side. After an initial incision by 
an AP endonuclease, exonucleases can degrade the DNA in 5’ to 3’ or 3’ to 5’ 
direction at the free ends created by the incision. Finally, a DNA polymerase inserts 
correctly paired bases in 5’ to 3’ direction. The final reaction in the pathway 
involves the formation of the last phosphodiester bond in the repaired strand by 
polynucleotide ligase (Demple and Harrison, 1994; Bohr et al, 1995; Loft and 
Poulsen, 1996). Another mechanism for removing single-strand damage is referred 
to as direct reversal. This mechanism depends on enzymes that can recognise some 
specific types of damage and then essentially reverse the damage-forming reaction to 
restore the intact sequence. This type of repair occurs with a narrow spectrum of 
damage that may have limited relevance to ageing. Double-strand damage is 
potentially important in ageing because it is difficult to repair. Excision repair is 
presumably ineffective in removing double-strand damage because this type of repair 
depends on the DNA strand opposite the damaged one being intact. Repair of 
double-strand damage can occur if the undamaged DNA duplex donates a single­
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stranded section to the damaged DNA molecule to allow replacement of its lost 
information. This process is referred to as recombinational repair which may be 
significant in resisting ageing (Bernstein and Gensler, 1993).
Another way to cope with unrepaired DNA damage is cellular redundancy (Gensler 
and Berstein, 1981; Berstein and Gensler, 1993). For example, in humans, more 
cells are formed in the brain than are necessary for normal function. In mammals, 
maximum potential life span was found to be proportional to relative brain size 
(Hofman, 1983). The correlation of longevity with relative brain size may reflect the 
advantage of a reserve supply of neurons to compensate for loss of neuron function 
due to DNA damage. Another way for a population of cells to cope with unrepaired 
DNA damage is to replace lethally damaged cells by replication of undamaged ones. 
Examples of rapidly replicating cell populations are haemopoietic cells of the bone 
marrow and intestinal epithelial cells. These cells have a very large capacity for self­
renewal and it appears that any cell loss due to DNA damage is compensated by the 
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DNA with apurinic/apyrimidinic (AP) site
Figure 1.3 Oxidative damage to DNA and its repair. The reaction of DNA with 
free radicals leads to the formation of damaged base. The original base can be 
restored by this process known as the excision repair (Weindruch et al, 1993).
1.3.2.5 DNA damage accumulation and ageing
Long-lived neurons, muscle cells, and other differentiated cells either do not divide 
or divide slowly, and accumulate DNA damage if the rate of DNA repair is exceeded 
by the rate of DNA damage. The brain is comprised largely of non-dividing neurons. 
Here, endogenous DNA damage accumulates with age, mRNA synthesis and protein 
synthesis decline, cell loss occurs, tissue function is reduced, and the functional 
impairments directly related to the central processes of ageing occur. Thus, for the
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brain, there appears to be a direct relationship between DNA damage accumulation 
and important features of ageing (Holmes et al, 1992).
Lymphocytes exist in a non-cycling state for years in humans. Consequently, 
lymphocytes are susceptible to the kinds of DNA damage accumulation found in 
other non-dividing cells. King et al (1997) and Piperakis et al (1998) presented 
evidence for accumulation of age-dependent DNA single-strand breaks and/or alkali 
labile sites in human peripheral lymphocytes. A number of different investigators 
have reported an increase in spontaneous chromosomal aberrations in lymphocytes 
with age. For instance, Fenech and Morley (1985) observed that as human beings 
age from newborn to 82 years, spontaneous chromosome aberrations in cultured 
peripheral blood lymphocytes increased by about four-fold. Other evidence suggests 
a relationship between DNA damage and functional decline in muscle and in the 
liver. This evidence is extensively reviewed by Bernstein and Gensler (1993).
1.3.3. The free radical theory of ageing
As discussed previously, the accumulation of free radical-induced oxidative damage 
by macromolecules may be directly related to ageing (Harman, 1992a, 1992b; Yu 
and Yang, 1996). The possibility that free radicals play a significant role in ageing 
processes and in the pathogenesis of late-life diseases continues to intrigue many 
gerontologists and other investigators.
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At present, the most popular and widely tested ageing theory is the free radical theory 
of ageing (Harman, -1956, 1981, 1992a, 1992b; Beckman and Ames, 1998). 
Individuals are constantly exposed both to exogenous and endogenous sources of 
oxidants. Various antioxidant defences have evolved to combat the constant oxidant 
load, but free radical damage inevitably accumulates with age. This has led to the 
free radical theory of ageing, first proposed by Denham Harman (1956). The theory 
postulates that ageing is caused by free radical reactions i.e. these non-specific, 
essentially irreversible reactions may be involved in the production of the ageing 
changes associated with the environment, disease and an intrinsic ageing process. It 
predicts that the life span of an organism can be increased by slowing the rate of 
initiation of random free radical reactions and/or decreasing the chain of these 
reactions. The former should be achieved by decreasing ingestion of easily oxidised 
dietary components, calorie intake, and temperature; the latter should be achieved by 
increasing the concentrations of free radical inhibitors in the organism or by 
increasing the resistance of its constituents to free radical attack.
Oxidant attack and antioxidant defence are closely matched, but defence is less than 
perfect, and free radical damage accumulates with age. It was proposed that this 
imbalance in favour of oxidants is a cause of ageing itself (Harman 1956, 1981). 
Harman stated that “the ageing process may be simply the sum of random changes 
produced by free radical reactions” (Harman, 1992a, 1992b). Support of Harman’s 
theory includes:
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a) studies of the origin and evolution of life (Harman, 1980a);
b) studies of the effect of ionizing radiation on living organisms (Upton, 1957);
c) dietary manipulations of endogenous free radical reactions (Eriksson et al, 1994);
d) the plausible explanations it provides for ageing phenomena (Harman, 1980b); 
and
e) the growing number of studies that implicate free radical reactions in the 
pathogenesis of specific diseases such as cancer, arteriosclerosis and other 
common degenerative diseases e.g. Alzheimer’s and Parkinson’s diseases 
(Harman, 1980c; Evans et al, 1995; Halliwell and Gutteridge, 1989; Youdim et al,
1994).
Because of the popularity of free radical research, a large number of reviews have 
addressed various aspects of the interplay between oxidants and ageing. The 
phenomenon and study of ageing are incredibly diverse, encompassing organisms 
from rotifers to mammals and techniques from physiology to genetics. The free 
radical theory has been extensively reviewed by Beckman and Ames (1998).
1.3.3.1 Sources of oxidants
Biological oxidants i.e. free radicals and reactive oxygen species can derive from 
external sources, for example, in the skin from exposure to ultraviolet light; 
chemotherapy and carcinogens. They can also be produced in the form of radicals. 
A radical is defined as any atom or molecule with one or more unpaired electrons in
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an outer valence shell (e.g. superoxide, hydroxyl and oxygen radicals). Two major 
sources of endogenous radicals are mitochondria and phagocytic cells. Mitochondria 
have long been recognised to generate superoxide radicals (0 2 *") during their 
oxidative metabolism (Cadenas et al, 1977). The superoxide radical can be 
damaging in itself, but it also has the potential to produce the destructive hydroxyl 
radical (*0H). Superoxide radicals can dismutate to produce hydrogen peroxide 
(H2O2) (Figure 1.4). Hydrogen peroxide is subject to Fenton chemistry (Gutteridge,
1995) in the presence of transition metal catalysts, for example, iron, to produce *OH 
(Figure 1.5). Phagocytic cells also produce O2’’ and H2O2 during their oxidative 
burst (Ames et al, 1993).
Uncatalysed dismutation reactions
0 2 ,' + H 0 2‘ + H + ^  H 2 O 2 + O 2
H 0 2' + H 0 2* + H + ^  H 2 O 2 + O 2
0 2* + 0 2 + 2H + ^  H 2O 2 + O 2
Superoxide dismutase catalysed reaction
0 2’ + 0 2" + 2H + - ► H 2O 2 + O 2
Figure 1.4 The dismutation of superoxide O2 * (Packer, 1995).
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0 2' + 0 2" + 2H+---- ► H20 2 + O;
*■ 'OH + OH + Fe
► 'OH + OH+ O
Figure 1.5 Fenton chemistry and the generation of hydroxyl radical ’OH 
(Packer, 1995).
1.3.3.2 Targets of oxidants
Proteins, lipids and nucleic acids have all been studied for their sensitivity to 
oxidative modification by a wide variety of free radicals and reactive oxygen species. 
The superoxide radical is not particularly reactive with lipids, carbohydrates, or 
nucleic acids, but does exhibit limited reactivity with proteins containing transition- 
metal prosthetic groups, such as heme moieties (Stadtman, 1990). Such reactions 
result in damage to amino acids. Hydrogen peroxide is an oxidant for many 
biological molecules, especially those containing sulphydryl groups and iron-sulphur 
clusters. Hydroxyl radical is the most reactive of all the oxygen radicals and will 
readily oxidize proteins, lipids, carbohydrates, DNA and RNA (Halliwell and 
Gutteridge, 1989; Beckman and Ames, 1998).
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1.3.3.2.1 Free radicals and DNA
Oxygen radicals may attack DNA at either the sugar or the base, giving rise to a large 
number of products. Attack at a sugar ultimately leads to sugar fragmentation, base 
loss, and a strand break with a terminal fragmented sugar residue. Such single­
stranded DNA breaks accumulate during exposure of bacterial and mammalian cells 
to H2O2, O2*’, y-irradiation, or ozone (Imlay and Linn, 1988). Some of the major 
products from the initial reaction of the 'OH with thymine, adenine and deoxyribose 
are shown in Figure 1.6. Once formed, these products can undergo a wide variety of 
reactions. In aerobic systems, one of the more significant reactions is with molecular 
oxygen to form organic hydroperoxides, as illustrated for the “6-yl radical” of 
thymine in Figure 1.7. Chemical or enzymatic reduction of the hydroperoxide leads 
to the production of an alcohol, for example, thymine glycol in Figure 1.7. Hydrogen 
peroxide can also produce ring-saturated thymines, hydroxymethyluracil, thymine 
fragments, and an adenine ring-opened product, presumably through oxygen radical 


























Figure 1.6 Examples of some initial products formed by reaction of hydroxyl 



















Figure 1.7 Possible mechanism of the formation of thymine glycol from 6-yl 
radical in aerobic cells (Saul et al, 1987).
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1.3.3.2.2 Free radicals and lipids
The earliest research on the destruction of biological molecules by oxidants involved 
lipids (Halliwell and Gutteridge, 1990). Food chemists have long understood that the 
rancidity of fats results from peroxidative chain reactions in lipids (autoxidation). A 
peroxyl radical (produced when conjugated dienes in lipids react with oxygen) 
abstracts a hydrogen atom from the double bond of neighbouring unsaturated lipid, 
forming a hydroperoxide and an alkyl radical. The latter combines with oxygen to 
regenerate a peroxyl radical capable of initiating another round of oxidation (Yu,
1993) (Figure 1.8). Ultimately, intramolecular reactions and decomposition yield 
cyclic endoperoxides and unsaturated aldehydes (e.g. malondialdehyde). Such 
unsaturated aldehydes are reactive and may act as mutagens or enzyme inactivators. 
Moreover, the primary effect of lipid peroxidation is decreased membrane fluidity, 
which alters membrane properties and can significantly disrupt membrane-bound 
proteins. A number of techniques are available for measuring the rate of 
peroxidation of membrane lipids or fatty acids and they are discussed in Chapter 4.
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Peroxyl radical abstracts H 
from another fatty acid causing 










Figure 1.8 Idealised representation of the initiation and propagation reactions 
of lipid peroxidation (Yu, 1993). The peroxidation of a fatty acid with three double 
bonds is shown.
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1.3.3.2.3 Free radicals and proteins
The oxidation of proteins is less well characterised, but several classes of damage 
have been documented. These include oxidation of sulphydryl groups, reduction of 
disulphides, oxidative adduction of amino acid residues close to metal-binding sites 
via metal-catalysed oxidation, reactions with aldehydes, protein-protein cross- 
linking, and peptide fragmentation (reviewed by Halliwell and Gutteridge, 1989). A 
particularly intriguing development has been the realisation that a number of 
enzymes possessing active-site iron-sulphur clusters are acutely sensitive to 
inactivation by O2 " (Flint et al, 1993). Moreover, differences between proteins in 
their sensitivities to oxidative attack have been reported (Berlett et al, 1996). 
Differential sensitivities raise the possibility that the loss of homeostasis, a hallmark 
of ageing, could result from the selective oxidation of proteins.
1.3.3.3 Antioxidant defence
Because of the potential damage that can be inflicted by oxidants, antioxidant 
defence has developed as summarised in Figure 1.9 (Culter et al, 1995). Protection 
against oxidant damage occurs at different levels. To survive reactive oxygen 
species, cellular antioxidant defence mechanisms have evolved to prevent or repair 
any damage caused by oxidative stress. These include:
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a) antioxidant enzymes, e.g. superoxide dism utase, glutathione peroxidase, catalase 
and glutathione reductase;
b) antioxidant compounds, e.g. glutathione, ferritin, ceruloplasmin, carotenoids, 
vitamin C, vitamin E, uric acid and bilirubin;
c) induced defence system, e.g. induction of heme oxygenase-1 expression in 
response to oxidative stress; and
d) dam age repair enzymes e.g. phospholipase Aj.
Dietary antioxidants Endogenous antioxidants
(e.g. vitam ins C & E, (e.g. glutathione, superoxide




Repair/Dam age  





Induced defence  
system  
(H em e oxygenase -1)
Cellular and extracellular  
targets




Free radicals and reactive oxygen species
Figure 1.9 Antioxidant defence (Culter et al, 1995).
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Oxidants can be removed by antioxidant enzymes (Halliwell and Gutteridge, 1989; 
Mitsuyoshi, 1993). Superoxide dismutase eliminates 02*" by catalysing its 
dismutation to H2O2 (Figure 1.4), which is then converted to water and oxygen by 
catalase or glutathione peroxidase (Figure 1.10). Glutathione peroxidase utilises the 
reducing power of glutathione (GSH), a tripeptide with a free sulphydryl, to detoxify 
H2O2 . In the process of reducing H2O2 , GSH is oxidised to glutathione disulpniae 
(GSSG). Glutathione reductase then utilises NADPH to re-reduce one molecule of 
GSSG to two molecules of GSH, thus permitting the continuous action of glutathione 
peroxidase (Figure 1.10). The role of glutathione (GSH and GSSG) as an antioxidant 
and its measurement are discussed in Chapter 5.
Catalase:
H2O2 + H2O2 * H 20 + H2O + O2 
G lutathione Peroxidase:
H2O2 + GSH + GSH *  GSSG + H2O + H2O 
G lutathione Reductase:
GSSG + NADPH + H+ *  2GSH + NADP+
GSH - reduced glutathione 
GSSG - oxidised glutathione
Figure 1.10 Mechanisms of antioxidant enzymes (Halliwell and Gutteridge, 
1989; Mitsuyoshi, 1993).
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Two non-enzymatic proteins, ferritin and ceruloplasmin, also appear to play 
important roles in the storage of transition metals and antioxidant defence in vivo 
(Balia et al, 1992). Ferritin binds iron in mammalian cells and ceruloplasmin binds 
copper in plasma, thereby preventing the formation of *OH through metal-catalysed 
oxidation. Other important biological antioxidant compounds include carotenoids, 
vitamin C, and vitamin E, which are all present in a well-balanced healthy diet. 
Carotenoids are singlet oxygen scavengers. Vitamin C scavenges O2’’ and other free 
radicals; and vitamin E is the major lipid-peroxidation chain-breaking antioxidant in 
lipid domains, such as membranes and lipoproteins. Many workers have studied the 
effect of dietary restriction or supplementation with dietary antioxidants on life span. 
Results have been mixed but encouraging (reviewed by Beckman and Ames, 1998). 
Other antioxidant compounds that may play a role in protecting against free radicals 
include uric acid (Ames et al, 1981) and bilirubin in plasma (Stocker et al, 1987). A 
number of techniques have been developed to measure the total antioxidant capacity 
of body fluids, allowing scientists to investigate the relationship between diet, 
oxidative stress, ageing and human disease. These techniques are discussed in 
Chapter 6. Some proteins can also be induced under oxidative stress and this 
provides an effective defence against reactive oxygen species. One such example is 
the enzyme heme oxygenase which plays a role in heme degradation. Its role in 
antioxidant defence will be discussed in Chapter 7.
Unlike defence against oxidants, which has been extensively characterised, the 
machinery for repairing oxidative damage is relatively unexplored. Nevertheless, it
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is clear that cells can repair oxidised macromolecules. For example, phospholipase 
A2 cleaves lipid peroxides from phospholipids (Pacifici and Davies, 1991); and 
glycosylases specifically recognise and excise oxidised bases from double-stranded 
DNA (Bohr and Anson, 1995).
1.3.3.3.1 Induced defence system -  heme oxygenase-1 gene induction
Ageing is associated with alterations in the level of oxidative stress and changes in 
gene expression (Thakur et al, 1993). Investigations in the adult housefly have 
indicated that the level of oxidative stress increases during ageing (Sohal and Allen, 
1986). The underlying cause for age-related increases in the level of oxidative stress 
appears to be both an increase in the rate of 0 {  and H2O2 production and a decline 
in the level of antioxidant defence such as catalase activity and GSH concentration. 
It was reported that the ability of organisms to respond to oxidative stress by 
increasing their rate of GSH synthesis decreased significantly with age (Harman and 
Henry, 1987). This age-associated increase in oxidative stress leads to changes in 
gene expression. In the course of expression of genes, the first step is the transfer of 
genetic information encoded by DNA in the form of a highly heterogeneous nuclear 
RNA which undergoes processing, splicing or editing to produce a functional mature 
mRNA. This message travels from the nucleus to the cytoplasm where it interacts 
with ribosomes, amino acetyl tRNAs and other components of the translational 
machinery and ultimately synthesizes a specific protein.
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An interesting group of genes that exhibit age- and oxidative stress-related 
expression is the heat shock genes (hsps). These genes and their encoded proteins 
(HSPs) are induced in response to stress generated by heat shock or chemical 
treatment (Fargnoli et al, 1990; Marini et al, 1996; Rao et al, 1999). The magnitude 
of this response varies with age. Studies by Fargnoli et al (1990) demonstrated an 
age-related reduction in cellular HSP70 expression after heat stress suggesting that 
the protein afforded by HSP70 induction may be impaired with ageing. Many other 
genes and proteins have also been shown to be inducible in response to stresses such 
as radiation and chemical treatment, for example, sodium arsenite and H2O2 in 
mammalian cells and tissues. These include the early response genes, c-fos, c-jun 
and jun-B, so called because they are all implicated in transcriptional regulation and 
may be responsible for the induction of many secondary DNA damage response 
genes; CL-100 which encodes a novel protein tyrosine phosphatase and heme 
oxygenase gene (Keyse, 1993).
The regulation of heme oxygenase (HO) is an example of a cellular mechanism that 
may protect organisms from oxidative stress. HO plays a defined and essential role 
in heme degradation by cleaving heme to form biliverdin and iron, with the 
concurrent release of carbon monoxide (CO). In mammals, biliverdin is then 
converted to bilirubin by the cytosolic enzyme biliverdin reductase; bilirubin is 
subsequently conjugated with sugars (mainly glucuronic acid) by UDP-glucuronyl 
transferase and then excreted into the bile (Abraham et al, 1996). Heme, a lipid- 
soluble and a transmissible form of iron, is a pro-oxidant in cells and its removal may
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be advantageous under conditions of oxidant stress. Moreover, bilirubin has been 
shown to possess antioxidant properties (Stocker et al, 1987; Gopinathan et al,
1994). It has also been suggested that HO may be induced in order to break down 
damaged respiratory cytochromes thus facilitating turnover of these proteins 
following oxidant damage. In addition to its role in regulating cellular levels of 
heme, HO is responsible for recycling iron from senescent red blood cells and extra- 
hematopoietic cells such as liver.
There are two forms of HO: HO-1 and HO-2 (Maines, 1988; Abraham et al, 1996). 
They are the products of two different genes and differ in their tissue expression and 
regulation. The primary structures of HO-1 and a HO-2 fragment of 91 amino acid 
residues show only 58 % homology, but share a region with 100 % secondary 
structural homology. This region is believed to be the catalytic and/or heme binding 
site of HO-1 and HO-2. HO-2 (34,000 Daltons) is constitutively expressed whereas 
HO-1 (32,000 Daltons) is inducible in mammalian cells by a variety of oxidising 
agents or circumstances. Examples include sodium arsenite, hydrogen peroxide, 
agents that deplete levels of the intracellular antioxidant glutathione (Keyse and 
Tyrrell, 1989; Oguro et al, 1996) and a variety of circumstances such as heat shock 
and intensive endurance exercise (Niess et al, 1999). Studies have shown that 
induction of HO-1 in skin fibroblasts is of value in protection against ultraviolet 
(UV) light-induced oxidative stress (Vile and Tyrrell, 1993). The authors concluded 
that the effect of such radiation, which also promotes an increase in ferritin levels, is 
mediated via HO-1 release of iron and CO from endogenous heme sources. They
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proposed that the increase in ferritin that follows UV light exposure and the 
associated HO-1 induction would decrease intracellular iron such that iron-catalysed 
free radical reactions would be restricted during periods of subsequent oxidative 
stress. Enhanced expression of the HO-1 gene is now being used in many 
laboratories as a marker of oxidative stress to eukaryotic cells. Various techniques 
have been developed to monitor its expression and these will be discussed in Chapter 
7. In contrast to HO-1, the role of HO-2 in cells is not well understood; however, it 
is apparent that HO-2 may have an important role in epidermal cells, germ cell 
development and signal transduction in neural tissues (Abraham et al, 1996).
1.4 Ageing and disease
Harman defined ageing as “the progressive accumulation of changes with time 
associated with or responsible for the ever increasing susceptibility to disease and 
death which accompany age” (Harman, 1981). The free radical theory of ageing 
(Section 1.3.3) provides a plausible explanation for the relationship between disease 
and ageing. A disease is a combination of changes, usually forming a readily 
recognised pattern, that have detrimental effects on function that in some cases may 
lead to death. The ubiquitous free radical reactions would be expected to produce 
progressive adverse changes that accumulate with age throughout the body. Those 
changes that are common within the human population produce the normal ageing 
pattern. Superimposed on this normal pattern of change are patterns that differ from 
individual to individual owing to genetic and environmental differences that
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modulate free radical damage. The superimposed patterns of change may become 
progressively more discernable with time and in some individuals may eventually be 
recognised as diseases. It has been suggested that lowering the free radical level by 
any means, for example, food restriction and antioxidant intake, should decrease the 
probability of developing any one of the “free radical” diseases. Minimising the 
contributing environmental factors in the case of a specific disease should further 
lower the free radical level (Harman 1991). Free radicals appear to play a major role 
in many conditions that increase dramatically with age, for example, heart disease, 
cancer and neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s 
disease (Gey, 1993; Busciglio et al, 1998).
1.4.1 Heart disease
The link between free radicals/oxidants and heart disease, a major killer in 
industrialised nations, is well established. For example, oxidation of low density 
lipoprotein (LDL) appears to play a key role in the development of atherosclerosis, 
prompting the formation and deposition of foam cells and eventual formation of 
atherosclerotic plaques (Gey, 1993). Although consequences of atherosclerosis, 
mainly coronary heart disease, are the leading cause of death in the United States, 
they generally do not appear until the sixth and seventh decade of life. 
Artherosclerotic lesions can be initiated and enhanced by substances capable of 
irritating the arterial wall. A possible constant source of such compounds is the 
reaction of molecular oxygen with the polyunsaturated compounds present in serum
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and arterial wall lipids. The oxidation products, including peroxides and compounds 
of higher molecular weight formed through oxidative polymerisation, as well as 
substances arising from the reaction of intermediate lipid-free radicals with proteins 
and other substances, may be produced in amounts sufficient enough to contribute 
significantly, directly or indirectly, to atherogenesis. In addition, oxy-radicals arising 
from leucocytes may also serve as an important source of vessel wall irritants. 
Evidences supporting the role of free radicals in atherosclerosis are reviewed in detail 
by Harman (1992a).
1.4.2 Cancer
A link has also been proposed between free radicals and cancer (Loft and Poulsen,
1996). The theoretical basis includes both the increased rate of mitosis caused by 
oxidants as well as the damage that free radicals can cause to DNA (Ames et al, 
1993, 1995). Increased cancer rates are associated with some chronic inflammatory 
conditions, with their resulting increased load of oxidants produced by leucocytes, 
and increased mitotic rates (Yu et al, 1991). Ionising radiation, which causes free 
radical production, is also a carcinogen (Pitot, 1982). Human epidemiological 
evidence indicates that increased consumption of fruits and vegetables, which are 
rich in antioxidants, leads to up to a doubling of protection against many common 
types of cancer (Block et al, 1992; Gey, 1993; Meydani, 1995). The protective effect 
of antioxidants is also true for heart disease. The evidence for radical involvement in
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some types of chemically induced carcinogenesis is reviewed by Harman (1992a, 
1992b).
1.4.3 Neurodegenerative diseases
Free radicals have been widely implicated in the pathogenesis of a number of 
pathological processes in the human brain (Evans, 1993). Central nervous system 
tissue contains high concentrations of mitochondria and undergoes a large, constant 
flux of oxygen. Mitochondria inevitably produce free radicals during the process of 
electron transport (Packer, 1995). Cerebrospinal fluid and possibly some brain areas 
contain non-protein-bound iron ions, which catalyse *OH generation through Fenton 
chemistry (Section 1.3.3.1). Mitochondrial DNA (mtDNA), which codes for many 
of the essential proteins in mitochondria, would be one of the first targets reached by 
*OH and it has been shown that mtDNA undergoes such peroxidative damage 
(Richter et al, 1988). Such damage may create a vicious cycle. Damaged mtDNA 
codes for altered proteins, some of which are involved in electron transport. Hence 
the possibility of oxygen radical formation increases, leading to more oxidative 
damage to mtDNA, more damaged proteins, etc. However the damage does not stop 
at the mitochondria, but affects the whole cell, both in terms of oxidative damage 
itself, and in terms of lower ATP production due to a reduced population of viable 




Parkinson’s disease (PD) is characterised by the selective and progressive destruction 
of the nigrostriatal dopaminergic neurons, resulting in a deficiency of the 
neurotransmitter, dopamine. Clinical characteristics of PD sufferers include cardinal 
signs of bradykinesia, resting tremor and cogwheel-type rigidity. Evidence for the 
role of free radicals/oxidants in mediating this neuronal loss is mounting (Packer,
1995). Oxidative metabolism of dopamine is associated with the generation of H2O2 
and the formation of the neurotoxin 6-hydroxydopamine. The initial discovery of 
increased nigral iron in Parkinsonian brains and its putative pathogenic role in 
causing lipid peroxidative tissue damage by the formation of 'OH, provided initial 
clues to the possible pathogenic role of free radicals/oxidants (Dexter et al, 1989). 
The findings of decreased concentrations of the antioxidant GSH in the substantia 
nigra compared with other brain areas and the reduction of nigral GSH levels in 
Parkinson’s disease, added further impetus to the idea of free-radical/oxidant- 
mediated injury (Spina and Cohen, 1989; Busciglio et al, 1998). In addition, the 
finding that the CuZnSOD gene is preferentially expressed in the substantia nigra 
suggests that the region is especially prone to oxidative stress (Ceballos et al, 1990). 
Moreover, l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP), an environmental 
toxin, can be oxidised by monoamime oxidases (MAO) and has been shown to 
inhibit complex I of the mitochondrial respiratory chain, causing destruction of the 
substantia nigra and Parkinsonian symptoms, sometimes after a single exposure 
(Packer, 1995).
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The concept that oxidative stress may contribute to PD has led to the rational 
proposal that intervention with antioxidants may be of therapeutic value in limiting 
the progression of the disease. Studies using vitamin E and the monoamine oxidase 
inhibitor deprenyl as the drug regime for PD patients demonstrated the efficacy of 
this regime in reducing the rate of the progression of the disease (Parkinson study 
group, 1989).
1.4.3.2 Alzheimer’s disease
In 1907, Alois Alzheimer, a German psychiatrist and neuropathologist, described the 
clinical and pathological findings of a 51-year-old woman with a 4.5-year course of 
progressive dementia, which subsequently became recognised as a disorder bearing 
his name. Autopsy of this patient revealed the presence of silver positive 
neurofibrillary tangles (NFT), severe cerebral cortical neuron loss, amyloid 
angiopathy, and alterations subsequently known as the senile plaques (SP). 
Alzheimer’s disease (AD) is a multi-neurotransmitter deficiency disease. The most 
consistent neurotransmitter alteration in the cerebral cortex in AD is the loss of the 
cholinergic markers, choline acetyltransferase and acetylchlolinesterase (Finch and 
Cohen, 1997; Berger, 1999). In addition, there are deficits in serotonin, 
noradrenaline, etc. AD results in a gradual decline in memory and intellectual 
function, and eventually deterioration in the ability to perform activities of daily 
living (Busciglio et al, 1998). The Alzheimer’s Disease Society estimates that
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dementia affects over 700,000 people in the United Kingdom in 1998 and 55 % of 
this group are affected by AD. By the year 2000, there will be roughly 18 million 
people with dementia in the world. Of these, it is thought that about 12 million 
people will be AD sufferers. The well-established prevalence rates for dementia in 
the United Kingdom are shown in Table 1.3.
Age Prevalence
40-65 1 in 1,000
65-70 1 in 50
70-80 1 in 20
80+ 1 in 5
Table 1.3 Prevalence rates for dementia in the United Kingdom in 1998 (The 
Alzheimer’s Disease Society),
While numerous hypotheses have been presented, the aetiology of Alzheimer’s 
disease remains unknown. Epidemiological studies into the risk factors associated 
with the development of the disease have confirmed that old age, a family history of 
AD and the presence of Down’s Syndrome are the most important risk factors 
(Henderson, 1988). It also appears that both genetic and environmental influences 
play an important role in the development of AD. Furthermore, there is strong 
evidence that free radicals play an important role in the pathogenesis of AD.
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1.4.3.2.1 Alzheimer’s disease and genetics
The most exciting recent findings in AD are in the area of molecular genetics. 
Mutations in the amyloid precursor protein (APP) gene on chromosome 21 have been 
described in a modest number of patients with familial early-onset AD (St. George- 
Hyslop, 1993). Amyloid beta peptide (AB), derived from the APP, is the major 
protein in SP and amyloid angiopathy. It has also been shown that apolipoprotein E 
£4 (Apo E £4) genotype is an important risk factor in late-onset familial and sporadic 
AD. Risk of AD increases and the age of onset decreases with the number of Apo E 
£4 alleles. Up to 90 % of individuals homozygous for Apo E £4 have a chance of 
developing AD by age 80. It has also been associated with early-onset AD and may 
influence the age of onset in some families with APP mutations (Roses, 1997; 
Ahmed et al, 1999). Apo E £2 genotype appears to be somewhat protective for AD 
(Schachter et al, 1994; Strittmatter and Rose, 1995). Recently, multiple mutations 
have been found on gene S I82 (Presenilin 1) on chromosome 14 in early-onset 
familial AD (Steiner et al, 1999). Another gene, E5-1 (Presenilin 2) on chromosome 
1, was found to contain mutations in patients with early-onset familial AD 
(Markesbery, 1997).
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1.4.3.2.2 Alzheimer’s disease and the environment
While there is strong evidence for genetic influence in at least some cases of AD, the 
evidence for specific environmental factors is more controversial. The possible role 
of aluminium has been studied by a number of researchers (Markesbery, 1997; 
Rogers and Simon, 1999). Aluminium silicate has been found in the core of plaques 
and a number of epidemiological studies have suggested a weak association between 
exposure to aluminium in drinking water and an increased prevalence of AD 
(Tobiansky, 1993). At the present time, it seems that although aluminium may be 
neurotoxic in certain conditions, there is no conclusive evidence that aluminium is a 
significant risk factor in AD (Rogers and Simon, 1999). Other environmental factors 
suggested include infective agents such as the prion agent that is known to cause the 
rare form of dementia, Creutzfeld-Jacob disease; viral agents and other microbes, but 
there is little evidence to support this view (Tobiansky, 1993).
1.4.3.2.3 Alzheimer’s disease and free radicals
As with Parkinson’s disease, the pathogenic role of free radicals has also been 
proposed for Alzheimer’s disease (Evans, 1993; Markesbery, 1997). Several 
processes increase free radical formation in the brain, for example, brain trauma, 
ageing and neurotoxin attack and they are all risk factors for AD (Figure 1.11). Brain 
injury results in the release of free iron and the formation of free radicals. Increased 
level of iron in AD brain tissue has been observed (Busciglio et al, 1998). It was
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also reported that NFT observed in dem entia pugilistica, which are believed to result 
from repeated brain trauma, are identical to those present in AD. Also, large 
am ounts o f free radical form ed during reperfusion of ischaemic tissue are believed to 
be responsible for reperfusion injury. Am yloid angiopathy, a comm on feature in AD, 
can cause blood flow to fluctuate in very small areas of the brain. This fluctuation 
m ight result in repeated ischaem ia and reperfusion with increased free radical 
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Figure 1.11 Possible modes of involvement of free radicals in the pathogenesis of 
dementia of the Alzheimer type (Volicer and Crino, 1990).
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The contribution of genetic factors to abnormal free radical metabolism in AD is 
suggested by the similarity of pathological changes observed in AD and Down’s 
Syndrome (Volicer and Crino, 1990). The gene coding for superoxide dismutase 
(SOD) is located in chromosome 21 and is overexpressed in Down’s Syndrome 
because of chromosome 21 trisomy. Increased activity of the enzyme results in 
increased conversion of O2*’ to H2O2 , the substrate for the Fenton reaction (Section 
1.3.3.1)! This results in an increase in *OH formation. Involvement of chromosome 
21 in AD is not clear but it was reported that activity of SOD is increased in some 
brain regions of AD patients (Marcus et al, 1988).
Free radicals alone may also induce cell damage by damaging lipids or proteins in the 
brain while reactions between free radicals and neurotransmitters may lead to 
formation of endogenous neurotoxins such as tryptamine-4,5,-dione (4,5-DKT). 
Evidence indicating an enhancement of oxidative stress in AD stems from studies 
showing increased levels of brain cell glutathione peroxidase activities, elevated 
susceptibility to membrane lipid peroxidation (Marcus et al, 1998), and reduced 
plasma levels of the antioxidant vitamins A and E and carotenoids (Zaman et al, 
1992). Co-localisation of lipofucin (“age pigment” which results from lipid 
peroxidation) with NFT and amyloid is further evidence of the intimate involvement 
of free radicals, as are the findings of an accumulation of oxidant-inactivated 
proteins, namely glutamine synthetase, in the brain of AD (Evans, 1993). Further 
evidence supporting this oxidative stress hypothesis for AD is discussed in details by 
Markesbery (1997) and Volicer and Crino (1990).
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Until recently, the treatment of AD has been primarily to replace deficient 
neurotransmitter. For example, Donepizil (Aricept, Pfizer) is a cholinesterate 
inhibitor whose major effect is to enhance brain acetylcholine concentrations. In 
recent years, clinical investigations in elderly humans using supplements of various 
mixtures of the antioxidant nutrients, vitamins E and C, selenium and zinc have 
provided encourageing results in slowing the progression of AD (Evans, 1993).
1.5 Aims and objectives
Different approaches have been used to test the free radical theory of ageing and one 
of the most popular approaches is oxidative phenomenology (defined by Beckman 
and Ames, 1998), in which age-related trends in oxidative damage and antioxidant 
defences were studied. Biomarkers of oxidative stress were identified and analytical 
methods were developed for their measurement. These analytical methods have been 
used to compare species, genetic mutants and populations with differing life span. 
The aim of this project was to investigate the effect of age and AD on oxidative- 
damage-related parameters and antioxidants in peripheral blood mononuclear cells 
(PBMCs) or blood plasma from three groups of volunteers: healthy individuals aged 
under 30, healthy individuals aged over 60 and patients diagnosed with AD of age 
over 60 (n = 25 in each group). Basal and fECb-induced DNA damage in PBMCs 
was compared in these three groups of volunteers using single cell gel 
electrophoresis (SCGE), also known as the comet assay and the effect of PECb on 
DNA damage was studied. Plasma malondialdehyde (MDA) level was assayed as an
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indicator of the extent of lipid peroxidation. The antioxidant defence system was 
investigated by studying the levels of GSH and GSSG and the total antioxidant 
activity in blood plasma. To understand the role of gene expression in ageing, 
attempts were also made to investigate the oxidative induction of HO-1 expression in 





2.1 Materials and reagents
2.1.1 General
Freshly double-distilled deionised water (dd^O ) was steam-sterilised and used to 
prepare all solutions (Milli-Q water purification system, Millipore, UK). Nuclease- 
free water (NF H2O) for PCR work was obtained from Promega, UK. Phosphate 
buffered saline (PBS) tablets were purchased from Sigma, UK. One tablet was 
dissolved in 200 ml and 400 ml of ddHoO to give solutions of 0.01 M and 0.005 M 
phosphate buffer salts, respectively (pH 7.4 at 25 °C). PBS (0.005 M) solution was 
only used in the total antioxidant activity assay. Hydrogen peroxide (30 % w/v) 
solution (Aristar, specific gravity =1.1) was purchased from BDH, UK. This stock 
solution was standardised daily using 39.4 ± 0.2 M '1 cm'1 as the molar extinction 
coefficient for H2O2 at 240 nm (Aebi, 1983). For the comet assay, a 882 pM H2O2 
stock solution was freshly prepared in RPMI 1640 medium. For the TAA assay and 
HO-1 assay, a 5 mM and a 100 pM H2O2 solution were freshly prepared in PBS, 
respectively.
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2.1.2 Preparation of peripheral blood mononuclear cells and plasma
Histopaque-1077 (Sigma, UK)




Ethylenediaminetetraacetic acid disodium salt (EDTA-Na2)
Sodium chloride (NaCl)
Sodium hydroxide (NaOH)
Triton X-100, tris(hydroxymethyl)aminomethane base (Trizma base)
The items listed above were all purchased from Sigma (UK).
Concentrated hydrochloric acid (HC1, AnalaR) (BDH, UK)
Ethidium bromide 10 mg/ml solution (Bio-Rad, UK)
Normal melting point agarose (Promega, UK)
SeaPlaque low melting point (LMP) agarose (FMC BioProducts, UK)
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Medium:
RPMI 1640 medium (1 x) without L-glutatmine and phenol red was purchased from 
Life Technologies (UK) as a sterile solution and stored at 4 °C.
Lysis solution:
NaCl, EDTA-Na2, Trizma base and NaOH were dissolved in 500 ml ddH20  to give a 
final concentration of 2.5 M, 100 mM, 10 mM and 300 mM, respectively and the pH 
was adjusted to 10.5 with NaOH. This solution was stable for up to one week when 
stored at room temperature. It was kept at 4 °C for one hour before use. Just before 
use, Triton X-100 and DMSO were added to the pre-cooled solution to give a final 
concentration of 1 % (v/v) and 10 % (v/v).
Electrophoresis buffer:
A 200 mM stock solution of EDTA-Na2 was prepared in ddH20 , filter sterilised and 
stored at room temperature. A 5 M NaOH stock solution was freshly prepared daily 
in ddH20 . Two litres of buffer (300 mM NaOH and 1 mM EDTA-Na2) was then 
freshly prepared for each run using ddH20  pre-cooled to 4 °C.
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Neutralisation buffer:
A 0.4 M Trizma base solution was prepared in ddHbO and the pH was adjusted to 7.5 
with concentrated HC1. The solution was filter sterilised and stored at room 
temperature.
Staining solution:
A 1 mg/ml stock solution of ethidium bromide was prepared in ddH2 0 . This was 
diluted 1 in 50 to give a working solution of 20 Jig/ml ethidium bromide which was 
stored at 4 °C in the dark.
2.1.4 Malondialdehyde measurement
Trichloroacetic acid (TCA) and thiobarbituric acid (TBA) were purchased from 
Sigma (UK). Hydrochloric acid (AnalaR HC1, specific gravity = 1.16) was 
purchased from BDH (UK). Stock TCA-TBA-HC1 reagent (15 % w/v TCA, 0.375 % 
w/v TBA, 0.25 N  HC1) was prepared with d d ^ O  and the solution was heated gently 












The items listed above were all purchased from Sigma (UK).
Sodium phosphate/EDTA buffer (0.1 M/5 mM, pH 8 ) and 0.1 N  NaOH were 
prepared in d d ^O . NEM (40 mM) and OPT (1 mg/ml) were prepared daily in 
ddH2 0  and methanol, respectively. TCA (10 % w/v) was prepared in ddH2 0  and 
stored at 4 °C until use. GSH (0.5-10 pM) and GSSG (0.25-10 pM) were prepared 
daily in the phosphate/EDTA buffer and 0.1 N  NaOH, respectively. Both solutions 
were kept on ice until use.
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2.1.6 Total antioxidant activity assay
Trolox:
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) was purchased 
from Sigma, UK. A 2.5 mM Trolox standard was prepared in PBS and stored at 
-20 °C for up to six months. Working standards (0.25, 0.50, 0.75, 1.00, 1.50 mM) 
were prepared daily.
Metmyoglobin:
Myoglobin from horse heart (minimum 90 % lyophilised, essentially salt free, 0.3 % 
iron content) and potassium ferricyanide (99 %) were purchased from Sigma, UK. 
Metmyoglobin (MetMb) was purified prior to use to ensure that the iron was in the 
ferric (Fe3+) form. This was achieved by adding a 400 |iM myoglobin solution 
(0.0752 g of myoglobin freshly prepared in 10 ml of PBS) to an equal volume of a 
578 pM potassium ferricyanide solution. After mixing, the solution was passed 
through a Sephadex G-25/PD-10 column (Pharmacia, UK) equilibrated with PBS. 
The first fraction was collected and its absorbance read at 490, 560, 580, 700 nm. 
The absorbance reading at 700 nm was subtracted from the readings at 490, 560,
580 nm to correct for background absorbance. Calculation of the relative proportions 
of the different forms of myoglobin was made by applying the Whitburn equations 
based on the extinction coefficients at 490, 560 and 580 nm (Whitburn et al, 1982):
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[MetMb] = 146 A490 -108 A560 + 2.1 A580 
[FerrylMb] = - 62 A490 + 242 A560 -123 A580 
[Mb02] = 2.8 A490 - 127 A560 +153 A580
where FerrylMb was ferrylmyoglobin and Mb0 2  was oxymyoglobin. MetMb 
prepared in this way was not suitable for use unless it was more than 94 % of the 
total haem species present. The MetMb prepared throughout this study was > 97 %. 
The purified MetMb was diluted to a concentration of 70 pM, divided into aliquots 
and stored at -20 °C for up to six months.
ABTS:
2,2’-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) - ABTS (98 % pure) was 
purchased from Sigma, UK. A 5 mM ABTS solution was prepared daily in PBS and 
protected from light.
Pure antioxidant substances:
L-ascorbic acid (AnalaR, 99.7 %) was purchased from BDF1, UK. Reduced 
glutathione (free acid, 98 %), uric acid (99 %) and lithium carbonate were purchased 
from Sigma, UK. Solutions (1.0 mM) of L-ascorbic acid and reduced glutathione
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were prepared in ddPLO and a 1.0 mM solution of uric acid was prepared in 0.5 g/1 
lithium carbonate solution that had no antioxidant activity.
2.1.7 Heme oxygenase-1 assay
Preparing plasmid DNA:
Plasmid pBsHO-1 (provided by Professor Rex Tyrrell, Department o f Pharmacy and 
Pharmacology, University o f Bath, UK)
Plasmid pBsHO-l/L (provided by Dr Abdu Ahmed, Research Institute o f the Care of 
the Elderly, St. Martin's Hospital, Bath, UK)
Luria Bertani (LB) Medium (all ingredients from Sigma, UK)
Luria Bertani (LB) Agar (all ingredients from Sigma, UK)
Antibiotics - Ampicillin sodium salt and Tetracycline hydrochloride (Sigma, UK) 
Wizard Plus SV Minipreps DNA Purification System (Promega, UK)
Hind DI (10 000 units/ml) and buffer (10 x) (Promega, UK)
EcoR I (HC) - 60 000 units/ml and (10 x) (Promega, UK)
In vitro transcription:
Riboprobe in vitro Transcription System using T3 RNA polymerase (Promega, UK)
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Preparing total RNAfrom human peripheral blood mononuclear cells:
RPMI 1640 Medium 
Foetal bovine serum 
L-Glutamine 200 mM solution (100 x)
Penicillin and Streptomycin (10 000 units and 10 000 |J<g/ml) solution
Supplemented RPMI 1640 Medium (RPMI 1640 Medium with 10 % foetal bovine 
serum, 300 mg/1 L-Glutamine, 100 units/ml penicillin and 100 Jig/ml streptomycin)
All items listed above were purchased from Life Technologies (UK).
RNeasy Mini Kit (Qiagen, UK)
PCR and RT-PCR:
PCR buffer with 15 mM MgCl2 (10 x) (Sigma, UK) 
dNTP mix (10 mM) (Life Technologies, UK)
Primer P] and P2 (5 jiM, sequences shown in Section 2.4.7) (Immunogen 
International, UK)
JumpStart Taq DNA Polymerase (2.5 units/jil) (Sigma, UK)
Titan One-tube RT-PCR System (Boehringer Mannheim, UK)
RNasin ribonuclease inhibitor (40 units/pl) (Promega, UK)
First strand buffer (5 x) (Life Technologies, UK)
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RNase-free DNase 1(10 units/jil) (Boehringer Mannheim, UK)
EDTA (Sigma, UK)
Oligonucleotides 50 pM pd(T)i2-is (Amersham, UK)
DTT (100 mM) (Life Technologies, UK)
Superscript II RNase H' Reverse Transcriptase (200 units/pl) (Life Technologies, 
UK)
Expand High Fidelity PCR System (Boehringer Mannheim, UK)
Primer Gj and G2 (5 jiM, sequences shown in Section 2.4.13) (Immunogen 
International, UK)
Total RNA from human skin fibroblast cell culture (FEK4) (provided by Professor 
Rex Tyrrell, Department o f Pharmacy and Pharmacology, University o f Bath, UK)
Preparing nucleic acid:
Chloroform (Sigma, UK)
Ethanol (70 and 100 %) (Sigma, UK)
Phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma, UK)
Sodium acetate buffer solution (3 M) (Sigma, UK)
Tris-EDTA buffer (100 x) (Sigma, UK)
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Gel electrophoresis:
Normal melting point agarose (Promega, UK)
Tris-borate (TBE) buffer (5 x)
DNA loading buffer
Ethidium bromide solution (10 mg/ml) (Bio-Rad, UK) 
pUC18 DNA Msp I digest (55 fxg/jj.1) (Sigma, UK)
ADNA/£c<?R I and Hind HI Marker (0.5 mg/ml) (Promega, UK)
DNA 100 bp ladder (1 fig/fil) (Life Technologies, UK)
Formaldehyde solution (37 %) (Sigma, UK)
MOPS (3-[N-morpholino]-2-hydroxypropanesulfonic acid) buffer (10 x) (all 
ingredients from Sigma, UK)
Gel running buffer (1 x) (all ingredients from Sigma, UK)
RNA loading buffer (5 x) (all ingredients from Sigma, UK)
RNA G319 marker (1 mg/ml) (Promega, UK)
2.2 Equipment
Disposable items:
Kartell UV grade quartz cuvettes (Fisher, UK)*
Micro Amp 0.2 ml capped reaction tubes (Perkin-Elmer, UK)
Microcentrifuge 0.5 ml and 1.5 ml tubes (Elkay, UK)
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Microcentrifuge 2 ml tubes (Sigma, UK)
Pasteur pipettes (Sigma, UK)
Petri dishes (Sterilin, UK)
Polystyrene cuvettes (Scientific Laboratory Supplies, UK)*
PrecisionGlide 21G x 1.5” needles (Becton-Dickinson, France)
Translucent polypropylene Corning 50 ml centrifuge tubes (Sigma, UK)
Universal 5 ml and 30 ml containers (Sterilin, UK)
Vacutainer blood collection tubes (10 ml) containing EDTA (Becton-Dickinson, 
France)
All items listed above were either obtained as sterile or sterilised after purchase 
except those denoted by *.
General:
Microcentrifuge (Beckman, UK)
MSE Mistral 3000i centrifuge (Fisons Scientific Equipment, UK)
PowerPac 300 Power Supply (Bio-Rad, UK)
Spectronic Genesys 2 (Life Science International Ltd., UK)
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Preparation of peripheral blood mononuclear cells and plasma:
Modified Fuchs Rosenthal 0.2 mm (1/16 mm2) D/C rhodium-coated haemocytometer 
with coverslips (Hawsley, UK)
Olympus BH2 light microscope (Olympus, UK)
Comet assay:
Borosilicate glass coverslips (Size: 22 x 22 mm; thickness: ’1 .S’) (BDH, UK)
Frosted glass microscope slides (Size: 76 x 26 mm; thickness: 1.0/1.2 mm; one 
frosted surface only) (Chance Propper Ltd., UK)
Gel electrophoresis tank from Maxi Easi-E Cast Gel system (Size: 28 x 10 x 37.5 
cm) (Hybaid, UK)
Nikon Optiphot 2 microscope fitted with epi-fluorescene illumination (FITC filter 
blocks, excitation filter at 450-490 nm, dichroic mirror at 510 nm and barrier filter at 
520 nm) (Nikon, UK)
Trays and racks for preparing, washing and staining the slides 
Workshop-made humidified airtight and lightproof container 
Workshop-made slide platform accommodating a maximum of 3 x 8  slides 
Zeiss Axiovert with LSM 510 laser scan (Carl Zeiss Ltd, UK)
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Glutathione measurement:
LS 50B Luminescence spectrometer and FL Win Lab software package (Perkin- 
Elmer, UK)
Total antioxidant activity assay:
Techne Dri-Block heater set (Techne, UK)
Heme oxygenase-1 assay:
Electrophoresis and gel assembly equipment (Bio-Rad, UK)
Gene Amp PCR System 2400 (Perkin-Elmer, UK)
Kodak Digital Science Electrophoresis Documentation and Analysis System 120 
(Anachem, UK)
Ultra-Micro quartz SUPRASIL cell (Hellma, UK)
2.3 Human subjects
All volunteers were enrolled from the Research Institute of the Care of the Elderly 
(RICE), St. Martin’s Hospital, Bath and the University of Bath, Bath. Thirty to forty- 
five millilitres of blood were collected using sterile 10 ml Vacutainers containing 
lithium heparin as an anticoagulant and sterile PrecisionGlide 21G x 1.5” needles.
61
This study was approved by the Bath Local Research Ethics Committee and written 
consent was obtained from each volunteer (Appendix I). Three groups of volunteers 
participated in this study: healthy individuals aged < 30, healthy individuals aged > 
60 and patients diagnosed with Alzheimer’s disease (AD) of age > 60. Twenty-five 
younger healthy volunteers (12 males and 13 females), 25 older healthy volunteers (7 
males and 18 females) and 25 Alzheimer’s patients (11 males and 14 females) were 
recruited. The choice of age 30 and 60 as the dividing points between young and 
old/AD group was arbitrary and was made to provide similar sample sizes in the 
three groups. Each subject was asked about his/her diet, health status, smoking 
habits, medications, intake of vitamins or antioxidants, minerals and other 
supplements; and regular exercise regimes in a self-administered questionnaire when 
blood was taken (Appendix II).
2.4 Methods
2.4.1 Preparation of peripheral blood mononuclear cells and plasma
Peripheral blood mononuclear cells (PBMCs) were isolated from blood samples 
within two hours of collection using Histopaque-1077 based on a method described 
by Boyum (1968). Fifteen millilitres of blood was carefully layered onto 15 ml 
Histopaque-1077 in a 50 ml translucent centrifuge tube, ensuring that the two layers 
did not mix. This was centrifuged for 30 min at 400 g after which the upper plasma 
layer was drawn off leaving the lymphocyte layer undisturbed at the opaque interface.
62
This plasma, which was essentially free of cells, was transferred to a 30 ml universal 
tube and stored at -70 °C for up to 6  months. The lymphocyte layer was transferred 
to a 50 ml translucent centrifuge tube. At least 3 volumes of PBS were added to the 
lymphocytes in the tube. This was mixed by gentle aspiration and centrifuged for 10 
min at 250 g. The supernatant was removed and the cell pellet was suspended in 5 
ml PBS. This was mixed by gentle aspiration and centrifuged for 10 min at 250 g. 
The supernatant was then removed. The pellet was washed again with PBS and the 
cell was suspended in PBS, ready for counting.
2.4.1.1 Cell counting and cell viability determination
The PBM Cs were counted using a Modified Fuchs Rosenthal 0.2 mm (1/16 mm2) 
D/C rhodium coated haemocytometer. The haemocytometer slide and coverslip were 
prepared by cleaning with 70 % ethanol. The edges of the coverslip were slightly 
wetted and pressed down over the slide grooves and semi-silvered counting area. The 
appearance of interference patterns indicated correct attachment, thereby determining 
the depth of the counting chamber. Ten microlitres of the cells were diluted with . 
90 pi of PBS and mixed thoroughly. One volume of the diluted cell suspension was 
mixed gently with 1 volume of 0.4 % trypan blue solution. A small amount of this 
mixture was transferred to the edges of the haemocytometer chamber where capillary 
action drew it under the coverslip. Any surplus fluid was blotted off, without 
drawing from under the coverslip. The haemocytometer was then transferred to the 
microscope stage for cell counting. Using x 40 objective and x 10 eyepiece, cells
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were counted in at least 4 x 4  small squares (1 mm2). One hundred was the 
minimum number of cells to be recorded. Cell numbers and cell viability were 
calculated as follows:
Cell count per millilitre
= average number of cells counted in each 4 x 4  subdivisions (n) 
x dilution factor of cells
x dilution factor of trypan blue
0 . 2  mm x 1 mm x 1 mm x 1 0 '3
Therefore,
Cell count per millilitre
= n x factors x 5 x 103 
% Cell viability
= total number of viable cells (unstained) x 1 0 0  % 
total number of cells (stained and unstained)
These cells were then centrifuged for 10 min at 250 g, suspended in clear RPMI 1640 
medium and incubated at 37 °C under 5 % CCb.
2.4.2 Comet assay
The method used in this study was based on that developed by Singh et al (1988) 
with some modifications. Three millilitres of 0.8 % normal agarose and 3 ml of
1.2 % LMP agarose were prepared in RPMI 1640 medium. The 0.8 % normal 
agarose was incubated at 45 °C and the 1.2 % LMP agarose was incubated at 37 °C.
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Frosted slides were pre-warmed to 50 °C on a metal baking tray. Eighty-five 
microlitres of 0 . 8  % normal agarose solution was added onto the frosted surface of 
the slide and a coverslip was lowered immediately and carefully onto the slide to 
avoid the formation of bubbles. When the agarose had been added to all the slides, 
the baking tray was placed over ice at 4 °C for 30 min to allow the agarose to set. 
PBM Cs were prepared from 30 ml of blood collected from volunteers (Section 
2.4.1). Eighty microlitres of cells (4 x 105 cells) from the 5 x 106 cells/ml stock were 
centrifuged for 10 min at 250 g and washed twice with RPMI 1640 medium. The 
cells were suspended at a density of 1 x 1 0 6 cells/ml in different concentrations of 
H2O2 prepared in RPMI 1640 medium (0, 5, 20 and 50 jiM) and incubated at 4 °C for 
30 min in the dark. All subsequent steps described below were performed in dim 
yellow light to prevent additional DNA damage.
After the treatment period, cells were centrifuged at 4 °C for 10 min at 250 g, washed 
twice with RPMI 1640 medium and suspended in 100 j l l I  of RPMI 1640 medium. 
One hundred microlitres of 1.2 % LMP agarose were added to the cell suspension 
and mixed at 37 °C. The coverslip was removed gently from each slide and 1 x 105 
cells i.e. 50 jllI of the cell suspension was loaded on top of the solidified normal 
agarose gel. A new coverslip was lowered onto the new LMP agarose layer as 
before. The same procedure was repeated for the duplicate slide. When the agarose 
had been added to all the slides, the tray was left on ice at 4 °C for another 15 min to 
set. To achieve uniformity of gel thickness which was essential to prevent the escape 
of DNA from cells near the surface during unwinding and electrophoresis, this
layering was carried out quickly as liquid agarose solidified rapidly on top of a cold 
agarose layer. The LMP agarose solidified after 15 min and the coverslips were 
removed. DMSO and Triton X-100 were added to the pre-cooled lysis solution 
(4 °C) and the slides were then placed into this solution at 4 °C for 1 h in the dark.
All subsequent steps described below were carried out at 4 °C to minimise DNA 
repair. Slides were removed gently from lysis solution after one hour, drained and 
placed on a horizontal slide platform side by side, avoiding spaces. Blank slides 
were placed in any empty spaces to ensure consistent geometry. The platform was 
placed in a gel electrophoresis tank and electrophoresis buffer was added gently to 
the tank to cover the slides completely but only just. The slides were left in buffer 
for 40 min to allow unwinding of DNA before electrophoresis. Electrophoresis was 
carried out at 26 V for 20 min at 300 mA in the same buffer. The current was 
adjusted to approximately 300 mA by raising or lowering the buffer level in the tank. 
After electrophoresis, slides were washed gently to remove alkali and detergents that 
could interfere with staining. The slides were placed on a rack, flooded slowly with 
the neutralising buffer and allowed to drain for 10 min. The same procedure was 
repeated twice. Slides were stained with 60 JJ.1 of 20 fig/ml ethidium bromide and a 
new coverslip was placed on each slide. Slides were placed in a humidified airtight 
and lightproof container at 4 °C until analysis to prevent drying of the gels, and 
analysed within 1-3 days.
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2.4.2.1 Comet analysis
To evaluate the extent of DNA damage, 50 randomly selected cells per slide were 
visually analysed at 400 x magnification using a Nikon Optiphot 2 microscope fitted 
with epi-fluorescence illumination and pictures were taken. They were visually 
graded into four categories, depending on the level of DNA damage (Figure 3.1). 
Categories were similar to those described by Anderson et al (1994). A rank number 
ranging from 0-3 was assigned to the categories: undamaged (0), slightly damaged 
(1), damaged (2) and highly damaged (3). The sum of rank number i.e. the total 
comet score for 50 cells was recorded. A score of 0 represented totally undamaged 
cells and a score of 150 represented the maximum level of damage. The number of 
cells scored in each category was also recorded. Analysis was performed by one 
investigator, thus minimising variability due to subjective scoring. Cells were 
selected by moving from top to bottom and left to right along the slide to avoid 
analysis of the same comet twice. Cells were selected at random with no attempt to 
select particular comets other than to avoid obvious debris and any comets that were 
too close together for accurate image resolution. Areas close to the edge of the 




All subjects for the following studies investigating the experimental variability of the 
comet assay were recruited from healthy volunteers of age > 19:
a) intra-assay variability (variation between each triplicate measurement);
b) inter-assay variability (variation between assays carried out at two different times
on the same day);
c) intra-subject variability (variation between samples collected from the same 
subject over a period of about a month);
d) inter-subject variability (variation between individuals in each group);
e) intra-slide variability (variation between the total comet score of 50 cells
obtained between six different areas on the agarose on each slide i.e. the effect of 
the distribution of cells on the agarose on total comet score).
2.4.3 Malondialdehyde measurement
Lipid peroxidation was measured by determining the malondialdehyde (MDA) 
production, using TBA (Buege and Aust, 1978). Plasma (1 ml) was mixed 
thoroughly with 2 ml of TCA-TBA-HC1 reagent and the mixture was heated in a 
boiling water bath (100 °C) for 15 min. After cooling, the flocculent precipitate was 
removed by centrifugation for 10 min at 1000 g. The supernatant was transferred to 
a cuvette. The absorbance of the sample was determined at 535 nm against a blank
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that contained all the reagents but the plasma. The MDA concentration of the sample 
was calculated using an extinction coefficient of 1.56 x 105 M 'lcm ' 1 as shown below 
(Buege and Aust, 1978):
MDA concentration (M) = Absorbance at 535 nm
1.56 x 105 M 'lcm" 1 x 1 cm
Intra-day variability (variation between assays carried out at two different times on 
the same day) and inter-day variability (variation between assays carried out on two 
separate days) were studied. Intra-assay, intra-subject and inter-subject variability 
were also estimated.
2.4.4 Glutathione measurement
GSH and GSSG levels were measured using a fluorometric method developed by Hu 
(1994). All measurements were carried out in triplicate. The LS 50B Luminescence 
spectrometer was set as followed: slit width at 5 nm, emission filter at ‘open’ 
position, integration time at 10 sec and the temperature at 17-24 °C.
2.4.4.1 GSH standard curve
A series of GSH solutions of known concentrations (0-10 jiM) were prepared in the 
phosphate/EDTA buffer. GSH solution (100 jil) was mixed with 1.8 ml of the 
phosphate/EDTA buffer and 100 jil of 1 mg/ml OPT to give a total volume of 2 ml.
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The mixture was incubated at room temperature for 15 min and was later transferred 
to a UV grade cuvette. Fluorescence emission at 420 nm was determined after 
excitation at 350 nm.
2.4.4.2 GSSG standard curve
A series of GSSG solutions of known concentration (0-10 jliM ) was prepared in 
0.1 N  NaOH. GSSG solution (100 pi) was mixed with 1.8 ml of 0.1 N  NaOH and 
100 |nl of 1 mg/ml OPT to give a total volume of 2 ml. The mixture was incubated 
and analysed as described in Section 2.4.4.1.
2.4.4.3 Experimental variability
The protocols used for this validation study are described in Section 2.4.4.4 and 
2.4.4.5. Intra- and inter-day, intra-assay, intra-subject and inter-subject variability 
were estimated.
2.4.4.4 GSH measurement
Plasma (500 pi) was added to 500 pi of cold 10 % TCA and allowed to stand on ice 
for 10 min and then centrifuged at 4 °C for 15 min at 3000 g. The supernatant
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(200 j l i I )  was mixed with 1.7 ml of the phosphate/EDTA buffer and 100 pi of 1 
mg/ml OPT to give a total volume of 2 ml and assayed as described in Section 
2.4.4.1.
2.4.4.5 GSSG measurement
Plasma (500 (il) was added to 500 pi of cold 10 % TCA and allowed to stand on ice 
for 10 min and then centrifuged at 4 °C for 15 min at 3000 g. The supernatant (500 
pi) was incubated with 200 pi of 40 mM NEM for 30 min at room temperature. To 
this mixture, 4.3 ml of 0.1 N  NaOH was added. This mixture (200 pi) was further 
mixed with 1.7 ml of 0.1 //NaOH and 100 pi of 1 mg/ml OPT to give a total volume 
of 2 ml and was assayed as described in Section 2.4.4.1 .
2.4.5 Total antioxidant activity assay
The total antioxidant activity of blood plasma was determined using the method 
developed by Miller and Rice-Evans (1996). The following concentrations of 
reagents were used per tube: 0.84 % Trolox/plasma; 2.5 pM metmyoglobin; 150 pM 
ABTS; 375 pM H2O2 and 0.005 M PBS to a total volume of 1.0 ml. The reagents 
were mixed thoroughly in the order shown: Trolox/plasma, PBS, metmyoglobin and 
ABTS. H2O2 was added to this mixture, the clock was started promptly and the 
reactants were mixed vigorously. This mixture was immediately transferred into a 
cuvette that had been pre-incubated at 30 °C. The mixture was incubated at 30 °C for
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200 s after which the final absorbance at 734 nm was read using a 
spectrophotometer. The assay was repeated three times. Timing, temperature, 
reagent concentrations and the choice of wavelength were established by Miller and 
Rice-Evans (1996) and strictly controlled throughout the assay. Solutions (1.00 mM) 
of L-ascorbic acid, reduced glutathione and uric acid were also analysed as before 
except the final concentration of H2O2 was decreased to 75 pM, the incubation 
period was increased to 6  min and the assay repeated six times. Moreover, intra- and 
inter-day, intra-assay, intra-subject and inter-subject variability were estimated.
2.4.5.1 Dose-response curve
Trolox standards of initial concentration 1.50, 1.00, 0.75, 0.50, 0.25 and 0 mM 
(buffer blank) were assayed as described above in Section 2.4.5. The percentage 
inhibition of absorbance at 734 nm (A734 nm) of standard was calculated as described 
in Section 2.4.5.2 and was expressed as a function of the initial concentration of 
Trolox to construct the dose-response curve. This curve was constructed to 
determine total antioxidant activity of blood plasma samples.
2.4.5.2 Calculation
A quantitative relationship exists between the percentage inhibition of absorbance at 
734 nm (A734nm) and the antioxidant activity of the added sample or standard (test).
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inhibition of A734 nm (%) = Buffer blank (A i â nm) - Test (A7^nm) x 100%
Buffer blank (A734 nm)
Inhibition of A734 nm (%) «= Antioxidant activity
The unit of antioxidant activity is the Trolox equivalent antioxidant capacity 
(TEAC), which is defined as the millimolar concentration of Trolox having the 
equivalent antioxidant capacity to a 1.00 mM solution of the substance under 
investigation.
2.4.6 Plasmid DNA purification
Plasmid pBsHO-1, containing the full length cDNA for HO-1 (1550 bp) inserted into 
the EcoR I site of phagemid pBluescript SK and plasmid pBsHO-l/L, containing the 
plasmid pBsHO-1 with a 45 bp linker inserted into its Nco I site, were constructed 
and then transformed into Escherichia coli XL-1 blue as described by Ahmed et al 
(1996). These transformed colonies growing on fresh LB agar plates containing 
50 Jig/ml ampicillin and 12.5 |Hg/ml tetracycline were supplied by Dr Abdu Ahmed 
(RICE, Bath). A single, well-isolated colony was used to inoculate 10 ml LB 
medium, containing the same concentrations of antibiotics. This primary culture was 
incubated at 37 °C overnight (12-16 h), aerated by gentle shaking. A 1-ml aliquot 
was then subcultured into 100 ml LB medium, containing the same concentrations of 
antibiotics. This secondary culture was incubated overnight at
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37 °C as before. Minipreps of plasmid DNA were performed using Wizard Plus SV 
Minipreps DNA Purification Systems according to the manufacturer’s protocol. The 
plasmid pBsHO-l/L DNA (4553 bp) and the plasmid pBsHO-1 (4508 bp) were 
finally eluted in NF H20 , quantified and evaluated using agarose gel electrophoresis 
(Section 2.4.15 and 2.4.16) and stored at -20 °C until use.
2.4.7 JumpStart PCR
All reagents were added in the order shown in Table 2.1 to a 0.5 ml microcentrifuge 
tube. They were mixed gently by pipetting and briefly centrifuged to collect all 
solutions at the bottom of the tube. The PCR reactions were performed in 0.2 ml 
capped MicroAmp reaction tubes, using GeneAmp PCR System 2400. The mixture 
was heated for 30 cycles at 94 °C for 1 min, 55 °C for 2 min and 72 °C for 3 min, 
followed by 1 cycle of 72 °C for 7 min and held at 4 °C. Samples (15 jllI) of the 
amplified DNA products were then evaluated by agarose gel electrophoresis (Section
2.4.16). Positive and negative control reactions were also included. To ensure the 
PCR system was set up properly, DNA template which had been successfully and 
consistently amplified in previous reactions was chosen to be the positive control 
DNA. To control for contaminating DNA amplicons from a previous PCR, a 
negative control reaction without DNA template was set up. All amplified samples 
were stored at -20 °C. Primers Pj (5' CCT TGT TGA CAC GGC CAT GAC CAC 
3 ) and P2 (5’ AGT TAG ACC AAG GCC ACA GTG CCG 3 ) were used in this 
PCR. These primers were designed to amplify the 1198 bp to 1440 bp region of
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HO-1 cDNA (242 bp fragment), containing the Nco I restriction site. Since plasmid 
pBsHO-l/L DNA contains the 45 bp linker inserted into its HO-1 region, its PCR 
amplified products using the same set of primers should be 45 bp larger (287 bp) 
than the same fragment amplified from plasmid pBsHO-1 DNA.
Reactants Amount Final concentration
PCR Buffer with Mg2+ (10 x)* 5 pi 1 x'
dNTP mix (10 mM)** 1 pi 200 pM each
Primer Pi (10 pM) 3 pi 0.6 pM
Primer P2 (10 pM) 3 pi 0.6 pM
JumpStart Taq DNA Polymerase 
(2.5 units/pl)




NF H20 to 50 pi -
Total volume 50 pi
*This buffer contains 100 mM Tris-HCl, 500 mM KC1, 0.01 % gelatin and 15 mM 
MgClo (pH 8.3 at 25 °C).
**10 mM dNTP mix contains 10 mM each of dATP, dCTP, dGTP and dTTP (2’-
Deoxyadenosine, 2’-Deoxycytidine, 2’-Deoxyguanosine and 2’-Deoxythymidine 
5’-Triphosphates)
*1.5 mM Mg2+
Table 2.1 PCR using JumpStart Taq DNA Polymerase. Plasmid pBsHO-1/L 
DNA and plasmid pBsHO-1 DNA were amplified using conditions shown above and 
the cycling parameters described in Section 2.4.7.
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2.4.8 Restriction digestion
To prepare for subsequent in vitro transcription, plasmid pBsHO-l/L DNA was 
linearised with Hind HI (5 units/fig). When setting up restriction digestion, reactants 
were kept on ice until use and mixed thoroughly before incubation at 37 °C for at 
least 1-2 h (Sambrook et al, 1989). After restriction digestion, the products were 
analysed by agarose gel electrophoresis (Section 2.4.16) to confirm complete 
digestion. The linearised products of plasmid pBsHO-l/L DNA were then extracted 
with phenol-chloroform-isoamyl alcohol, concentrated with ethanol and quantified as 
described in Section 2.4.15.
2.4.9 In vitro transcription
Plasmid pBsHO-l/L DNA was transcribed in vitro using T3 RNA polymerase 
(Riboprobe in vitro Transcription Systems) according to the manufacturer’s 
instructions. Five micrograms of DNA template were used per preparation and a 
yield of 5-10 fig RNA/jig plasmid DNA was obtained. The components were added 
at room temperature since DNA can precipitate in the presence of spermidine if kept 
at 4 °C. The mixture was incubated at 37 °C for 2 h. Subsequently, the DNA 
template was degraded using RQ1 RNase-free DNase (1000 units/|il) at a 
concentration of 1 unit per 1 fig of DNA template. This mixture was then incubated 
at 37 °C for 30 min. The RNA transcripts (1697 b) were subsequently extracted with 
phenol-chloroform-isoamyl alcohol and concentrated with ethanol (Section 2.4.15).
The synthetic RNA was suspended in NF H2O, quantified and stored at -70°C. 
When verifying RNA transcripts on a gel, RNA was diluted in RNA loading buffer 
and heated to 65 °C for 5 min prior to loading on an agarose gel as an alternative to a 
denaturing gel. Details of RNA quantification and denaturing gel electrophoresis 
were described in Section 2.4.15 and 2.4.16.
2.4.10 Treatment of peripheral blood mononuclear cells with hydrogen peroxide
PBMCs were isolated as described in Section 2.4.1 and then exposed to H2O2 . The 
cells were treated with 100 pM H2O2 prepared in PBS at 37 °C for 30 min at a cell 
density of 1 x 107 cells/ml. The cells were then washed twice with PBS and 
incubated in supplemented RPMI 1640 medium at a cell density of 1 x 107 cells/ml at 
37 °C for 2 h under 5 % CO2 . Using trypan blue dye (see Section 2.4.1), the % cell 
viability was determined before and after the treatment period; and after the 2-h 
incubation period.
2.4.11 Total RNA preparation from peripheral blood mononuclear cells
Total RNA was extracted from FBCb-treated PBMCs using the RNeasy Mini Kit 
according to manufacturer’s protocol. Cell pellets or cell lysates were stored at 
-70 °C and processed soon after harvesting. RNA was eluted in NF H2O, and stored 
at -70 °C until use. The isolation was carried out as quickly as possible to maintain 
integrity of the RNA.
77
2.4.12 Competitive one step Mone-tubeM RT-PCR
RT-PCR assays were performed for each RNA sample (pBsHO-l/L RNA and total 
RNA) using the Titan One-tube RT-PCR System, the primers Pi and P2 (Section 
2.4.7) and the Gene Amp PCR System 2400. The protocol used for the RT-PCR 
assay is shown in Table 2.2. Reaction components for master mix 1 and master mix 
2 were set up separately. Master mix 1 (25 jil) was then added to 25 |il of master 
mix 2. This mixture (50 jil) was then heated for 1 cycle at 50 °C for 30 min and 94 
°C for 2 min; followed by 45 cycles of 94 °C for 30 sec, 60 °C for 30 sec and 68 °C 
for 45 sec; followed by 1 cycle at 68 °C for 7 min and held at 4 °C. To control for 
contaminating DNA amplicons from a previous PCR, a negative control reaction 
without RNA template was set up. Another negative control reaction was also set up
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where RT was eliminated by inactivating the Avian myeloblastosis virus Reverse 
Transcriptase (AMV RT). Master mix 2 was heated at 94 °C for 2 min before master 
mix 1 was added to it. This mixture was then subjected to thermal cycling as before 
but eliminating the RT step (50 °C for 30 min). To ensure the RT-PCR system was 
set up properly, an RNA template which had been successfully and consistently 
amplified in previous reactions was used as a positive control. Samples (15 jil) of 
the amplified DNA products were evaluated by agarose gel electrophoresis (Section
2.4.16). PCR products were stored at -20 °C.
Serial dilutions of pBsHO-l/L RNA (competitor) containing a fixed amount of total 
RNA (target) extracted from PBMCs were reverse transcribed and co-amplified 
(using the same set of primers) in one-tube reactions under the same conditions as 
described in Table 2.2. Samples (15 jil) of the amplified DNA products were then 
evaluated by agarose gel electrophoresis (Section 2.4.16). Data analysis using 
densitometry is described in detail by Ahmed et al (1996).
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Reactants Amount Final concentration
Master mix 1
DTT (100 mM) 2.5 pi 5 mM
dNTP mix (10 mM) 1 pi 200 pM
Primer Pi (10 pM) 3 pi 0.6 pM
Primer P2 (10 pM) 3 pi 0.6 pM
RNase inhibitor (40 units/pl) 0.25 pi 10 units
RNA template (pBsHO-l/L RNA x pi 1 Pg-l Hg
or total RNA or both)
NF H20 to 25 pi -
Total volume 25 pi
Master mix 2
RT-PCR buffer with Mg2+ (5 x)* 10 pi 1 X1
Titan enzyme mix** 1 pi -
NFH20 14 pi -
Total volume 25 pi
Final volume (Mix 1+2) 50 pi
*This buffer contains 1 ml DMSO and 7.5 mM MgCK
**This enzyme mix contains Expand High Fidelity enzyme mix (Taq DNA 
polymerase and Pwo DNA polymerase) and AMV RT in a storage buffer.
*1.5 mM MgClj
Table 2.2 Protocol for RT-PCR using Titan One-tube RT-PCR System.
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2.4.13 Optimisation of RT-PCR
Amplification of plasmid pBsHO-l/L RNA using the primers P| and P2 was achieved 
with relative ease when compared to that of total RNA using the same set of primers. 
Successful performances of RT-PCR depend on a number of factors. For example, if 
the starting material is substantially degraded before the cDNA synthesis, then it is 
unreasonable to expect the RT-PCR to work. To check the integrity of the total 
RNA, GAPDH primers (Gj: 5’ GAC ATC AAG AAG GTG GTG AA and G2: 5’ 
TGT CAT ACC AGG AAA TGA GC 3) were used to amplify the abundant 
housekeeping gene, glyceraldehyde-3-phosphate dehydrogense (GAPDH). 
Amplified products at 187 bp should confirm the integrity of this starting material 
and at the same time, the efficiency of RT-PCR. The latter can also be checked by 
amplifying the HO-1 gene in human cultured FEK4 total RNA (“positive control” 
RNA) using the primers Pi and P2. Induction of HO-1 gene expression by UVA 
radiation, H20 2 and sodium arsenite in FEK4 cells was previously demonstrated by 
Keyse and Tyrrell (1989). Amplification of the HO-1 gene in FEK4 total RNA can 
also be used to check the suitability of primers P| and P2. The final concentration of 
the primers in the reaction should also be optimised. RT-PCR was carried out using 
1, 0.8, 0.6, 0.4, 0.2 pM of each primer during optimisation. Another factor to be 
considered in RT-PCR optimisation is the number of thermal cycles. Most RNA 
samples can be detected using 30-40 cycles of amplification. If the target RNA is 
rare or if only small amount of starting material is available, it may be necessary to 
increase the number of cycles to 45-50. This strategy was taken in this study in
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amplifying the total RNA. Annealing temperature was also varied in an attempt to 
achieve amplification. Magnesium and dNTPs concentration may also be varied 
during optimisation although they were both kept constant in this study.
2.4.14 Semi-quantitative RT-PCR
While setting up competitive one step “one-tube” RT-PCR for the study of HO-1 
gene expression, difficulty was encountered because the amplification of total RNA 
was inconsistent. A different approach was therefore required to tackle this problem. 
Semi-quantitative RT-PCR described here is a more basic and simpler approach 
because the RT and the PCR step are separated and the elimination of a competitor 
means that optimisation of the reaction is easier since there is only one set of RNA to 
be amplified. PBMCs of 13 healthy volunteers (7 from the younger group and 6  
from the older group) were treated with H2O2 and the total RNA was isolated as 
described in Section 2.4.10 and 2.4.11. To ensure RNA purity, genomic DNA 
contamination was eliminated from total RNA by treatment with RNAase-free 
DNase I (10 units/p.1) (Dilworth and McCarrey, 1992). The reaction was set up as 
shown in Table 2.3. The mixture was incubated at 37 °C for 15 min. EDTA (25 
mM) was added to the reaction mixture to a final concentration of 2.5 mM and this 
mixture was incubated at 65 °C for 10 min to inactivate the RNase-free DNase I.
8 2
Reactants Amount Final concentration
Total RNA sample 2  M-g 0 .1  pg/pl
First strand buffer (5 x) 4 pi 1 X
RNase-free DNase I 
( 1 0  units/pl)
2  pi 2 0  units
NF H20 to 2 0  pi -
Total volume 20 pi
Table 2.3 Removal of genomic DNA from total RNA by RNase-free DNase I.
For first strand cDNA synthesis, 2 j l l I  of 50 pM oligo pd (T) 1 2 - 1 8 was added to 10 pi 
(1 jug) of the DNase-treated RNA to give a final concentration of 5 pM in the final 20 
j l l I  reaction mixture (H). This mixture was denatured at 70 °C for 10 min and chilled 
immediately on ice (G). The RT reaction mixture ( 8  pi of F) was added to 12 pi of 
the denatured RNA mixture (G) to give a total volume of 20 pi (H) (Table 2.4). The 
final 20 pi mixture (H) was reversed transcribed using Superscript II RNase H' 
Reverse Transcriptase at 42 °C for 60 min, 95 °C for 5 min and held at 4 °C. The 
newly synthesised cDNA was stored at -20 °C.
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A First strand buffer (5 x) 4 1 X
B DTT (100 mM) 1 5 mM
C dNTP (10 mM) 1 500 pM
D RNasin ribonuclease 
inhibitor (40 units/pl)
1 40 units
E Superscript II (200 units/pl) 1 2 0 0  units
F
"G
RT mixture (A+B+C+D+E) 8 -
Denatured RNA mixture 1 2 i ng
H Total volume (F+G) 20
Table 2.4 Protocol for the reverse transcription of total RNA from PBMCs 
using Superscript II RNase H' Reverse Transcriptase.
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The newly synthesised cDNA was used as a template for PCR amplification using 
the Expand High Fidelity System. This system is similar to the Titan One-tube RT- 
PCR System but no AMV RT is included in the enzyme mix. Reactants were added 
to a PCR reaction tube in a volume of 25 (J.1 (Table 2.5). cDNA template was added 
last outside the UV-PCR hood. This mixture was then heated at 94 °C for 5 min, 
followed by 35 cycles of 94 °C for 30 sec, 56 °C for 30 sec and 72 °C for 30 sec, 
followed by 1 cycle at 72 °C for 7 min and held at 4 °C. The housekeeping gene, 
GAPDH was used as a control to estimate the amount of HO-1 mRNA per sample. 
GAPDH primers (Gi and G2) and HO-1 primers (P] and P2, Section 2.4.7) were used 
to amplify cDNA obtained from the same total RNA. PCR amplified products by 
GAPDH primers and HO-1 primers were 187 bp and 242 bp long, respectively. 
Samples (15 jil) of the amplified DNA products were evaluated by agarose gel 
electrophoresis (Section 2.4.16). To check for genomic DNA contamination, a 
negative control was set up using DNase-treated RNA which had not been reverse 
transcribed as the template. To check for any other sources of DNA contamination, 
another negative control was set up without any template.
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Reactants Amount Final concentration
PCR buffer with Mg2+ (10 x)* 2.5 pi 1 xT
dNTP mix (10 mM) 0.5 pi 200 pM
HO-1 or GAPDH primers
Pi or Gi (5 pM) 2.5 pi 500 nM
P2 or G2 (5 pM) 2.5 pi 500 nM
Expand High Fidelity enzyme 0.125 pi -
mix**
cDNA 1.25 pi 5 %
or DNase-treated RNA 1 0  pi 1 K
or NF H20 1.25 pi -
NF H20 to 25 pi
Total volume 25 pi
*This buffer contains 100 mM Tris-HCl, 500 mM KC1 and 15 mM MgCl2 (pH 8.3 at 
2 0  °C).
**This enzyme mix contains Taq DNA polymerase and Pwo DNA polymerase. 
t 1.5mM MgCl2
Table 2.5 Protocol for PCR reaction using the Expand High Fidelity System.
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2.4.15 Nucleic acid purification, concentration and quantification
Purification of nucleic acid and inactivation/removal of protein by 
phenol:chloroform:isoamyl alcohol extraction were routinely carried out in this study 
according to the protocol described by Sambrook et al (1989). The nucleic acid was 
recovered by precipitation with 3 M sodium acetate (pH 5.2) and ethanol. The 
nucleic acid pellet was suspended in NF H2O. The concentration of nucleic acid was 
determined spectrophotometrically using a Ultra-Micro quartz SUPRASEL cell and a 
Spectronic Genesys 2 as described by Sambrook et al (1989). Concentrations were 
calculated as follows:
Concentration of DNA (p.g/ml) = A260 x 50 p,g/ml x Dilution factor
Concentration of RNA (|ig/ml) = A260X 40 jig/ml x Dilution factor
Concentration of oligonucleotides (jig/ml) = A260X 20 pg/ml x Dilution factor
2.4.16 Gel electrophoresis
Gel electrophoresis was performed as described by Sambrook et al (1989). During 
the preparation of materials for RT-PCR assays, electrophoresis of DNA samples 
using a 1 % agarose gel pre-stained with ethidium bromide was used to identify any 
DNA fragments. Following RT-PCR, 15 p.1 samples of amplified products were 
electrophoresed through a 2 % agarose gel. For fine separation and analysis of RNA, 
a denaturing gel system (1  %) utilising formaldehyde as the denaturing agent, was
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used (Sambrook et al, 1989). Documentation of gels was carried out using 
ultraviolet illumination and the Kodak Digital Science Electrophoresis 
Documentation and Analysis System.
2.5 Statistical analyses
Statistical analyses were carried out using either the parametric two-sample t test for 
normally distributed data or the non-parametric Mann-Whitney U test for non-normal 
data, employing the Minitab Release 11.12 statistical software package. P values < 
0.05 (95 % confidence intervals) were considered significant. Mean values, standard 
deviations (SD) or standard error (SE) and 95th percentile reference interval (mean ± 
1.96 x SD) were calculated. Variability was expressed as a coefficient of variation 
(CV) as shown below:
coefficient of variation (CV) = standard deviation (SD) x 100 %
mean
The higher the CV value, the higher the variability observed. Dose-response curves 
were constructed using the regression-fitted line plot function in Minitab. The 
adjusted R-squared (R2) value was used to assess the goodness-of-fit of the 
regression line. A value of 100 % indicated the existence of a perfect linear 
relationship between two variables. The Anderson-Darling normality test was used 
to study the normality of the data, utilising Minitab, where P > 0.05 indicated 
normality and P < 0.05 indicated that the data deviated from normality. In addition,
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the effect of various factors on the collected data was studied using either one-way or 
two-way analysis of variance (ANOVA), followed by the Tukey’s comparison tests 
for normal data; or the Kruskal-Wallis test, followed by Mann-Whitney U test for 
non-normal data, utilising Minitab. Statistical analyses used throughout this study 





Active oxygen radicals are known to induce chromosomal aberrations with high 
efficiency and significant oxidative DNA damage (e.g. single- and double-strand 
breaks) resulting from endogenous free radical attack has been suggested to 
contribute to ageing and age-related diseases (Section 1.3.2.1). Hydrogen peroxide, 
for example, is a common intermediate in a variety of oxidative stresses. It induces 
DNA damage leading to mutagenesis (Imlay and Linn, 1988), although it does not 
interact with DNA directly to produce oxidative lesions. The hydroxyl radical 
produced when H2O2 is subjected to the Fenton reaction (Section 1.3.3.1) is the 
reactive oxygen species responsible for DNA damage. The aim of this study was to 
evaluate H2C>2-induced DNA damage in the PBMCs of all three groups of volunteers 
using the single cell gel electrophoresis (SCGE) technique, also known as the comet 
assay. The effect of age, Alzheimer’s disease (AD) and gender on oxidative DNA 
damage of PBMCs was assessed.
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3.1.1. Detection of DNA single-strand breaks
Procedures for measuring DNA strand breaks are generally based upon the principle 
that strand breaking agents reduce the size of the large duplex DNA molecule (Olive, 
1992). In addition, DNA single- and double-strand breaks can have dramatic effects 
on higher-order chromatin structure because of its supercoiling and tight packaging 
within the nucleus. Assays that measure DNA single-strand breaks generally require 
unwinding of the double stranded DNA molecule for sensitive detection. Nucleoid 
sedimentation makes use of the fact the degree of DNA supercoiling or unwinding, 
reflecting strand break levels, can be measured by the rate of sedimentation (Cook 
and Brazell, 1975). A high pH (> 12.3) is generally utilised to facilitate denaturation, 
unwinding, and expression of single-strand breaks as well as DNA breaks that only 
become apparent after exposure to alkali i.e. alkali labile lesions. Alkaline sucrose 
sedimentation is based upon the assumption that larger DNA fragments sediment 
further in a sucrose gradient than smaller fragments (McGrath and Williams, 1966). 
Alkaline filter elution measures the rate of DNA elution through a filter membrane 
under alkaline conditions, and the amount of DNA single-strand breaks or lesions 
converted to single-strand breaks under alkaline conditions is estimated on the basis 
of the increase in DNA elution rate (Kohn, 1991). Most of these techniques require 
radiolabelling of DNA for sensitive detection of breaks, and they can only provide an 
indication of average number of breaks per cell. An exception is the in situ nick 
translation method that requires the presence of free 3' OH groups to serve as 
templates for incorporation of radiolabelled nucleotide precursors. This method
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gives an indication of the extent of damage in individual cells (Krause et al, 1993).
3.1.2 Development of the comet assay
The detection of DNA single-strand breaks in individual cells was first described by 
Rydberg and Johanson (1978). Cells were embedded in agarose on microscope 
slides and lysed under mildly alkaline conditions in order to allow a partial 
unwinding of the DNA. After neutralisation, the cells were stained with acridine 
orange and the extent of DNA quantitated. A ratio of green to red fluorescence, 
representing the ratio of double to single-strand DNA, respectively, was determined. 
In order to increase the sensitivity of damage detection, Ostling and Johanson (1987) 
subsequently modified these procedures and included a neutral electrophoresis step. 
Comets formed as relaxed DNA loops or broken DNA free ends, stretched out as a 
tail in the direction of the anode. They observed that the extent of DNA liberated 
from the head of the comet during electrophoresis was a function of the dose of 
irradiation. The nature of comets, and the physicochemical events underlying their 
formation, are not fully understood or agreed upon and it has been investigated by 
Collins et al (1997a). The generally adopted SCGE technique was introduced by 
Singh et al (1988), in which the procedure of Ostling and Johanson (1987) was 
modified by performing the electrophoresis at high pH, thus revealing the alkaline 
labile site and breaks. Following staining with ethidium bromide, increased 
extension of the DNA from the nucleus towards the anode was observed in cells with 
increased damage caused by either X-rays or H2O2 . The number of studies based on
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the comet assay has increased over recent years, although most use the Singh method 
with slight variations in different steps (McKelvey-Martin et al, 1993; Fairbaim et al 
1995). The comet assay has also become a particularly valuable technique since it 
allows detection of intercellular differences in DNA damage and repair in virtually 
any eukaryote cell population that can be obtained as a single-cell suspension; it 
requires only extremely low cell numbers ( 1 - 1 0 , 0 0 0  cells); and results can be 
obtained in a single day. Apart from image analysis, which greatly facilitates and 
enhances the possibilities of comet measurements, the cost of performing the assay is 
low. To date, the comet assay has been usefully applied to screen lymphocyte 
samples from human populations for their susceptibility to oxidative damage, UV 
and ionising radiation (Singh et al, 1988; Olive et al, 1990; Green et al, 1995). The 
comet assay can also be applied in the study of radiation biology, genetic toxicology 
and apoptosis. Comprehensive reviews of the comet assay, its modifications and 
applications have been published by McKelvey-Martin et al (1993), Fairbairn et al 
(1995) and Collins et al (1997a, 1997b). A summary of DNA-damaging agents that 
have been used in various comet assay-based studies was also provided by 
McKelvey-Martin et al (1993). Leroy et al (1996) evaluated the three methods 
generally used to detect DNA single-strand breaks in human lymphocytes: alkaline 
elution, nick translation and the comet assay; the latter was demonstrated to be the 
most feasible, sensitive and reproducible method to monitor populations exposed to 
genotoxic agents.
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The comet assay, based on that developed by Singh et al (1988), was used in this 
study to detect DNA strand breaks in individual human PBMCs after treatment with 
different concentrations of H20 2. The degree of DNA damage in H20 2-treated 
PBMCs was analysed from three groups of volunteers: healthy individuals under the 
age of 30, healthy individuals over the age of 60 and Alzheimer’s patients over the 
age of 60; taking into the account age, gender and the concentration of H20 2 used.
3.2 Results
3.2.1 Human subjects
The average age of the healthy younger group, the healthy older group and the 
Alzheimer’s group was 24 ± 3 (range: 19-29 years), 12 ± 4  (range: 62-80 years) and 
78 ± 6  (range: 62-86 years), respectively. Each subject was asked about his/her diet, 
health status, smoking habits, medications, intake of vitamins or antioxidants, 
minerals and other supplements; and regular exercise regimes. This information is 
summarised in Table 3.1 and Appendix HI. The majority of volunteers were 
Caucasian and non-smokers; therefore the effects of race and smoking habits were 
not studied. Vitamins or antioxidants taken by the volunteers included vitamin B, 
vitamin C (ascorbic acid), vitamin E (a-tocopherol) and multivitamins. Minerals
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and other supplements taken included calcium, magnesium, iron, multi-minerals, cod 
liver oil, evening primrose oil, garlic oil, halibut oil, coenzyme Q10 and gingko 
biloba. The healthy volunteers were of good general health although some of the 
older volunteers suffered health problems such as hiatus hernia and hypertension but 
none was diagnosed with AD or taking drugs for the treatment of AD. The 
Alzheimer’s group included patients recruited from RICE and the diagnosis of these 
patients was established in accordance with the DSM-IV (Diagnostic and Statistical 
Manual of Mental Disorders-IV) criteria and NINCDS-ADRDA (National Institute 
of Neurological and Communicative Disorders and Stroke-Alzheimer’s Disease and 
Related Disorders Association) classification for probable AD. Most of these 
patients have been/are involved in clinical trials, carried out by RICE, to determine 
the safety and efficacy of drugs such as donepezil, galanthamine, propentofylline or 
T-588 in the treatment of AD. Some of the 25 AD volunteers were/are receiving the 
active drug or placebo. In the case of volunteer number 20 in this group (Appendix 
IE), it was not known whether the active drug was taken since the study was double­
blinded in nature. Full details of these studies and the selective criteria of AD 
patients were obtained from RICE and remained confidential. Further details of the 




(% in each group)
Young 
(age < 30) 
n = 25
Old
(age > 60) 
n = 25
Alzheimer’s 
(age > 60) 
n = 25
Gender
Male 12 (48) 1(28) 11 (44)
Female 13(52) 18(72) 14 (56)
Ethnic origin
Caucasian 24 (96) 24 (96) 25 (100)
Others 1 (4) 1 (4) None
Smoker 3(12) 3 (12) None
Intake of vitamin(s)/antioxidant(s) 4(16) 1 (28) 4 (16)
Intake of mineral(s) and other 2(8) 11 (44) 5(20)
supplement(s)
Medication(s)
Contraceptives 5(20) None None
Others 3 (12) 11 (44) 16 (64)
Trial drug(s) None None 18(72)
Health problem(s) 4(16) 13 (52) 25 (100)
Table 3.1 Summarised information on the 75 volunteers recruited for this study.
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3.2.2 Experimental variability
Experiments of various kinds were used to illustrate the performance of the assay and 
to assess its reproducibility and validity. The PBMCs count was at least 1 x 107 cells 
per 1 ml of fresh blood. Cell viability, measured before and immediately after H2O2 
treatment, always exceeded 90 %. Table 3.2 shows the variability observed in the 
comet assay expressed as coefficients of variation (CV). The higher the 
concentration of H2O2 used for treatment, the smaller the CV values of intra- and 
inter-assay, intra-subject and intra-slide variability i.e. the smaller the variability 
observed. The inter-subject variability expressed as CV was shown in Table 3.3. 
Again, the higher the concentration of H2O2 used for treatment, the smaller the CV 
values of inter-subject variability. The inter-subject variability for basal and induced 






Variability expressed as 
mean ± standard deviation (range) 









0 66.4 ±43.9 
(34.5-179.2)
5 24.5 ± 15.4 
(8.3-57.3)




37.4 ± 18.0 
(20.9-77.9)
2 0 15.4 ±5.1 
(5.8-24.2)




15.5 ± 10.1 
(4.2-31.9)
14.1 ± 6 . 8  
(3.4-23.6)














0 74.0 (n = 25) 95.0 (n = 24) 101 (n = 25)
5 60.2 (n = 25) 72.1 (n = 25) 82.0 (n = 25)
2 0 25.4 (n= 15) 39.5 (n = 18) 62.7 (n = 24)
50 18.9 (n = 25) 21.4 (n = 25) 42.4 (n = 25)
Table 3.3 Inter-subject variability in the comet assay.
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3.2.3 Scores of DNA damage in peripheral blood mononuclear cells
The comet assay was used to study oxidative DNA damage on PBM Cs of all 75 
volunteers. A preliminary study (n = 10) was carried out to establish the 
concentration range of H2O2 used for this work. The degree of DNA damage was 
quantified by visual classification of cells into four categories, which are shown in 
Figure 3.1. Figure 3.2 shows a typical example of the appearance of PBMCs after 
treatment with different concentrations of H2O2 . Table 3.4 summarises the total 
comet scores of the three groups of volunteers after incubation with various 
concentrations of H2O2 . Non-parametric statistical tests (Section 2.5) were used for 
data analysis. The mean total comet score observed in untreated PBMCs i.e. 0 pM 
H2O2 in the young was not significantly different from that in the old (P = 0.20). 
However, a significant difference was revealed in the mean total comet scores 
between young and old healthy volunteers after PBMCs were treated with 5, 20 or 
50 pM H2O2 (P = 0.039, P = 0.030 and P = 0.034, respectively). A higher mean
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total comet score i.e. a higher level of DNA damage was observed in the H2O2- 
treated PBMCs of the younger volunteers than in the older group. On the other hand, 
no significant difference was observed in the mean total comet scores in both 
untreated and H2 0 2 -treated PBMCs between the old and healthy group and the 
Alzheimer’s group (P > 0.05). Figure 3.3 shows the distribution patterns of DNA 
damage among different groups of volunteers expressed as the number of cells in the 
four comet categories, from 0 (undamaged) to 3 (highly damaged), as a function of 
H2O2 concentration. There was an increasing number of category 3 comets observed 
with increasing concentration of H2O2 in all cases. However, a large number of 
comets always remained in category 0. The frequency distribution pattern of DNA 
damage in response to the doses of H2O2 was not significantly different between the 
three groups (P = 1 .0 0 ).
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Figure 3.1 Visual categories of DNA damage. A: Category 0 (undamaged);
B: Category 1 (slightly damaged); C: Category 2 (damaged); D: Category 3 (Highly 
damaged).
Figure 3.2 A typical example of the appearance of PBMCs after treatment with 
different concentrations of H20 2. A: 0 pM; B: 5 pM; C: 20 pM; D: 50 pM.
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Concentration of
Total comet scores expressed as 
mean ± standard error
















24.68 ± 4.05 
n = 25
20 63.00 ±4.13 
n =  18
48.94 ±4.56 
n = 15
47.04 ± 6.02 
n = 24






Table 3.4 Comparison of total comet scores obtained from the healthy young 
and old and the Alzheimer’s group. PBMCs were treated with various 
concentrations of H2O2 before comet assay was carried out to study the status of 
oxidative DNA damage. Data shown as mean ± SE. Note that 20 jliM H2O2 was 
introduced at a later stage into the experimental system, hence n < 25.
103
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Figure 3.3 Comparison of the distribution of DNA damage, expressed as 
number of cells in the four comet categories (0-3) between group A-C, after 
treatment with H2C>2. Data based on 50 cells per slide and duplicate slides from 25 
subjects for each group. Data expressed as mean ± SE.
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3.2.4 Effect of hydrogen peroxide and gender
Figure 3.4 shows the effect of increasing concentrations of H2O2 on the total comet 
scores i.e. the extent of DNA damage in human PBMCs (n = 25 in each group) using 
the comet assay. A statistically significant dose-response relationship was seen with 
significant responses at all dose levels (P = 0.00). PBMCs showed dose-dependent 
increases in DNA damage following H2O2 treatments. The concentration range of 
H2O2 was established by a preliminary study (n = 1 0 ) and the results were included in 
the final data. Analysis was also carried out considering gender as a factor and the 
results were of no significance (P > 0.05).
— Yo ung and healthy. (Age < 30) 
— o —  o id  and  healthy, . (Age > 6 0 )  





o  6 0 -
co
o  5 0 -
o  4 0 -  
75
"  3 0 -
20-j,-
20 500 5 10 15 25 30 35 40 45
Concentration of hydrogen peroxide 
(micromolar)
Figure 3.4 Mean dose-response curve for PBMCs from the three groups of 
volunteers (in duplicate) after in vitro exposure to different concentrations of 
H2O2 in the comet assay. Mean ± SE (n = 25 in each group) of total comet scores 
are given here and also in Table 3.4.
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3.3 Discussion
3.3.1 Variability in the comet assay
The comet assay, which measures DNA strand breaks at the level of single cells, can 
be easily applied to human PBMCs, and therefore lends itself to human 
biomonitoring studies. However, before applying the assay to these studies, the 
variability inherent in this method has to be determined, thus allowing us to 
understand the power and the limitation of this assay in detecting DNA damage. 
Variability was expressed as a CV for this study (see Section 2.5) and that conducted 
by Holz et al (1995a). The findings in this work are similar to those presented by 
Holz et al (1995a) and Collins et al (1997b). As the concentration of H2O2 used for 
treatment increased, the CV values of intra- and inter-assay, intra- and inter-subject 
and intra-slide variability decreased, indicating a gradual decrease in the variability 
observed. The values of the intra-assay, inter-assay and intra-slide variability were 
lower than that of the intra- and inter-subject variability. Therefore, when 
standardising the comet assay, real physiological variations inherent to individuals 
could present a bigger problem than variations arising during the experimental 
procedures. CV values of inter-subject variability for basal and induced DNA 
damage were the highest amongst all other variability observed in each group of 
volunteers; with the highest CV values observed in the AD group and the lowest CV 
values observed in the young and healthy group. Volunteers in the young and 
healthy category are generally “drug-free” and “disease-free” and this may explain a
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relatively low variability observed between individuals in this group. In contrast, it is 
inevitable that some of the volunteers from the old and healthy category suffer from 
health problems at some point in their lives and are currently on prescription drugs 
(see Table 3.1 and Appendix ID). Again, most of the AD patients recruited have 
other health problems and all are involved in AD drug trials (see Table 3.1 and 
Appendix ID) and this may explain the relatively high variability observed between 
individuals. To minimise inter-subject availability, the problem of limited 
availability of old and AD volunteers needed to be addressed. It is also important to 
take into account that age-associated changes in the structure and function of various 
systems within our bodies do not occur at the same rate for different individuals and 
substantial variability exists between people of the same age (Rowe and Kahn, 1987).
So, what are the other sources of variability? The type of cells under investigation 
provides the majority of variations observed in the comet assay. Virtually any 
eukaryotic cell can be analysed for DNA damage using the comet assay but the most 
commonly examined human cells are lymphocyte populations (Fairbairn et al, 1995). 
PBMCs, which consist mainly of lymphocytes and monocytes, are widely used in 
biomonitoring of DNA damage. For studies of reproducibility, these cells have the 
advantage that they can be obtained repeatedly from single subjects, which is not 
feasible with other cells. Lymphocytes and/or blood samples also have the additional 
advantage that they can be stored and processed later, without loss of viability or 
factors affecting responses. Visvardis et al (1997) evaluated the comet assay using 
cryopreserved lymphocytes. The induction of DNA damage, as well as the repair
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capacity of y-ray- and KhCVexposed cryopreserved human lymphocytes, was found 
to be the same as that of freshly isolated lymphocytes. In addition, Anderson et al 
(1997) demonstrated that blood samples stored at 4 °C or room temperature for up to 
four days were suitable for use in the comet assay for studies in human cells. 
However, many parameters can affect the response of lymphocytes in the comet 
assay. Both findings from present study and Collins et al (1997b) demonstrated 
considerable intra-subject variability of comet formation with time. Such variability 
may reflect handling variation or real physiological variation -  for example, a 
transient increase in oxidative stress resulting from an infection or a diet-induced 
change in antioxidant status, which could be excluded by using cryopreserved 
PBMCs instead of fresh PBMCs (Holz et al, 1995a). This observation may not be 
applicable to this study because no sudden variations in diet and health status were 
recorded. Some reports have pointed to a variety of possible factors that may be 
responsible for differences in cell response including the age of the blood donor 
(Singh et al, 1990, 1991), the physical activity of the donor (Hartmann et al, 1994) 
and whether or not the donor smokes (Betti et al, 1994). In addition, cell cycle status 
is likely to impose an additional level of complexity to the problem, since chromatin 
structure, which is fundamental to replication and transcriptional activity, will affect 
DNA during comet formation (Olive and Banath, 1993). Sampling time was 
therefore found to influence the comet test (Betti et al, 1995). Possible changes in 
cellular composition should also be taken into account when assessing single-strand 
breaks using PBMCs. Findings by Holz et al (1995b) indicated that monocytes have 
both a lower degree of basal DNA damage and a lower susceptibility to H2O2-
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induced DNA damage than lymphocytes isolated from the same blood sample. 
Despite the risk of reduced sensitivity, most investigators using the comet assay seem 
to prefer to use the whole leukocyte population (PBMCs) when studying induced 
DNA damage and basal levels of DNA damage in “peripheral lymphocytes”. 
Fractionation of cells, during which introduction of damage to the cells is possible, is 
generally tedious and usually requires special equipment and access to specific 
antibodies. Also, there is always the question of how far to go when trying to 
separate different cell types.
The ability to measure DNA damage accurately also depends on several technical 
factors. For example, lysis conditions (i.e. salts concentration, pH, and lysis time in 
particular) can profoundly affect the ability to detect damage (Klaude et al, 1996). 
Washing and equilibrating the slides with the running buffer before electrophoresis 
were also important in avoiding problems caused by residual salt from the lysis 
solution. For this study, an incubation temperature of 4 °C was chosen to reduce the 
formation of single-strand breaks in control cells. McKelvey-Martin et al (1993) 
showed that when cells were incubated at 37 °C for 1 hr in PBS, either additional 
repair of pre-existing breaks or additional strand breaks occurred. Scoring can also 
be a source of variability in the comet assay (as shown by intra-slide variability) 
although measures were taken in this study to reduce the extent of such variations 
(see Section 2.4.2.1). One consistent difficulty with comparing results produced in 
different laboratories using the comet assay is the variability in the application of the 
technique itself. Even with the adoption of a standardised assay protocol, it may still
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be necessary to tailor lysis and electrophoresis conditions to the expected level of 
damage. This is because the extent of DNA damage will vary depending on the 
agent used to induce damage, the nature of the lesions produced, the type of 
biological conditions the cells are exposed to and the amount of strand rejoining 
allowed.
Although considerable variation is seen in samples of cells collected from different 
individuals in the same group and from the same person on different occasions, 
differences between groups of individuals can reliably be measured, given only a 
sufficient number of individuals per group. For the determination of minimum 
difference and minimum sample sizes, power analysis was carried out by Holz et al 
(1995a) based on the quantification of the sources of variability as determined in 
their study. The minimum true difference between the groups that would be 
clinically valuable has to be defined and established by general consent of scientists 
in this area of research before the appropriate sample size can be determined by 
power analysis.
3.3.2 Comet image analysis
In this study, comet slides were analysed within 1-3 days of the experiment. Klaude 
et al (1996) air-dried and fixed the slides in methanol, allowing analysis at a later 
time. The methods of comet image analysis reported are as varied as the applications 
for which the assay has been used. The simplest method is to score the comets
1 1 0
empirically on the basis of damage extent. A series of pictures can be taken of 
comets with varying degrees of damage (Figure 3.1) and it is possible to allocate 
comets to the appropriate class of damage, provided adequate precautions are used to 
protect against observer bias as this study has shown. Although this method of 
evaluation lacks the sophistication of image analysis, it has been used successfully by 
Anderson et al (1994) and Holz et al (1995a) and was used in this study. Other 
investigators collect head diameter, comet length and comet area data either 
manually (McKelvey et al, 1990) or using commercially available image analysis 
systems (Green et al, 1995). Other parameters measured by image analysis systems 
and reported in various studies include tail moment, tail length, tail length/head 
radius and tail fluorescence (McCarthy et al, 1997). Collins et al (1997b) carried out 
parallel scoring by eye and image analysis of human lymphocyte comets showing a 
wide range of degrees of damage. A close correspondence between the visual and 
computer scores was observed. The manual method would therefore appear to offer 
a good, reliable and relatively inexpensive method of analysing comet slides. 
However, it is considerably slower than the image analysis method and it does not 
provide any information on the area or the fluorescent intensity of the comet.
3.3.3 Dose-response relationship
The mean extent of basal and ^Cb-induced DNA damage as a function of the 
increasing concentration of H2O2 was measured by means of visual scoring of the 
comets. These values were presented in Figure 3.4 and show similar dose-response
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relationship to those previously reported by Holz et a\ (1995a), Collins et al (1997a) 
and Piperakis et al (1998). Similar dose-response relationships also existed when 
other known DNA damage-inducing agents, for example, bleomycin (Anderson et al, 
1994) and radiation (Green et al, 1995; Collins et al, 1997a) were used.
3.3.4 Factors affecting the extent of DNA damage
According to some predictions of the DNA-related theories of ageing and age-related 
diseases, cells from older individuals or individuals who suffer from age-related 
diseases should be expected to have increased levels of basal DNA damage, possibly 
accompanied by a reduced rate of damage recognition and repair (Lindahl, 1993). 
Attempts to show an increase in DNA damage with age have yielded conflicting 
results. Singh et al (1990) and Betti et al (1995) both reported a non-significant 
relationship with age. In the study conducted by Piperakis et al (1998), an increase 
in basal and induced DNA damage was generally observed with increasing age. In 
this study, the reverse was observed i.e. a decrease in induced DNA damage was 
observed with increasing age although age did not have an effect on the basal DNA 
damage. Age-associated changes in our bodies do not occur at the same rate for 
different individuals and substantial variability exists for people of the same age 
(Rowe and Kahn, 1987). High genomic stability and an increased resistance to 
oxidative stress have been highlighted within centenarians (probably the best 
example of successful ageing) (Franceschi et al, 1995). There appears to be evidence 
for a link between lifespan, genomic stability and defence systems which protect
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against genomic damage. To understand this, various genetic and defence endpoints 
can be analysed over a long period (age 50-75). The results of this study should 
highlight two extreme subsets of data, one presumably demonstrating a trend of age- 
related increases in genetic damage and development of pathology and the other 
showing individuals who remain healthy for longer. Conflicting data on changes to 
cellular DNA repair capacities with age have been reported and reviewed (Barnett 
and King, 1995). King et al (1997) showed that lymphocytes from individuals in the 
75-80 age groups exhibited DNA repair capacities comparable to those observed for 
lymphocytes from subjects in the 35-39 age group. These results highlight the 
importance of DNA repair capacity in the maintenance of genomic stability and may 
explain the results obtained from this study. In contrast to the prediction of the DNA 
damage theory of ageing and age-related diseases, the effect of AD was not 
significant. This again maybe explained by the theory of genomic stability. This 
may also explained by an artifact effect since 72 % of the volunteers from the AD 
group were taking AD trial drugs which aimed to alleviate the symptoms of AD. 
Since clinical trial information is highly confidential, it is not possible to decide 
whether these drugs can interfere with the study of DNA damage in PBMCs using 
the comet assay. However, many studies have demonstrated the implication of 
oxidative stress in the pathogenesis of AD, as reviewed by Markesbery (1997). For 
example, in a study of AD subjects compared with control subjects, there was a 
significant increase in mitochondrial DNA oxidation in parietal cortex in AD 
(Mecocci etal, 1994).
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In this study, DNA damage in PBMCs increased with increasing concentration of 
H2O2 . The concentration range of H2O2 chosen for this study was widely used (Holz 
et al, 1995a; Collins et al, 1997b; Piperakis et al, 1998). A preliminary study (n = 
10) carried out for this work demonstrated that this concentration range was 
sufficiently high to induce visible changes in the cells for analysis without killing the 
cells. H2O2 can penetrate the cell membrane easily and can initiate the generation of 
highly reactive species. In order for the reactive oxygen species to proceed to DNA 
damage, a sufficient concentration must be available to overwhelm the threshold of 
antioxidant capacity. This consists of the presence of antioxidant enzymes, 
scavenger molecules and the ability of cells to remove altered molecules by turnover. 
The observed differences in the physiological response of one group compared with 
the other group are possibly due to the effects of age, disease state and smoking on 
the formation of reactive oxygen species inside cells, and to their influence on 
protective cellular pathways against induced oxidative damage.
In this study, an increasing number of category 3 comets was observed with 
increasing concentration of H2O2 in all cases. However, a large number of comets 
always remained in category 0. Similar observations were made by Collins et al 
(1997a) and these may be due to the existence of subpopulations in PBMCs which 
respond in different extents to H2O2 exposure. However, the frequency distribution 
pattern of DNA damage in response to the doses of H2O2 was not significantly 
different between the three groups of volunteers.
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Like other work such as that conducted by Betti et al (1995), this study revealed that 
gender has no significant effect on DNA damage in PBMCs. The effect of smoking 
on DNA damage of PBMCs was not investigated in this work but it has been 
extensively studied by Betti et al (1995) and Piperakis et al (1998) who reported that 
smoking significantly increased the extent of DNA damage observed using the comet 
assay. Smoking is an important variable in inducing significant alterations to genetic 
material. The classes of compounds identified in tobacco e.g. aromatic hydrocarbons 
and amines, are all well-known sources of reactive oxygen species, such as ’OH, O2*’ 
and peroxides. The effect of antioxidant intake on DNA damage in PBMCs was not 
studied in this work although intake of non-prescribed vitamins and minerals was 
recorded (see Table 3.1 and Appendix El). However, it has been extensively studied 
by Anderson et al (1994), Green et al (1994) and Collins et al (1997a). The results 
were inconclusive although it seems that antioxidants may provide a protective effect 
in PBMCs against DNA damage. Further studies would be required to establish such 
a relationship. The restricted number of human blood donors included in the present 
study makes it impossible to draw firm conclusions about associations between the 
recorded levels of DNA damage in the. PBMCs and various types of personal 
exposures and/or habits. Nevertheless, this work is a valuable introductory study of 
basal and induced DNA damage in PBMCs in human populations by the comet 
assay.
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3.3.5 Modification of the comet assay
The comet assay used in this study was simple and economical. However, it only 
measured strand breaks and alkali-labile sites. Strand breaks are not a major form of 
damage with most genotoxins -  or if they are, as in the case of ionising radiation, 
they are quickly rejoined by cellular repair. Strand breaks and apurine/apyrimidine 
(AP) sites appear as intermediates in the cellular processing of damage (Section 
1.3.2.4). Thus, the results of this study gave us only some idea of the extent of 
oxidative DNA damage in PBMCs. Collins et al (1997a, 1997b) described a 
modification of the comet assay, by including digestion with lesion-specific 
endonucleases, in order to obtain specific information about oxidative DNA damage 
and its repair in human cells, as well as to increase the range and sensitivity of the 
assay. Digestion with endonuclease El and formamidopyrimidine glycosylase (FPG) 
was incorporated into the comet assay protocol to reveal oxidised pyrimidines and 
oxidised purines (mainly 8-OHdG), respectively. This modified comet assay has 
been applied to study the oxidative DNA damage in human disease such as insulin- 
dependent diabetes mellitus (Collins et al, 1997b), the effect of dietary antioxidants 
on oxidative DNA damage (Green et al, 1995; Collins et al, 1997a; Panayiotidis and 
Collins, 1997) and the kinetics of repair of oxidative DNA damage in human cells 
(Collins et al, 1995).
Several questions about the relationship between DNA damage and ageing are 
frequently asked. First, what is the functional importance of the PBMCs with high
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levels of DNA single-strand breaks and/or alkali labile sites? For example, is the 
DNA damage evenly distributed among all PBMCs, or limited to a functional 
subpopulation? Another possibility is that our subjects’ immune systems are ageing 
at different rates and therefore their cells might display different levels of damage. A 
final question is whether these results apply just to PBMCs or to other types of cells. 
While further research will be required to assess these questions, it is clear that the 
comet assay has provided an important insight into basal and induced DNA damage 





Lipid peroxidation is a complex process known to occur in both plants and 
animals. It involves the formation and propagation of lipid radicals, the uptake of 
oxygen, a rearrangement of the double bonds in unsaturated lipids producing a 
variety of breakdown products, including alcohols, ketones, aldehydes, and ethers 
(Section 1.3.3.2.2). Biological membranes are often rich in unsaturated fatty 
acids and bathed in an oxygen-rich metal-containing fluid. Therefore, it is not 
surprising that membrane lipids are susceptible to peroxidative attack. 
Conditions that accelerate lipid peroxidation include exposure of the microsomes 
to y-irradiation, light, hyperoxia, ozone and radical initiators, such as dialuric 
acid. The incorporation of molecular oxygen into polyunsaturated fatty acids to 
yield hydroperoxides as the primary initial product is the focus of intense current 
interest in biomedical and pharmacological research. The basis of this interest 
rests with the potential role of lipid peroxidation and peroxidation products in the 
degeneration associated with ageing and in the pathogenesis of several clinically 
significant diseases (Beckman and Ames, 1998; Marcus et al, 1998). This 
increased interest demands quantitative methods which are diagnostic of the 
process and meet basic analytical criteria regarding accuracy, reliability, 
sensitivity and specificity. A number of techniques are available for measuring 
the rate of lipid peroxidation (Halliwell and Gutteridge, 1989). For example,
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three measurable species are produced during microsomal lipid peroxidaton, 
including lipid hydroperoxides, lipids containing conjugated dienes and 
malondialdehyde (MDA). Reduction of iodide by peroxides is a convenient 
method for determining the amount of lipid hydroperoxides present in a 
membrane sample and it permits an accurate comparison of lipid peroxide levels 
in dissimilar lipid membranes. However, its use is limited by the fact that lipid 
hydroperoxides are transient species that are exposed to factors such as transition 
metals that catalyse their breakdown. In vivo and in vitro lipid peroxidation is 
accompanied by a rearrangement of the polyunsaturated fatty acid double bonds, 
leading to the formation of conjugated dienes, which absorb at 233 nm. 
Therefore, lipid peroxidation can be also measured by recording the increase in 
absorbance of extracted membrane at this wavelength. MDA, formed from the 
breakdown of polyunsaturated fatty acids, serves as a convenient index for 
determining the extent of the peroxidation reaction. The chemistry and biology of 
MDA and its formation from lipid are extensively reviewed by Janero (1990). 
Methods for the quantitative analysis of MDA include HPLC, UV and 
fluorescene spectrophotometry, and the commonly used thiobarbituric acid (TBA) 
test (Janero, 1990). The TBA test allows simple and direct quantification of fatty 
peroxide-derived, TBA-reactive MDA in the form of stable, red MDA:TBA (1:2) 
adduct whose formation requires no sample preparation other than acidification. 
In acid solution, the product absorbs light at 535 nm (Buege and Aust, 1978; 
Uchiyama and Mihara, 1978). Most of the MDA that reacts in the TBA test was 
not present in the sample assayed but formed by decomposition of lipid peroxides 
during the acid heating stage of the TBA assay. This test has been widely 
employed to detect and quantify lipid peroxidation in a variety of biological
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samples (Suleiman et al, 1996; Nielsen et al, 1997; Marcus et al, 1998; Liu et al, 
1999). Due to its sensitivity and specificity, the TBA test was used to measure 
MDA levels in the three groups of volunteers recruited for this study and the 
effect of age, AD and gender were investigated.
4.2 Results
Lipid peroxidation was measured by determining the MDA production, using 
TBA (Buege and Aust, 1978). The MDA level was measured in the blood plasma 
of the three groups of volunteers and all measurements were carried out in 
triplicate.
4.2.1 Experimental variability
Experimental variability was studied and the results were summarised in Table
4.1. Inter-subject variability showed CV of 17.0 % for the healthy younger group 




Variability expressed as 
mean ± standard deviation (range) 
coefficient of variation (CV) in %
Intra-day 4.6 ±3.4
(n = 3) (1.3-8.0)
Inter-day 34.5 ± 7.0
(n = 3 ) (26.4-38.7)
Intra-assay Age < 30 5.6 ±3.3
(n = 25) (0.8-13.3)
Age > 60 6.5 ±4.8
(n = 25) (0.7-21.1)
Intra-subject 5.6 ±2.9
(n = 5) (1.6-8.7)
Table 4.1 Intra- and inter-day, intra-assay and intra-subject variability in 
MDA assay.
4.2.2 Plasma malondialdehyde concentration
A two sample t-test and ANOVA were used for analysis because the data were 
normally distributed. This was shown by the Anderson-Darling normality test 
(.P = 0.57, n = 75). The plasma MDA concentration in the blood plasma of all 




Plasma MDA concentration (pM)
Sample size
(n)
mean ± SD Range
All volunteers 1.32 ± 0.18 0.74-1.72 75
Healthy (age < 30) 1.28 ±0.22 0.94-1.71 25
Healthy (age > 60) 1.26 ± 0.15 0.74-1.48 25
Alzheimer’s
(age > 60) 1.41 ±0.12 1.12-1.72 25
Table 4.2 The plasma MDA concentration of the three groups of volunteers: 
healthy young (age < 30) and old (age > 60); and the Alzheimer’s group (age 
>60).
Statistical analysis revealed no significant effect of age (P = 0.20) and gender (P 
= 0.19) on plasma MDA level. However, the plasma MDA level of the AD group 
was significantly higher than that of the healthy older group (P = 0.0003).
4.3 Discussion
One of the most frequently used biomarkers of the overall lipid peroxidation level 
is the plasma concentration of MDA, one of several by-products of lipid 
peroxidation processes. Proper utilisation requires reliable reference intervals 
from large unselected human population and thorough evaluation of the influence
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of age and gender, as well as other variations within the population. Nielsen et al
(1997) conducted a study of plasma MDA using the TBA test (with additional 
HPLC as a separation step) to establish a reference interval in a sample group and 
to assess the possible influence of age, gender, smoking and alcohol on plasma 
MDA. Their findings revealed no significant effect from age but from gender 
with men having higher plasma MDA levels than women. Also, smokers were 
revealed to have a significantly higher plasma MDA level than non-smokers. 
Plasma MDA was also found to correlate with alcohol consumption. In this 
study, the effect of age, AD and gender on plasma MDA level was investigated 
but only AD had a significant effect on plasma MDA. This observation is similar 
to that reported by Marcus et al (1998) where there was an overall average 
increase in lipid peroxidation (MDA-TBA level) in all sampled regions of the AD 
brain. Other studies on various AD brain regions also showed an increase in 
oxidative stress as evidenced by elevated levels of peroxidation products 
(Richardson, 1993; Markesbery, 1997). Although age was revealed to have no 
effect on lipid peroxidation measured in this study and that by Marcus et al
(1998), other studies have demonstrated an increase of lipid peroxidation with 
age (Mizuno and Ohta, 1986; Beckman and Ames, 1998), reflecting a high level 
of oxidative stress experienced during the ageing process as proposed by the free 
radical theory of ageing.
Two underlying assumptions are implicit from the widespread use of the TBA 
test to assess lipid peroxidation: an operative and quantitative relationship exits 
between lipid peroxidation and MDA; product formation during the TBA test is 
diagnostic of the presence and amount of fatty peroxides. Although the TBA
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assay is the most frequently used method for determining the extent of membrane 
lipid in vitro, it is not suitable for in vivo study since MDA is readily metabolized 
in vivo and in tissue suspensions. In addition, MDA reacts with tissue 
components to form cross-linked lipofucin pigments, thus decreasing its 
intracellular concentration. MDA production during the peroxidation of 
microsomal membranes varies among different types of tissues, thus making it 
difficult to accurately compare the extent of lipid peroxidation. This is caused in 
part by the different amounts of polyunsaturated fatty acids present in the 
microsomal membranes from different tissues. Since only unsaturated fatty acids 
with three or more methylene-interrupted double bonds can ultimately form 
MDA, variation in MDA production may be a reflection of the lipid composition 
rather than the susceptibility to lipid peroxidation. Tissue aldehydes and sugars 
also react with TBA to produce a chromophore absorbing at 535 nm. Both 
acetaldehyde and sucrose interfere with the detection of MDA when present in 
millimolar quantities. Reducing the temperature in the heating step from 100 °C 
to 80 °C can minimise interference from sucrose present in buffers. Furthermore, 
the anticoagulant used during blood sampling might affect the plasma MDA 
level. However, EDTA-treated plasma that was used in this study was found to 
generate the least interference to the degree of lipid peroxidation at the time of 
blood sampling (Nielson et al, 1997). Despite these problems, the TBA assay 
remains a useful tool in monitoring lipid peroxidation in vitro owing to its 
sensitivity and simplicity. It is important to remember that the TBA test is by no 
means the only method for the assessment of lipid peroxidation. Different 
techniques measure different products of lipid peroxidation and to date, no single 
method sufficiently meets analytical standards in all applications to make it the
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method of choice. ' In future work, it would therefore be useful to measure 
different parameters using two or more methods to assess lipid peroxidation. 
This would provide a better understanding of the effect of oxidative damage to 





Glutathione is an extremely important water-soluble intracellular antioxidant, found 
primarily in the cell cytosol (Meister and Anderson, 1983). Oxidants, in particular 
H2O2 , are neutralised by conversion of reduced glutathione (GSH) to its oxidised 
form, GSSG, after which GSH is reformed through the glutathione peroxidase- 
reductase enzyme system (Section 1.3.3.3) (Halliwell and Gutteridge, 1989). GSH is 
also important in maintaining ascorbate levels, the reduced form of vitamin C, in the 
cytosol and in plasma. Ascorbate in turn maintains levels of the lipid soluble vitamin 
E in the cell membrane, necessary to prevent lipid peroxidation (Martensson and 
Meister, 1991). GSH is widely distributed in human tissues (Meister and Anderson, 
1983) and participates in the protection of cells against the toxic effects of free 
radicals which are produced during oxidative stress and are involved in human 
diseases, ageing and age-related diseases such as AD (Section 1.3.3). One of the 
claims in the free radical theory of ageing is that there is a significant decrease in the. 
defence mechanism towards stress in old cells relative to young cells. (Harman, 
1981). This reduction results in biological damage to essential macromolecules, 
eventually leading to cell death (Beckman and Ames, 1998). AD has been described
126
as a "free radical" disease by Harman (1992), suggesting the involvement of 
oxidative stress in the pathogenesis of the disease.
Several methods have been devised to measure tissue levels of GSH and GSSG. The 
HPLC technique proposed by Fariss and Reed (1987) is universally considered as a 
standard method but it is time-consuming. A commonly used procedure is the 
enzymatic assay developed by Tietze (1969). A fluorometric method was proposed 
by Hissin and Hilf (1976). More recently, a simple, patented colorimetric method 
(GSH-400, Bioxytech, France) has also been made available. These three commonly 
used non HPLC-based methods were extensively evaluated for the rapid 
determination of glutathione in guinea-pig heart and liver by Floreani et al (1997). 
The enzymatic method was found to be the most reliable method for tissue 
glutathione measurements but the fluorometric method is still widely used because of 
its high sensitivity. For plasma glutathione measurement in humans, the enzymatic 
method is not sufficiently sensitive since plasma contains mainly albumin and only 
small amounts of GSH and a modified version of the fluorometric method developed 
by Hu (1994) can be used instead.
5.1.1 Fluorometric method for the determination of GSH and GSSG
A convenient method for measuring tissue glutathione using the fluorescent reagent 
OPT, (Hissin and Hilf, 1976) has been modified to measure plasma glutathione (Hu, 
1994). This method was shown to be specific for GSH and GSSG, since the
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fluorescence observed with a variety of other substances appeared to be minimal 
compared to that seen-for GSH and GSSG. GSH is the predominant form of total 
glutathione under physiological conditions. The GSSG assay utilises NEM to 
prevent oxidation of GSH to GSSG, removing the error that may arise from this 
unintentional conversion. GSH was shown to react specifically with OPT at pH 8, 
yielding a highly fluorescent product that could be activated at 350 nm with an 
emission peak at 420 nm (Cohn and Lyle, 1966). The reaction was found to be pH- 
dependent since the fluorescent intensity decreased below pH 8. At pH 12, the 
conversion of GSH to GSSG was negligible and the absorbance and emission spectra 
for the OPT-GSSG reaction were similar to that for GSH, namely 350 nm and 420 
nm, respectively. To understand the role of glutathione in the defence mechanism 
against free radical attack, the effects of age, AD and gender on the plasma GSH and 
GSSG levels were investigated using this fluorometric technique.
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5.2 Results
5.2.1 Standard GSH and GSSG curves
In constructing GSH and GSSG standard curves (Figure 5.1 and 5.2), variations were 
observed. The results for standard curves derived from three sets of separately 
prepared stock standards permitted study of the intra-day variation (i.e. all three 
curves constructed in one day) and the inter-day variation (i.e. two curves 
constructed on two separate days) in system standardisation. A good linear 
relationship existed in these standard curves as indicated by high adjusted R-squared 
values (96.2 % - 99.4 %). The fluorescence intensity for the OPT-GSH action at 
pH 8 was directly related to GSH concentration and was linear in the concentration 
range of 0.5-10 juM (Figure 5.1). Similarly, the fluorescence intensity for the OPT- 
GSSG at pH 12 was observed to be linear over the concentration range of 
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Figure 5.1 Intra-day (A) and Inter-day (B) GSH standard curves. Fluorescence 
intensity was measured at 420 nm (excitation was at 350 nm) and expressed as a 
function of the concentration of GSH. A: Intra-day curve was derived from three 
separate standard curves obtained within one day, R2 (adjusted) = 99.3 %; B: Inter­
day curve was derived from two separate standard curves obtained on two separate 
days, R2 (adjusted) = 96.2 %.
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Figure 5.2 Intra-day (A) and Inter-day (B) GSSG standard curves. Fluorescence 
intensity was measured at 420 nm (excitation was at 350 nm) and expressed as a 
function of the concentration of GSSG. A: Intra-day curve was derived from three 
separate standard curves obtained within one day, R2 (adjusted) = 99.4 %; B: Inter­
day curve was derived from two separate standard curves obtained on two separate 
days, R2 (adjusted) = 99.3 %.
5.2.2 Experimental variability
Experimental variability was studied and the results were summarised in Table 5.1
and 5.2.
Variability
Variability expressed as 
mean ± standard deviation (range) 
coefficient of variation (CV) in %
GSH GSSG
Intra-day 25.2 ±11.1 27.8 ± 5.4
(n = 3) (16.2-37.6) (22.6-33.3)
Inter-day 30.2 ±24.1 14.8 ± 1.4
(n = 4) (4.5-61.3) (13.4-16.8)
Intra-assay
Healthy
Age < 30 28.1 ± 14.3 11.6 ±7.5
(5.3-61.8) (2.1-27.8)
(n = 24) (n = 25)
Age > 60 24.3 ± 11.8 13.6 ± 12.4
(n = 25) (4.9-44.4) (0.8-50.0)
Alzheimer's
Age > 60 10.2 ±7.8 3.6 ±2.2
<Nii (1.0-30.9) (0.1-9.2)
Intra-subject 25.5 ±5.7 17.9 ± 11.6
(n = 5) (18.6-34.0) (6.1-32.0)






coefficient of variation (CV) in %
Young (age < 30) 
n = 25
Old (age > 60) 
n = 25
Alzheimer’s (age > 60) 
n = 25
GSH 46.6 48.8 68.0
GSSG 51.8 40.0 22.1
Table 5.2 Inter-subject variability in the GSH and GSSG assay.
5.2.3 Measurement of GSH and GSSG in plasma
Using this fluorometric method, GSH and GSSG levels in human blood plasma 
collected from three volunteer groups were measured. These values were 
summarised in Table 5.3. Using non-parametric statistical tests (Section 2.5), age, 
AD and gender were revealed to have no significant effect on the levels of GSH (P = 
0.90, P = 0.24 and P = 0.64, respectively). However, in the male, over 60 subgroup, 
GSH levels in the healthy sector were found to be significantly higher than that in the 
AD group. For GSSG measurements, the effect of both age and gender were 
insignificant (P = 0.50 and P = 0.32). However, AD was revealed to have a 
significant effect on GSSG levels with that in the healthy older group significantly
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lower than that in the AD group (P = 0.002). The level of GSH was found to be 
significantly higher than that of GSSG in all three volunteer groups (P = 0.00).
Age group Mean ± SD (pM) Range (pM) Sample 
size (n)
All age group 
GSH 4.83 ±2.61 1.44-12.7 75
GSSG 2.22 ±0.88 0.80-4.65 75
Healthy 
Age < 30
GSH 4.99 ± 2.33 2.03-11.2 25
GSSG 2.29 ±1.18 0.82-4.65 25
Healthy 
Age > 60
GSH 4.96 ±2.42 1.44-10.8 25
GSSG 1.90 ±0.70 0.80-3.71 25
Alzheimer’s 
Age > 60
GSH 4.55 ± 3.09 1.48-12.7 25
GSSG 2.48 ± 0.55 1.72-4.21 25




In this study, the GSH and GSSG levels of the three volunteer groups were 
compared. The values of the intra-day, inter-day, intra-assay and intra-subject 
variability were lower than that of the inter-subject variability. Therefore, when 
standardising the GSH and GSSG assay, real physiological variations inherent to 
individuals could present a bigger problem than variations arising during the 
experimental procedures. Due to limited availability of volunteers, it was difficult to 
apply strict selection criteria during recruitment and therefore variations such as 
lifestyle, diet and intake of antioxidants may affect the findings and explain a high 
inter-subject variability. To minimise inter-subject availability, the problem of 
limited availability of old and AD volunteers needed to be addressed. GSH was the 
predominant form of glutathione in blood plasma. In general, age, AD and gender 
did not affect GSH measurements although in the male old subgroup, GSH level was 
higher in the healthy sector than in the AD sector. A better antioxidant defence in 
healthy individuals compared to that in Alzheimer’s patients may explain this 
observation although why this difference is observed exclusively in males is not 
understood. Age and gender did not affect GSSG measurements but AD was found 
to have a significant effect on the measurements. GSSG levels in the AD group were 
found to be significantly higher than that in the healthy older group. The explanation 
for this observation may be due to the high level of oxidative stress possibly found in 
AD patients, with glutathione mainly in the oxidised form. Various complications 
arise during interpretation of data collected for any glutathione studies. One of these
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is that defence is induced in response to stress. Therefore, a higher level of GSH 
may indicate better protection, or alternatively, greater need for antioxidant defence 
due to increase in oxidant generation. On the other hand, a lower level of GSH may 
indicate a depletion in the antioxidant reserve following oxidative stress or it may 
simply be a result of a low antioxidant supply in the diet. In addition, interactions 
between antioxidants are complex, which aggravates the problem. Few studies have 
been carried out to monitor glutathione levels in humans and these findings suggest 
that glutathione levels may vary with several demographic and health-related 
attributes such as age, gender, disease, diet and diet-supplementation (Flagg et al, 
1993; Hu et al, 1996; Liu and Wei, 1999). Flagg et al (1993) found that total plasma 
glutathione decreased with age in females but increased with age in males; Liu and 
Wei (1999) found that the level of total blood glutathione was significantly higher in 
young smokers than in ageing smokers. In the study conducted by Hu et al (1996), 
short-term supplements of a-tocopherol increased both plasma a-tocopherol and 
GSH in a time-dependent and dosage-dependent fashion. Data from human 
glutathione studies, including this investigation, should be interpreted with caution 
because several factors may affect the study results. Sample size was often small 
and only allowed preliminary conclusions and should be considered as a pilot project 
for a larger confirmatory study in the future. Furthermore, GSH and GSSG were 
assayed separately in some studies while a combination of these two forms was 
assayed in others. It is also important to note that glutathione levels have been 
measured in various extracts, for example, liver, blood and plasma and different 
levels have been detected at different sources (Ikegami et al, 1994). Plasma GSH
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has been found to be a useful marker of a generalised increase in oxidant activity and 
a decrease in antioxidant defence since plasma GSH level were found to reflect other 
tissue GSH levels (Ikegami et al, 1994). In contrast, plasma GSSG levels did not 
reflect GSSG levels in tissue. Also, conditions for sample storage and processing 
can affect glutathione levels. Furthermore, it is difficult to compare data from 
different studies because the methods for measurement are often different. A large 
number of glutathione studies have been carried out in animal models and those 
studies that have measured age-related changes in antioxidant defence have 
generated conflicting results (Beckman and Ames, 1998). GSH decreased in the 
ageing rat brain whereas GSSG remained practically constant or dropped only 
slightly thus lowering the glutathione redox index during ageing (Benzi et al, 1988). 
In contrast, an inconsistent pattern of changes with age was observed in GSH levels 
in various tissues of gerbils (Sohal et al, 1995). In conclusion, glutathione levels do 
seem to change with age but the pattern of change has yet to be established.
Oxidative stress, meaning an imbalance between the spread of reactive oxygen 
species and the antioxidant defence may be involved in the pathogenesis of AD 
(Benzi and Moretti, 1995). Age-related GSH depletion leads to reduced protein and 
DNA synthesis because of its pivotal role as a reducing equivalent for the 
glutaredoxin system supplying electrons to ribonucleotide reductase. GSH depletion 
in the rat led to striking degeneration of brain mitochondria (Jain et al, 1991). After 
GSH oxidation, mitochondria are unable to export GSSG and this may be an 
important mechanism of neuronal derangement or death. Benzi and Moretti (1995)
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suggest there may be a compensatory increase in GSH in the ageing AD brain 
concomitant with an even larger increase in GSSG. Data obtained for the plasma 
GSSG level of AD patients from this study agree with this suggestion. There is no 
doubt that glutathione plays an important role in the antioxidant defence mechanism 
against oxidative stress in ageing and AD. Further human studies are needed to 
establish the method of choice for glutathione measurements and to investigate the 
GSH and GSSG relationship with age and AD.
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CHAPTER 6
TOTAL ANTIOXIDANT ACTIVITY ASSAY
6,1 Introduction
Ageing and age-related diseases are often proposed to be associated with 
increased oxidative stress (Section 1.4). Excess production of reactive oxygen 
radicals by various enzymatic and non-enzymatic processes in living organisms 
has been associated with the oxidation of DNA, lipids and proteins (see Section 
1.3.3.2). Antioxidants, which assist cells to cope with oxidative stress by 
effectively quenching free radicals, have been linked to disease prevention (Gey, 
1993). A broad definition of an antioxidant is “any substance that when present 
at low concentration compared to those of an oxidised substrate, significantly 
delays or prevents oxidation of that substrate” (Halliwell and Gutteridge, 1989). 
L-ascorbic acid, reduced glutathione, uric acids and enzymes such as glutathione 
peroxidase and superoxide dismutase are examples of antioxidants which protect 
living organisms from oxidative damage.
A number of methods to measure total antioxidant activity (TAA) in biological 
fluids such as plasma and serum have been reported over the last decade, 
reflecting the increasing interest in this area. The majority of these assays are 
based on the inhibition of accumulation of oxidised products and utilise 
fluorescent or chemiluminescent end points. The generation of free radical
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species is inhibited by the addition of antioxidants, which reduces the end point 
by scavenging the free radical. The radical that is generated, the end point that is 
used, and the reproducibility of the generating process vary. These methods were 
extensively reviewed by Miller and Rice-Evans (1996). The most widely used 
TAA assay has been the TRAP assay of Wayner et al (1985) and its subsequent 
developments (Metsa-Ketela, 1991). Briefly, peroxyl radicals are produced at a 
constant rate by thermal decomposition of 2,2’-azobis-(2-amidinopropane) in the 
aqueous phase. Peroxyl radical reactions are monitored by luminol-enhanced 
chemiluminescence. The time for which the added test sample of plasma 
extinguishes the reaction is directly proportional to the peroxyl radical-trapping 
antioxidant capacity of the sample i.e. TRAP which is expressed as micromoles 
of peroxyl radicals trapped by one litre of the sample. A further modification has 
been the introduction of an assay for antioxidants in the lipid phase using 2,2 - 
azobis-(2,4-dimethylvaleronitrile) as the source of peroxyl radicals (Metsa-Ketela 
and Kirkkola, 1992). Another enhanced chemiluminescent reaction involving 
horseradish peroxidase and luminol to detect antioxidants and measure 
antioxidant capacity was reported by Whitehead et al (1992).
6.1.1 Spectrophotometric determination of TAA by inhibition of the radical 
cation of ABTS*+ formation
The principle behind the ABTS*+ assay system (Miller et al, 1993; Rice-Evans 
and Miller, 1994) is the formation of the ferrylmyoglobin radical from 
metmyoglobin and H2O2 in the presence of the peroxidase ABTS (^max 342 nm) 
to produce the ABTS radical cation (ABTS*+), a blue/green chromogen with
characteristic absorption maxima at 645, 734, and 815 nm, as well as the well- 
recognised maximum at 417 nm (Figure 6.1). The formation of this coloured 
radical cation can be suppressed by hydrogen-donating antioxidants. The extent 
of the suppression can be directly related to the antioxidant capacity (activity) of 
the sample being investigated. There are several strategies for studying the 
antioxidant activity of compounds using this method. These strategies are:
a) a decolourisation assay, in which the reaction between ABTS and H2O2 is 
allowed to proceed until a mixture with a stable colour is produced by the 
generation of a stable ABTS#+ radical. An aliquot of the antioxidant- 
containing sample is added and the colour lost or the colour remaining can be 
used as an index of TAA;
b) an inhibition assay, measuring the parameters at a fixed point in time; ABTS, 
MetMb and the sample are mixed and the reaction is initiated by adding 
H2O2 . After a fixed time, the absorbance is read, along with a buffer blank 
which will have a higher absorbance value than a solution containing 
antioxidant(s). The percentage inhibition is determined by comparison with 
the blank assay (Section 2.4.5.2);
c) an inhibition assay in which the reaction rates are measured. All the reagents 
are added together, and the reaction is started by addition of H2O2 . 
Comparisons are made using the reaction rates rather than absorbance at a 
fixed time point; and
d) lag time measurement. All the reagents are mixed together at time zero and 
the time taken for a colour to develop in steady state is monitored. The length
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of the lag time before reaching the steady state in the reaction is proportional 
to the concentration of antioxidant in the sample.
The strategy followed in the development of the assay protocol by Miller and 
Rice-Evans (1994) was outlined in b) above and Figure 6.2. This procedure 
(automated or manual) has been applied to body fluids, physiological antioxidant 
compounds and radical-scavenging drugs, and an antioxidant ranking was 
established based on their reactivity relative to a 1.0 mmol/1 Trolox standard. 
Assay conditions (75 pM H2O2 and incubation time of 6 min) in the original 
method (Miller et al, 1993) allow the slowest reaction rate to take place and is 
most suitable for TEAC determination of pure substances. The plasma protocol 
(375 jliM H2O2 and incubation time of 200 s) is more suitable for use with 
complex mixtures which may have endogenous peroxidase activity (Miller and 
Rice-Evans, 1996). The manual procedure was used in this study to investigate 
the total plasma antioxidant activity of the young and old healthy volunteers and 
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Figure 6.1 ABTS (Xmax 342 nm) and its radical cation (^max 417 nm, peaks at 
645, 734 and 815 nm) and dication derivatives (A,max 513 nm) (Miller and Rice- 
Evans, 1996).
HX - Fe1" + H20 2
MetMb






Figure 6.2 Formation of the ABTS*+ radical cation from activated myoglobin 
(Rice-Evans and Miller, 1994).
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6.2 Results
The derivation of a TEAC value allows investigation of the effect of age, AD and 
gender on the total antioxidant capacity of human plasma collected from the three 
groups of volunteers.
6.2.1 Standardisation of the assay
The system was standardised using Trolox, an a-tocopherol analogue with 
enhanced water solubility. The dose-response curve for percentage inhibition of 
A734 nm versus Trolox concentration was highly reproducible under the conditions 
described in Section 2.4.5.1. Two types of dose-response curve were constructed 
for this assay, with the incubation period being 200 s and 6 min, respectively. 
The results for dose-response curves derived from three sets of separately 
prepared stock standards allowed study of the intra-day variation (i.e. all three 
curves constructed in one day) and the inter-day variation (i.e. three curves 
constructed on three separate days) in system standardisation. These results are 
summarised in Figure 6.3 and 6.4. Regression lines were fitted and a linear 
relationship existed in each dose response curve (adjusted R2 = 95.8-98.5 %).
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Figure 6.3 Intra-day (A) and Inter-day (B) dose-response curve (t = 200 s) 
for the determination of TEAC values of blood plasma samples. Percentage 
of inhibition of the absorbance at 734 nm was expressed as a function of the 
concentration of Trolox. A: Intra-day curve was derived from three separate 
calibration curves obtained within one day, R~ (adj) = 98.4 %; B: Inter-day curve 
was derived from three separate calibration curves obtained on three separate 














Concentration of Trolox (mM)
1.0
B. Inter-day
Figure 6.4 Intra-day (A) and Inter-day (B) dose-response curve (t = 6 min) 
for the determination of TEAC values of pure antioxidant substances.
Percentage of inhibition of the absorbance at 734 nm was expressed as a function 
of the concentration of Trolox. A: Intra-day curve was derived from three 
separate calibration curves obtained within one day, R2 (adj) = 95.8 %; B: Inter­
day curve was derived from three separate calibration curves obtained on three 
separate days, R2 (adj) = 97.7 %. The incubation period was 6 min. Mean ± SD 
shown (n = 3).
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6.2.2 Experimental variability
Experimental variability was studied and the results are summarised in Table 6.1. 
Inter-subject variability showed a CV of 19.2 % (n = 25) for the young, 15.6 % (n 
= 25) for the old and 54.1 % (n = 25) for the Alzheimer’s patients.
Variability
Variability expressed as 
mean ± standard deviation (range) 
coefficient of variation (CV) in %
Intra-day 13.7 ±7.8
(n = 12) (5.5-31.1)
Inter-day 7.0 ±8.6
(n = 4) (1.4-19.7)
Intra-assay
Healthy
Age < 30 5.3 ±3.6
(n = 25) (0.9-15.3)
Age > 60 5.8 ±3.3
(n = 25) (0.0-12.9)
Alzheimer’s
Age > 60 4.8 ±3.3
(n = 25) (0.00-10.1)
Intra-subject 26.2 ±22.2
(n = 5) (9.2-65.0)
Table 6.1 Intra- and inter-day, intra-assay, intra-subject variability in 
TEAC assay.
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6.2.3 Total antioxidant activity of plasma
The total plasma aiitioxidant activity of all three groups of volunteers was 
measured and the findings are summarised in Table 6.2.
Volunteer group TEAC value (mM) Sample size
(n)mean ± SD Range
All volunteers 0.84 ± 0.33 0.20-1.92 75
Healthy (age < 30) 0.76 ±0.15 0.52-1.07 25
Healthy (age > 60) 0.80 ±0.12 0.60-1.03 25
Alzheimer’s
(age > 60) 0.96 ± 0.52 0.20-1.92 25
Table 6.2 Total antioxidant activity (TAA) for human plasma samples from 
three groups of volunteers: healthy young (age < 30) and old (age > 60); and 
the Alzheimer’s group (age > 60). Trolox equivalent antioxidant capacity 
(TEAC) was used as the unit for TAA.
Non-parametric statistical tests (Section 2.5) were used to compare the results 
shown in Table 6.2 (data deviated from normality). No significant difference was 
observed between the total plasma antioxidant status of the three groups of 
volunteers. Neither age nor AD were revealed to have any significant effect on 
TEAC values of the plasma population in this study (P = 0.29 and P = 0.62, 
respectively). Further analysis revealed no significant effect of gender on the
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TEAC values as a whole (P = 0.23). However, in the healthy female group, 
TEAC values were found to be significantly higher in the old than in the young (P 
= 0.031).
6.2.4 TEAC values of pure antioxidant substances
Solutions of antioxidant substances were compared to Trolox solutions by means 
of this assay, and hence to one another on the basis of molar antioxidant activity. 
TEAC values of potential antioxidants were derived and the results are shown in 
Table 6.3. The table shows that the data collected from this study and that from 
another study were similar (Rice-Evans and Miller, 1994). Table 6.3 also shows 
that the plasma antioxidants ascorbate, urate and glutathione had similar 
antioxidant capacity to Trolox. Double distilled deionised water and lithium 
carbonate solution were both used in preparing the antioxidants and they both had 
TEAC values of 0.00 indicating that they did not influence the total antioxidant 
value of the sample.
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Substance Published data* Data from this study
TEAC n SD TEAC n SD
L-ascorbic acid 0.99 5 0.04 0.91 6 0.12
Reduced glutathione 0.90 3 0.03 0.94 5 0.12
Uric acid 1.02 5 0.06 1.02 6 0.14
*Rice-Evans and Miller, 1994
Table 6.3 Trolox equivalent antioxidant capacity (TEAC) values of pure 
antioxidant substances. TEAC is the concentration in millimolar of Trolox 
having the equivalent antioxidant capacity to a 1.00 mM solution of the substance 
under investigation.
6.3 Discussion
The derivation of a TEAC value provides a method to compare the antioxidant 
activity among groups of compounds, provided they are water-soluble or can be 
solubilised, or of body fluids, such as plasma and serum. Applying this method, 
the plasma TAA of 75 volunteers was monitored and the effect of age, AD and 
gender on the TAA status was investigated. Blood plasma was obtained for this 
study because of its ease of collection and its reflection of the total antioxidant 
capacity of the human body. According to Miller and Rice-Evans (1996), the 
principle antioxidants of human plasma are albumin and uric acid which account
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for 57 % of the TAA of most samples. The residual activity is referred to as the 
“antioxidant gap”, which reflects the combined activity of ascorbic acid, a- 
tocopherol, bilirubin, p-carotene and other plasma antioxidants such as 
flavonoids. Applying the method devised by Rice-Evans and Miller (1994), 
ascorbate, urate and glutathione had almost the same molar equivalent antioxidant 
capacity as Trolox (TEAC value about 1.00). Similar findings were reported by 
Miller et al (1993). They also reported that bilirubin was a more efficient 
antioxidant (TEAC value: 1.50) and albumin is less active (TEAC value: 0.63) on 
a mole for mole basis.
The reference interval (95th percentile range) obtained from the 75 volunteers for 
this study was 0.19-1.49 mM. This value is lower than that quoted by Miller et al 
(1993) in their study of TAA in premature neonates using the same TEAC
thmethod. An adult reference interval (95 percentile range) of 1.32-1.60 mM was 
derived for their method, based on 312 normal human plasma or serum samples 
(information on subjects not given). This difference maybe accounted for by the 
difference in the selection criteria of subjects, the sample size of the two studies 
and the type of protocol used. We used the manual TAA protocol in this study 
compared with the automated TAA protocol using premixed reagent and the 
Cobas Bio Centrifugal analyser, carried out by Miller et al (1993). The 
automated method offers the advantages of better control of timing and 
temperature, the ability to process a large batch of samples at one time, simplicity 
and speed. However, the manual method is a cheaper alternative and with strict 
regulation of timing and temperature, can be used for TAA study effectively. In 
other studies which measure plasma or serum TAA, Wayner et al (1985) quoted a
reference interval of 0.81-1.12 mM for human plasma TAA using the TRAP 
assay and Whitehead et al (1992) quoted a reference interval of 0.75-0.91 mM for 
human serum TAA using the technique of enhanced chemiluminescence.
Ageing and the diseases that typically follow with increasing age are often 
proposed to be involved in increased oxidative stress. In this study, neither age 
nor AD was shown to have a significant effect on human plasma TAA. However, 
in the healthy female subgroup, plasma TAA was found to be higher in the old 
(age > 60) than in the young (age < 30). Aejmelaeus et al (1997) using a 
chemiluminescence assay to assess TRAP in human plasma, demonstrated that 
TRAP changes with age. In females, TRAP increased significantly during the life 
span which is consistent with the findings of our study in TEAC. In males, 
TRAP increased until age 51-74, and then significantly decreased. Aejmelaeus et 
al (1997) suggested that these changes in TRAP in both sexes were mainly due to 
the contribution of unidentified antioxidants. Uric acid concentration, determined 
by HPLC, was also found to increase significantly with age in the female group, 
contributing to 57 % in the increase in TRAP. Previous results indicated that 
plasma uric acid concentration is clearly lower in the female than in the male 
population until the sixth decade of life (Akizuki, 1982), possibly because either 
17-p oestradiol partly regulates purine biosynthesis and uric acid metabolism or 
tubular urate postsecretory reabsorption is lower in premenopausal women 
(Mateos et al, 1986). Uric acid may preserve the ability of vascular endothelium 
to mediate dilatation by preventing oxidative inactivation of endothelial cyclo- 
oxygenase and angiotensin converting enzyme. Uric acid scavenges 
peroxynitrite, the formation of which may be accelerated in ischaemic tissues.
This is why increasing uric acid concentration may be beneficial in 
postmenopausal women, who have lost the protecting properties of oestradiol, 
which is proposed to regulate arterial relaxation and prevent oxidative damage of 
low density lipoprotein (Aejmelaeus et al, 1997). It should be stressed that the 
interpretation of assay values can be made in different ways. High values may 
indicate an induced response to oxidative stress. On the other hand, low values 
may indicate lack of antioxidant supply in the diet e.g. ascorbate or from the 
endogenous sources e.g. urate, thus leaving the individual susceptible to oxidative 
damage during periods of stress. Alternatively, it may be seen as evidence that 
the antioxidant reserve has been depleted following oxidative stress. The former 
can be substantiated by measuring the concentration of an individual antioxidant 
in plasma. The latter seems to be the case with the acute falls seen following 
stressful events such as acute inflammatory diseases or burns (Whitehead et al, 
1992). Oxidative stress has also been implicated in the pathogenesis of AD 
(Markesbery, 1997). Although the effect of AD on plasma TAA was found to be 
insignificant in this study, the study carried out by Zaman et al (1992) proved 
otherwise. Plasma concentrations of vitamins A and E and carotenoids were 
found to be significantly lower in AD patients than those in controls.
Plasma is essentially a mixture of known and unknown antioxidants and this has 
presented scientists with the challenge to develop an assay which not only 
determines the overall antioxidant capacity of plasma but also to study the nature 
of the antioxidant profile. Each existing assay has its own characteristics and 
therefore none of the assays can give a complete picture of the antioxidant profile 
of a compound. The TAA assay developed by Rice-Evans and Miller (1994)
used in this work is widely used, however several pitfalls have to be considered 
when it is used to determine total scavenging capacity. The time course of radical 
formation in the presence of the compound, and the length of the lag phase clearly 
indicate that the antioxidant effects of the compounds are different. Therefore, 
consideration has to be given to the fact that the assay does not distinguish 
between a scavenger effect and an inhibitory effect in the rate of ABTS radical 
formation. This is because the absorbance is measured at a fixed time point 
regardless of the time course of ABTS formation. This point has also been 
stressed by Amao et al (1996). To circumvent the effect of the compounds on 
radical formation, Strube et al (1997) used the post-addition assay in conjunction 
with the method devised by Rice-Evans and Miller (1994), in which the test 
compound was added after the ABTS radicals had formed. The decrease in 
absorption caused by the test compound reflected ABTS radical scavenging 
capacity, not inhibition of radical formation. The decrease in the slope after 
addition of the test compound indicated that the test compound inhibited radical 
formation. Strube et al (1997) found that Trolox acts only by scavenging ABTS 
radicals, while another antioxidant, quercetin displays a mix of scavenging and 
inhibitory effects. The TEAC value of a compound such as quercetin may 
depend on the time point at which absorbance was measured, due to the effect of 
the compound on the rate of radical formation. Since plasma contains a mixture 
of antioxidants, it is likely that it may display a mix of scavenging and inhibitory 
effects and so the post addition assay described by Strube et al (1997) may be 
useful if discrimination between these two effects is required. It should also be 
emphasised that the inhibitory and scavenging effects observed in in vitro systems 
such as ABTS-type assays do not necessarily reflect the in vivo situation.
Therefore, the physiological significance of the in vitro results should be 
confirmed by in vivo studies. In extrapolating the results to an in vivo situation, 
one has to ask a) if the peroxidase process mimics the process of radical 
formation in vivo and b) if the ABTS radicals resemble the radical species 
involved in an in vivo situation. Further studies are required to establish the 
relevance of these antioxidant measurements in vivo. Nevertheless, the ABTS- 
type assay is a useful tool in studying the effect of age and age-related disease on 





Oxidants induce expression of the heme oxygenase-1 (HO-1) by enhancing the 
transcription rate and so altered expression can be monitored at a variety of levels. 
Direct measurement of altered transcription rates is preferable; however the run-on 
transcription assay usually used for this measurement is labour-intensive and subject 
to inter-experimental variation. One-dimensional sodium dodecyl sulphate - 
polyacrylamide gels are normally sufficiently sensitive to detect induction of de novo 
synthesis of the protein corresponding to HO-1, but background levels are high due 
to the large number of constitutive proteins in this molecular range (Marini et al, 
1996). Western blot analysis has been used to study HO-1 activity using antibodies 
(Maines et al, 1988). Induction of HO-1 enzyme activity several hours after the 
initial treatment is easy to measure by a spectrophotometric assay which requires 
exogenous sources of biliverdin reductase (Gabis et al, 1996). Recently, an assay for 
HO (HO-1 and HO-2) activity in cultured human cells, using high performance 
liquid chromatography of biliverdin and bilirubin has been developed by Ryter et al 
(1998). Currently, the method of choice for gene expression analysis is the 
measurement of the accumulation of HO-1 mRNA (Crawford et al, 1994; Tyrrell and 
Basu-Modak, 1994).
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7.1.1 Techniques for measuring mRNA accumulation
An important aspect in the determination of gene expression is measuring mRNA 
levels of specific genes. Classical techniques to determine mRNA levels include the 
transcriptional run-on assay and Northern blot analysis (Tyrrell and Basu-Modak, 
1994). The transcription run-on assay is used to quantify the amount of primary 
RNA transcript transcribed from isolated cell nuclei, whereas northern blot 
hybridisation is used to assess the modulation of mRNA levels in the cell, regardless 
of whether the changes are due to altered transcription, stability, or transport. Tyrrell 
and Basu-Modak (1994) have described detailed methodology based on the Northern 
blot procedure to measure HO-1 mRNA levels and provided an example in which 
increased accumulation of HO-1 mRNA after oxidative stress by UVA radiation or 
H2O2 was suppressed by the free radical scavenging antioxidant, N-acetylcysteine. 
Both transcription run-on assay and Northern blot analysis have the limitation of 
requiring large amounts of total RNA, making their use unfeasible when limiting 
numbers of cells are available. With the recent advent of Reverse Transcription- 
Polymerase Chain Reaction (RT-PCR), the sensitivity and specificity for mRNA 
determination has been increased dramatically, and this technique is becoming 
widely used in gene expression studies involving small amounts of total RNA 
(Samar et al, 1994; Riedy et al, 1995).
158
7.1.2 PCR and RT-PCR
PCR is a rapid procedure for in vitro enzymatic amplification of a specific segment 
of DNA developed by Mullis et al (1986) and Saiki (1989). The first stage of RT- 
PCR reaction is the RT reaction in which RNA from cells or tissues is reverse 
transcribed to complementary DNA (cDNA) by a reverse transcriptase. The newly 
synthesised cDNA is then used as a template for PCR, using primers designed to 
amplify a selected cDNA region of a specific RNA message in the presence of DNA 
polymerase(s). The PCR-generated product is then analyzed by agarose gel 
electrophoresis and typically identified on the basis of its size. The PCR product can 
further be validated by hybridization, restriction digestion and/or nucleotide 
sequencing if desired. While Northern blot analysis typically requires several 
micrograms of total RNA with a detection limit of approximately 105-107 molecules, 
RT-PCR can be performed with much lower quantities of total RNA and can detect 
transcripts representing as little as 6 pg of total RNA. Thus RT-PCR is extremely 
well suited to detect rare transcripts and transcripts in small localized tissue samples. 
Another unique aspect of RT-PCR is that it allows for simultaneous analysis of 
multiple gene transcripts (Saiki, 1989).
7.1.3 Heme oxygenase-1 assay
Because senescence is characterised by a reduced ability of an organism to maintain 
homeostasis in response to oxidative stress, the purpose of this study was to measure
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HO-1 gene expression to determine if ageing or age-related disease affects the ability 
of human PBMCs to respond to the oxidative stress of H2O2 treatment. A 
competitive one-step "one-tube" RT-PCR assay for the quantification of HO-1 
mRNA was developed by Ahmed et al (1996). Competitor RNA is an RNA 
sequence which contains the same primer sequences present in the target transcript 
and thus competes with the target for those same primers. When a competitor is 
used, a restriction site or a sequence is added (as in this study) or deleted so that the 
target sequence can be differentiated from the competitor by electrophoresis due to 
the difference in the size of the two RNAs (Siebert and Larrick, 1992). Following 
RT-PCR, the amount of products generated by the competitor and the target are 
compared and the initial amount of target mRNA deduced. Competitive one-step 
"one-tube" RT-PCR was used initially for this study but it was later replaced by 
semi-quantitative RT-PCR due to inconsistencies associated with the competitive 
technique when amplifying total RNA in preliminary studies. Semi-quantitative RT- 
PCR uses an ubiquitously-expressed gene such as GAPDH as a control to estimate 
the relative level of gene expression. The procedures used were similar to that 
described for competitive RT-PCR but no competitor RNA standard was included 
and the steps, RT and PCR were separated. The level of expression or PCR signal 
observed for the test gene is normalised to the PCR signal obtained for the control 
gene in the same sample (Chelly et al, 1990).
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7.2 Results
7.2.1 Preparation of competitor and target RNA
Minipreps of plasmid pBsHO-l/L and pBsHO-1 were used to prepare the respective 
plasmid DNAs. Since the size difference between plasmid pBsHO-l/L and 
pBsHO-1 DNAs was very small (45 bp), their identification by gel agarose 
electrophoresis was not possible. A PCR assay using JumpStart Taq DNA 
Polymerase was therefore carried out to confirm their identities. This PCR assay 
utilises Taq DNA polymerase and TaqStart antibody and aims at improving “hot 
start” PCR. This PCR analysis confirmed the incorporation of the synthetic 45 bp 
linker into the plasmid pBsHO-1 to give the plasmid pBsHO-1/L. The amplified 
products of pBsHO-l/L and pBsHO-1 DNA were 287 bp and 242 bp, respectively 
(Figure 7.1). Plasmid pBsHO-l/L DNA was then linearised with Hind III in 
preparation for in vitro transcription. Since only one Hind III restriction site exists in 
this plasmid, linearisation by the enzyme produced one DNA fragment of 4553 bp as 
predicted (Figure 7.2). The linearised DNA template was transcribed in vitro and the 
presence of RNA (1697 b) was confirmed by gel electrophoresis (Figure 7.3). This 
RNA was used as the competitor in the competitive one-step "one-tube" RT-PCR. 
To prepare the target RNA, PBMCs from volunteers were treated with H2O2 which 
has been shown to induce HO-1 mRNA gene expression in other studies (Keyse and 
Tyrrell, 1989). The aim was to use a sub-lethal concentration of H2O2 that did not 
kill the cells. As a starting point, the cells were treated with 100 JJ.M H2O2 and the %
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cell viability before and after the treatment period; and after the 2-h incubation 
period always exceeded 95 %. Total RNA was extracted and analysed on a 1 % 
denaturing agarose gel. rRNA - 28S (5.1 kb) and 18S (1.9 kb) were resolved. As 
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Figure 7.1 Analysis of the PCR amplified products of pBsHO-l/L (lane 1) and 
pBsHO-1 DNA (lane 2) on a 2 % agarose gel stained with ethidium bromide.
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Figure 7.2 Analysis of the Hind III digestion of pBsHO-l/L DNA on a 1 % 
agarose gel stained with ethidium bromide M : 1 pg o f >X>NA/£c<?R I and Hind  
III M arker (0.5 mg/ml); 1: 1 pg of undigested pB sH O -1/L  DNA (circular, linear and 
supercoiled DN A); 2: 1 pg of the H ind  III digest product of pB sH O -l/L  DNA at 
4553 bp.
M  1 2
Figure 7.3 Analysis of the RNA product after in vitro transcription of 
pBsHO-l/L DNA on a 1 % denaturing gel stained with ethidium bromide. M : 1
pg o f G319 RNA M arker (1 mg/ml); 1: In vitro  transcribed product, positive control 




Figure 7.4 Analysis of total RNA prepared from human PBMCs on a 1 % 
denaturing gel stained with ethidium bromide. A sm ear (mRNA) with two clear 
ribosom al bands (28S at 5.1 kb and 18S at 1.9 kb) as seen after electrophoresis.
7.2.2 Competitive one-step "one-tube” RT-PCR
Separate RT-PCR assays were performed on pB sH O -1/L  RN A and total RNA, 
allowing various assay param eters to be established for both RNAs before the 
com petitive RT-PCR assay was carried out. Figure 7.5 shows the amplified products 
of an RT-PC R assay (using the Titan One-Tube RT-PC R System and primers Pi and 
P 2) on plasm id pB sH O -l/L  (1000 pg) and total RN A (1 jig) in separate tubes. The 
am plified products of pBsH O-1/L RNA and total RN A were 287 bp and 242 bp, 
respectively. To establish the sensitivity of the assay, five-fold dilutions of the 
pB sH O -l/L  RNA (130000, 26000, 5200, 1040, 208, 41.6, 8.32 pg) were prepared 
and then am plified in separate tubes (Figure 7.6). Prelim inary RT-PCR assays
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carried out on total RNA prepared from PBM Cs were not as successful as that on 
pB sH O -l/L  RNA and the amplification was weak and inconsistent. This problem 
with am plification, com bined with lim ited availability o f total RNA, made it difficult 
for further optim isation of the assay to be carried out. N evertheless, a number of 
com petitive RT-PCR assays have been carried out and generally, co-amplification 
was weak, inconsistent and unsatisfactory. Figure 7.7 shows an exam ple of this co­
amplification. Two amplified products (287 bp and 242 bp) were observed on both 







Figure 7.5 Analysis of the amplified products of an RT-PCR assay on pBsHO- 
1/L RNA (lane 1) and total RNA (lane 2) on a 2 % agarose gel stained with
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Figure 7.6 Analysis of amplified products of an RT-PCR assay, using different 
amount of pBsHO-l/L RNA as template on a 2 % agarose gel stained with 
ethidium bromide. M: 1 pg of pUC18 DNA M sp I digest (55 pg/pl); 1-7: 15 pi of 
the am plified products (287 bp) from RT-PCR of pB sH O -l/L  RNA. Five-fold 
dilutions of pB sH O -l/L  RNA were used as templates: (1)130000 pg; (2) 26000 pg; 





Figure 7.7 Analysis of the co-amplified products of a competitive one-step "one- 
tube” RT-PCR on pBsHO-l/L RNA and total RNA on a 2 % agarose gel 
stained with ethidium bromide. M: 1 pg of pUC18 D N A  M sp digest (55 pg/pl); 
1: 15 pi o f the co-am plified products after com petitive RT-PCR of pB sH O -l/L  RNA 
(1000 pg) and total RN A  (1 pg), products at 287 bp and 242 bp, respectively; 2: 15 
pi o f the co-am plified products after competitive RT-PCR of pB sH O -l/L  RNA (200 
pg) and total RNA (1 pg), products at 287 bp and 242 bp, respectively.







7.2.3 Optimisation of RT-PCR
Many attempts have been made to optimise the conditions for the HO-1 
amplification of total RNA extracted from human PBMCs (e.g. varying primer 
concentration, the number of thermal cycles and the annealing temperature) but the 
amplification still failed. Was the template intact? The integrity of this template was 
confirmed by running an aliquot on a denaturing gel. 28S (5.1 kb) and 18S (1.9 kb) 
ribosomal bands were resolved and the mRNA ran as a smear between the 2 
ribosomal RNA bands. Any degraded RNA generally run below the 18S band but 
this was not observed throughout the study (Figure 7.4). The integrity of this 
template was further confirmed by the successful amplification of the GAPDH gene 
using the Gj and G2 primers (product size: 187 bp). The efficiency of the RT-PCR 
was confirmed by this GAPDH amplification and also by the successful 
amplification of HO-1 gene in total RNA extracted from human FEK4 cells (product 
size: 242 bp). The suitability of primers Pi and P2 was also confirmed by this HO-1 
amplification of FEK4 total RNA. Despite numerous attempts to optimise RT-PCR 
conditions such as the concentration of primers and the number of thermal cycles, 
HO-1 amplification of PBMCs total RNA was unsuccessful.
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7.2.4 Semi-quantitative RT-PCR
Semi-quantitative RT-PCR was carried out at a later stage of this study in an attempt 
to over come the difficulty encountered previously in the original RT-PCR protocol. 
In this protocol, GAPDH was used as a control to estimate the relative level of gene 
expression, the RT and PCR steps were carried out separately and the competitor 
RNA was eliminated. Preliminary studies were carried out on samples donated by 
13 healthy volunteers. The amplification signal of total RNA was strong and all 
H2C>2-treated PBMCs expressed GAPDH gene but only 4 (2 from each age group) 
expressed the HO-1 gene. Thus, no densitometric analyses were performed to 
estimate the level of HO-1 expression. Figure 7.8 shows the gel analysis of the 
amplified products of semi-quantitative RT-PCR on these 4 samples of total RNA. 
GADPH and HO-1 gene were successfully amplified in all RNA samples collected at 
different stages of the experiment in subject 1 (age < 30) and 4 (age > 60). 
Amplification of RNA extracted from PBMCs after the 30-min H2O2 treatment in 
subject 2 and amplification of RNA extracted from PBMCs after the 2-h post­
treatment incubation period in subject 3 were both unsuccessful. Amplified products 
by GAPDH primers and HO-1 primers were 187 bp and 242 bp, respectively. 
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Figure 7.8 Analysis of the amplified products of semi-quantitative RT-PCR on 4 
samples of total RNA (Subjects 1-4) on a 2 % agarose gel stained with ethidium 
bromide. All 4 sets of RNA samples collected at different stages of the experiment were 
either amplified with GAPDH primers (lane 1-8, 13) or HO-1 primers (lane 9-12) giving 
products at 187 bp and 242 bp, respectively. Negative controls included no RT step (lane 
2,4,6,8) and no RNA template (lane 13). Each set of amplified products (15 pi) was loaded 
for lane 1-13. M: 1 pg of DNA 100 bp ladder (1 pg/pl); A: Untreated RNA, control for B; 
B: RNA extracted after 30-min H20 2 treatment; C: Untreated RNA, control for D; D: RNA 
extracted after 2-h post-treatment incubation; H: NF H20 .
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7.3 Discussion
Expression of the HO-1 gene is a marker of oxidative stress in mammalian cells, 
including that caused by UVA radiation or H2O2 (Keyse and Tyrrell, 1989; 
Applegate et al, 1991). It can be postulated that induction of HO-1 gene expression 
increases with oxidative stress and decreases with age and age-related disease, 
possibly due to an age-associated dysfunction in the signalling mechanism of the 
oxidative stress response (Section 1.3.3.3.1). In this study, RT-PCR methods were 
chosen to study the expression of the HO-1 gene in H202-treated human PBMCs of 
volunteers from different age groups. Initially, the competitive one-step RT-PCR 
assay for quantification of HO-1 developed by Ahmed et al (1996) was used. 
Despite numerous attempts to optimise the RT-PCR conditions, amplification of total 
RNA extracted from PBMCs remained weak and inconsistent. Semi-quantitative 
two-step RT-PCR was used later. Improved amplification was observed but the total 
RNA amplification remained inconsistent. So, what may be the reasons behind this 
difficulty in amplification?
7.3.1. Factors affecting RT-PCR performance
RNA degradation may affect the performance of RT-PCR but this was unlikely to be 
the source of inconsistencies in this study. PBMCs were lysed and homogenised in 
the presence of a highly denaturing guanidinium isothiocyanate-containing buffer 
which immediately inactivated RNases to ensure isolation of intact RNA. Total
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RNA was further protected from degradation by the inclusion of an RNAase 
inhibitor in the RT-PCR. Its integrity was confirmed by the successful amplification 
of the GAPDH gene and the absence of degraded RNA below the 18S rRNA band 
after resolution on a denaturing gel. The purity of the template is essential for 
successful amplification. Total RNA preparations with A260/A280 ratios of 1.8-2.0 
were obtained throughout the study suggesting they were essentially free of protein 
contamination. RNA-isolation methods involving the use of phenol and chloroform, 
which can inhibit RT-PCR, were replaced by the RNeasy procedure in this study in 
which total RNA was isolated using membrane and microspin technology. To 
remove genomic DNA contamination, DNase digestion of the purified RNA with 
RNase-free DNase was carried out before the semi-quantitative RT-PCR.
Poor design of primers may account for low PCR performance but the suitability of 
HO-1 primers (Pi and P2) was confirmed by the successful amplification of HO-1 
gene using FEK4  total RNA. Pi and P2 sequences were checked repeatedly to ensure 
the accuracy of amplification. The potential of the formation of internal secondary 
structure and primer-dimers in Pi and P2 were minimised by avoiding sequences that 
were complementary within each primer or between the two primers. Pi and P2 
primers were both 24 bases long and the G-C content were 58.3 % in both primers. 
These parameters were within recommendations (PCR Protocols and Reference 
Guide, Promega, September 1996) and these primers should permit the use of an 
annealing temperature high enough to enhance reaction specificity but low enough to 
enable hybridisation between primer and template.
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Low RT-PCR efficiency may also account for the weak amplification signal 
although the success in the amplification of HO-1 gene in FEK4 cells and GAPDH 
gene in PBMCs demonstrated efficient RT-PCR. Inconsistencies occurring in RT- 
PCR amplification may be reflected by the observation that the basal and induced 
level of HO-1 gene expression varies in human cells cultured from different tissues 
(Applegate et al, 1991). The abundance of basal and induced HO-1 mRNA may be 
too low in PBMCs (mainly lymphocytes and few monocytes) to be detected. This 
view is further supported by Niess et al (1998) in their investigation of the effect of 
heavy endurance exercise on the expression of HO-1 in leukocytes (PBMCs and 
granulocytes). They reported an almost undetectable baseline expression of 
HO-1 in the lymphocytes of the trained subjects. Expression of HO-1 was induced 
by exercise in most of the lymphocytes, but the amount of HO-1 expressed was less 
compared to monocytes and granulocytes. Usually, 1 jig of cytoplasmic RNA is 
sufficient for amplification of rare mRNA sequences (1 - 10 copies per cell) 
(Kawasaki, 1990). Better amplification may occur with a higher concentration of 
RNA template in some cases but this method will become unfeasible since the 
number of PBMCs available is limited and the use of RT-PCR as a sensitive tool of 
detecting gene expression will be questioned. The HO-1 mRNA level in PBMCs 
may also vary between individuals, giving rise to inconsistent RT-PCR amplification 
across the populations.
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RT-PCR has been widely used to study gene expression. Whilst it has many 
advantages over RNA blot methods, it can be difficult to obtain quantitative 
information. This is due to the exponential nature of the PCR amplification where 
small variations in amplification efficiency result in dramatic changes in product 
yields. Small differences in any of the factors that influence the reaction efficiency 
will dramatically affect the level of specific PCR products. Even when these 
parameters are controlled precisely, there are sometimes unexpected sample-to- 
sample and day-to-day variations. In addition, the amount of product generated 
plateaus during later stages of the reaction due to consumption of necessary 
components and generation of inhibitors. These characteristics of PCR can obscure 
differences in the initial amounts of target sequences during the course of 
amplification. However, these problems can be overcome by the inclusion of 
internal controls in the PCR (Zamorano et al, 1996). The advantage of the use of 
RNA competitors (Section 7.1.3) in competitive RT-PCR is that the difference in the 
efficiency of amplification between the target and competitor sequences is minimal 
since the same primers are used. However, RNA competitors are not infallible. 
RNA is susceptible to nuclease-induced degradation. Unlike total RNA extracted 
from PBMCs, the competitor RNA used in this study was amplified consistently. 
However, the co-amplification of total RNA and competitor RNA resulted in no 
amplification observed for the former with its signal either too low to be detected or 
overwhelmed by that generated from the latter.
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As an alternative to competitive RT-PCR, the constitutively expressed 
"housekeeping" gene GAPDH was used as an internal control in the semi- 
quantitative RT-PCR. This gene is usually expressed at moderate levels and is easy 
to detect. For many experimental designs, the expression level for this gene will 
remain constant across the experimental samples. However, expression of GAPDH 
can often be affected by experimental treatments, stage of development and cell type 
(Spanakis et al, 1993). Also, due to the high abundance of this gene, its amplified 
products accumulate at earlier cycles than those of the target sequences, which 
creates difficulties when one is working under the limitation of having to set the 
same number of cycles for both products. In addition, primers containing different 
sequences were used, potentially leading to different efficiencies. Many researchers 
carried out co-amplification of a control gene such as p-actin and GAPDH to correct 
for variation in tube-to-tube amplification efficiency (Mullis et al, 1994). However, 
in view of the difficulties encountered with co-amplification in competitive RT-PCR, 
GAPDH was not co-amplified with the HO-1 gene in the same tube during this 
study, in an attempt to obtain better amplification signals.
Despite numerous attempts to optimise the conditions of RT-PCR and a change of 
approach from competitive to semi-quantitative RT-PCR, the amplification of total 
RNA from PBMCs remained unsuccessful. Better amplification of total RNA was 
observed when RT and PCR were performed separately in different tubes (semi- 
quantitative RT-PCR) in contrast to competitive RT-PCR when the two steps were 
performed in a single tube in the same buffer. This difference in amplification
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performance may be due to a difference in RT efficiency in the two systems. 
Overall, amplification signals obtained in this study were not strong enough to give a 
reliable estimation of basal and induced HO-1 gene expression. Further work will be 
required to assess the sources of inconsistencies of RT-PCR amplification. Further 
optimisation of RT-PCR conditions such as magnesium and dNTPs concentrations 
should be carried out. Primers can be redesigned manually or by using commercially 
available computer program. It may be necessary to take a different approach to 
measure HO-1 gene expression at the mRNA level by using poly (A)+ RNA as the 
template. The use of poly (A)+ RNA in downstream applications offers a variety of 
advantages. For cDNA synthesis and RT-PCR, the use of poly (A)+ RNA ensures 
lower mRNA-independent synthesis. However, the selection of poly (A)+ RNA from 
very small amounts of total RNA can be technically challenging. The polyadenylytic 
acid tail that is added to the 3’ end of the RNA during nuclear processing can be used 
to isolate poly (A)+ mRNA from a complex mixture of the cellular RNA and 
contaminating DNA. This can be done by annealing this sequence to poly(dT) 
affixed to a support and capturing the tethered RNA. It may also be necessary to use 
a different technique to measure HO-1 gene expression at the mRNA level, for 
example, the northern blotting technique described by Tyrrell et al (1994). 
Alternatively, HO-1 gene expression can be assessed at the protein level using 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis as described by Marini 
et al (1996) in their study of the induction of stress proteins in human lymphocytes. 
They reported the induction of a set of eight proteins in peripheral blood 
lymphocytes by exposure to heat, H2O2 and HO-1 was found to be up-regulated by
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oxidative stress. As discussed before, the level of induction of HO-1 gene 
expression varies in human cells cultured from different tissues and therefore it may 
be necessary to consider using a different human cell type that may express HO-1 
gene to a detectable level in RT-PCR. Alternatively, cultured human lymphocytes 
may be used to provide a constant supply of total RNA for PCR optimisation and 
experimentation. However, the nature of HO-1 gene expression may be altered in 
cultured cells. Also, sodium arsenite may be used as an alternative to H2O2 as the 
source of oxidative stress in this study. Both sodium arsenite and H2O2 were found 
to induce HO-1 mRNA accumulation in human lymphoblastoid cell lines but the 
former stimulated the accumulation to a greater extent (Applegate et al, 1991). 
Sodium arsenite interacts with or modifies cellular glutathione levels and the 
intracellular redox level strongly influences the magnitude of the inducible response. 
These observations strongly support the hypothesis that induction of the enzyme is a 
general response to oxidant stress in mammalian cells and are consistent with the 
possibly that glutathione plays a key role (Chapter 5). The study of the induction of 
HO-1 gene expression in human PBMCs is at an early stage of development and 
more effort will be required to provide a better understanding of the techniques and 
the mechanisms involved.
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7.3.2 Heme oxygenase-1 induction and its relationship with age and Alzheimer’s 
disease
As discussed in Section 1.3.3.3.1, HO is the rate-limiting enzyme in heme 
catabolism. Two isoenzymes of HO exist: HO-1 and HO-2; the former is inducible 
by various agents, a variety of circumstances such as heat shock and other forms of 
cellular stress and the latter is constitutively expressed. HO-1 activity is increased in 
whole animal tissues following treatment with its natural substrate heme, as well as 
various metals, xenobiotics and endocrine factors. Many cells in culture, including 
hemopoietic, hepatic, epithelial, endothelial cells, retinal pigmented epithelial cells 
and fibroblasts, respond to these agents in a similar manner i.e. by a marked increase 
in HO-1 activity (Basu-Modak and Tyrrell, 1993; Kutty et al, 1995; Gabis et al, 
1996). Furthermore, HO-1 is a heat shock protein (HSP) induced by elevated 
temperature and also a stress protein induced by oxidative damage (Shibahara et al, 
1987; Keyse and Tyrrell, 1989). It is therefore possible that the induction of HO-1 
may be an essential event for some types of acute reactions and for cellular 
protection following injury or long term oxidative stress experienced in the process 
of ageing. This hypothesis implies that induction of HO-1 enables the removal of the 
potentially toxic molecule, heme, a lipid soluble, transmissible form of iron, as well 
as the generation of bilirubin and biliverdin, metabolites with antioxidant properties 
(Stocker et al, 1987). Also, the increased iron concentration produced by HO-1 
activity is believed to be the cause for the increased expression of ferritin and ferritin 
synthesis, which serves to sequester iron, a potent oxidant for cells (Vile and Tyrrell,
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1993; Tyrrell, 1997). Finally CO, a by-product of heme degradation, may mimic NO 
and thus also serves as an important modulator of endothelial cell function following 
haemorrhagic injury. CO is a powerful vasodilator; it may therefore, together with 
NO, counteract the vasoconstrictor properties of hemoglobin and heme (Verma et al, 
1993). The induction of HO-1 is extremely rapid - indeed Lutton et al (1992) have 
shown that heme causes an immediate increase in HO-1 in as little as 5 min, 
producing a 50-fold increase in HO-1 in hepatocarcinoma cell line. Activation of the 
HO-1 gene by heme resulted in an increase in RNA polymerase II, as evidenced by 
its inhibition by oc-amantitin. The rapid enhancement of HO-1 activation was not 
prevented by inhibitors of protein synthesis and this suggests that transcription 
regulation plays an important role in HO-1 gene. Lavrovsky et al (1994) have 
identified two regulatory elements in the HO-1 promoter, NF-kB and AP-2. They 
are important transcriptional factors mediating the role of HO-1 in the response to 
oxidative stress/injury and growth-differentiation processes. NF-kB can be activated 
in many different cell types following a challenge with primary (e.g. viruses) or 
secondary pathogenic stimuli (e.g. inflammatory cytokines). The activated factor 
then leads to a rapid induction of genes encoding defence and signalling proteins, 
implicating NF-kB as an immediate early mediator of immune and inflammatory 
responses. AP-2 exerts a crucial function in mediating the regulation of gene 
expression in response to a number of different signal transductions (Abraham et al, 
1996). One of the mechanisms by which hormones, growth factors and other stimuli 
induce gene expression is by activating various transcription factors. This is a rapid 
process which frequently involves transcriptional or structural activation of the
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factor(s) and allows its presence in or transfer to the nucleus. These processes may 
be part of the mechanism by which various agents, including heme, increase HO-1 
expression and activity. Involvement of cellular regulators such as DNA-binding 
elements has also been implicated in the regulation of HO-1 (Abraham et al, 1996).
A change in HO levels has been observed with age and in a wide range of 
pathophysiological conditions (Maines, 1988; Abraham et al, 1996). To study the 
possible effect of ageing on HO-1 induction, HO is differentially expressed during 
the development of mouse germ cells (Kurata et al, 1993). HO mRNA accumulates 
in the spermatogonia and this accumulation is maintained through meiosis to the 
spermatocyte stage, mainly due to high transcription rate of the HO-1 gene during 
the spermatogonia stage. HO protein is expressed maximally at the spermatocyte 
stage and then both protein and mRNA levels rapidly decline until no longer 
detectable in the spermatozoa. The study by Lin et al (1989) revealed that HO 
mRNA levels are high in foetal liver during prenatal maturation and reach a 
maximum 24-h after birth. Thereafter, the levels declined but remained above adult 
levels throughout the course of study. A lower expression of HO-1 observed in older 
models suggests a possible age-related dysfunction in the induced response of HO-1. 
Alternatively, it may be due to a lower pro-oxidant state of the cells reflecting an 
adaptation mechanism to long-term oxidative stress, a view supported by Niess et al
(1998) who observed a down-regulation of the baseline expression of HO-1 in 
atheletes who are constantly exposed to oxidative stress. Very few age-related 
studies have been carried out on HO-1 gene expression and the results are
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fragmentary and inconclusive. Similarly, as reviewed by Thakur et al (1993), studies 
measuring expression of other gene such as c-fos, elastin and hsp70 yield 
inconclusive results. An interesting gene whose age-related expression has been 
extensively studied in fibroblast culture is a special group of heat shock genes (hsps). 
Similar to HO-1, these genes and their encoded proteins (HSPs) are induced by 
living cells in response to stress generated by heat shock or chemical treatment. The 
magnitude of this response varies with age. Fargoli et al (1990) have examined the 
induction of expression of hsp70 gene by elevated temperature in fibroblast culture 
obtained from the lung or skin of young and old male rats. The magnitude of 
induction of hsp mRNA and HSP protein is lower in confluent primary lung and skin 
fibroblast cultures derived from aged animals. As mentioned above, very few age- 
related HO-1 gene expression studies have been carried out but the induction of 
HO-1 as a defence against oxidative stress such as y-irradiation and H2O2 exposure 
has been demonstrated in many studies (Abraham et al, 1996). Since oxidative stress 
plays an important role in ageing, this observation may lead to the hypothesis that 
HO-1 induction may vary with age. Furthermore, findings from Premkumar et al
(1995) suggest a specific association between HO-1 and the neurofibrillary 
pathology of AD. An increased expression of HO-1 transcripts was found in the 
cerebral cortex and cerebral vessels from subjects with AD compared with age- 
matched non-AD controls. Schipper et al (1995) have shown that HO-1 is over­
expressed in neurons and astrocytes of Alzheimer-diseased human temporal cortex 
and hippocampus relative to age-matched, non-demented controls. In any gene 
expression studies, an increase in the induction of gene or protein can be a response
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to an acute or chronic oxidative stress or a result of an impairment of the defence 
mechanism. Further research is therefore required to understand various aspects of 
the expression of genes and its regulation during different stages of the life span for 
unravelling the basic mechanism of ageing and age-related disease such as AD.
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CHAPTER EIGHT
CONCLUDING DISCUSSIONS AND FUTURE WORK
8.1 Concluding discussions
The ageing process is multifactorial in nature and as yet many of the contributing 
mechanisms have not been identified. Several theories of the ageing process have 
been proposed that attribute ageing to, amongst other mechanisms, somatic 
mutations and free radicals (Medvedev, 1990). The free radical theory of ageing, 
first proposed by Harman (1956), suggested free radicals were responsible for the 
ageing and death of all living things (Harman, 1992). Many endogenous reactions, 
including the reduction of oxygen to water and the respiratory burst of phagocytes, 
may lead to the production of free radicals. Exogenous sources of free radicals 
include ionising radiation and cigarette smoke. Free radicals can damage cellular 
macromolecules such as DNA and lipids with consequent disruption of cellular 
function. Cellular defence systems such as antioxidants and stress-induced enzymes 
exist to counteract such damage but these mechanisms are not perfect and mutations 
may still occur. It has been suggested that an accumulation of somatic cell, 
mutations, on their own or in combination with other age-related changes, may play 
a causative role in ageing and the development of age-related pathologies such as 
AD. An understanding of the extent of oxidative damage and the defence
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mechanisms in the ageing human population is not only of immense scientific 
interest, it is also important in opening new avenues to age-related diseases.
This investigation is a preliminary study of oxidative-damage-related parameters and 
antioxidant defence in human blood as a function of age and AD. Basal and oxidant- 
induced DNA damage were studied in PBMCs of the three volunteer groups using 
the comet assay. This study and previous studies have demonstrated that DNA 
damage increased with increasing concentration of oxidant but conflicting results 
were obtained when the effect of age was investigated. Singh et al (1990) and Betti 
et al (1995) both reported a non-significant relationship of DNA damage with age 
but Piperakis et al (1998) observed a general increase of DNA damage with age. 
The findings from the present study contradicted that from Piperakis et al (1998) and 
a higher level of DNA damage was found in the HaCVinduced PBMCs of the 
healthy younger volunteers than in the healthy older group. Moreover, AD was 
shown to be a non-significant factor in oxidative DNA damage in PBMCs. At first 
glance, these results seem to contradict the hypothesis that DNA damage increases 
with age as proposed by the free radical theory of ageing and that free radicals may 
be involved in AD (Volicer et al, 1990). However, a high DNA repair capacity to 
maintain genomic stability and an increased resistance to oxidative stress found in 
the aged population may explain these results (Franceschi et al, 1995), highlighting 
the ability of human body to adapt to changes throughout its lifetime and the 
complexity of the mechanisms involved in the defence system. Following the same 
line of investigation, the extent of oxidative damage to lipids as a function of age and
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AD was studied in blood plasma. MDA level was used as the biomarker for lipid 
peroxidation and the TBA test was used for its measurement. Findings from this 
study showed that AD had a significant effect on MDA level, an observation 
supported by previous studies of lipid peroxidation level in AD brain, suggesting 
oxidative damage may play a role in the pathogenesis of AD (Markesbery, 1997). 
However, age was shown to have no effect on MDA level in this study, an 
observation also made by Marcus et al (1998) but contradicted by others (Yu, 1993).
Following on from the study of oxidative damage to DNA and lipids as a function of 
age and AD, a different approach was taken and the defence system against oxidative 
stress was investigated. Many studies dealing with the free radical theory of ageing 
have focused on the possibility that antioxidant levels decrease as a function of age 
and age-related pathologies. On the other hand, it may simply be a result of lack of 
antioxidant supply in the diet. It has also been proposed that the defence system may 
be induced in response to oxidative stress and the antioxidant level may in fact 
increase with age. This makes interpretation of any antioxidant assay extremely 
difficult. In this study, glutathione (GSH and GSSG) level and total antioxidant 
activity in blood plasma were measured. Glutathione is an important antioxidant 
which has been widely used as a parameter in antioxidant and ageing studies (Flagg 
et al, 1993; Hu et al, 1996). Findings from this study suggest that neither age nor 
AD have any effect on GSH level. Conversely, GSSG level was found to be 
significantly affected by AD but not age, with GSSG level higher in the AD group 
than in the healthy older group. Oxidative stress has been implicated in AD and this
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may explain the accumulation of glutathione in its oxidised form (Benzi and Moretti, 
1995). Other glutathione studies have generated conflicting results (Benzi et al, 
1988; Sohal et al, 1995) and the pattern of change of glutathione level with age and 
AD is yet to be established.
Interactions between antioxidants are complex and this can create further problems 
in any antioxidant studies. To avoid the problems posed by assays of individual 
antioxidants, aggregate measures of antioxidant defence such as the TAA assay have 
been devised (Rice-Evans and Miller, 1994). Total antioxidant activity (TAA) in 
blood plasma was measured in this study to take into account the complexity of the 
defence mechanism. Neither age nor AD was shown to have a significant effect on 
TAA in general. However, TAA measured in healthy females over 60 was found to 
be significantly higher than that in healthy females under 30, possibly due to the fact 
that postmenopausal women seem to have a higher level of plasma uric acid which 
acts as an antioxidant (Section 6.3). This observation in females is consistent with 
another study by Aejmelaeus et al (1997). As mentioned above, interpretations of 
data from antioxidant studies are extremely complex and therefore an increase in 
TAA with age would neither contradict nor prove the free radical ageing of theory.
In recent years, increasing number of investigators have become aware that a major 
role of HO is not only to degrade haemoglobin from senescent red blood cells, but 
also to serve as a key enzyme in the modulation of oxidative stress as part of the 
sophisticated defence system (Abraham et al, 1996; Tyrrell, 1997). It has been
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demonstrated that HO-1 expression can be induced in response to oxidative stress or 
various circumstances such as UV light-exposure (Section 1.3.3.3.1). In this study, 
attempts have been made to study the induction of HO-1 expression in PBMCs after 
oxidative stress as a function of age and AD using RT-PCR techniques. Difficulties 
arose during the amplification of total RNA from PBMCs and inconsistent results 
were obtained within and between samples. Various explanations have been 
suggested for these poor and inconsistent findings (Section 7.3.1). The main concern 
is that HO-1 mRNA may be of extremely low abundance in human PBMCs 
rendering its level undetectable. Moreover, the use of RT-PCR techniques for 
quantitative purposes is still highly debatable. There is no doubt that HO-1 is an 
important stress-induced enzyme in the defence system against oxidative stress and 
its role in ageing and AD is yet to be established.
Despite strict adherence to protocols and the implementation of various measures to 
avoid artifacts, it is inevitable that factors other than age and AD may have an effect 
on the findings obtained from this study. Individual variations exist in any 
investigation that involves humans as study subjects. Due to the limited access to 
both healthy and AD volunteers, it was impossible to set up strict selection criteria 
during subject recruitment. As a result, various volunteer parameters such as life 
style, diet and intake of prescription drugs and antioxidants could not be strictly 
controlled. A large proportion of elderly volunteers took antioxidants, minerals and 
other supplements regularly compared to the younger volunteers and this may have 
an overall effect on our findings, since it is believed that dietary antioxidants can
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improve the defence system (Section 1.3.3.3). In addition, all AD patients recruited 
were involved in AD random drug trial and it was impossible to establish what drugs 
they were taking if any, as the trials were placebo-controlled. It is unknown whether 
these AD trial drugs have had any effect on the defence status of individuals.
Many studies have been carried out to explore the effect of age on both the levels of 
markers of oxidative damage and the basal levels of various antioxidants (Lopez- 
Torres et al, 1994; Barnett and King, 1995; Mendoza-Nunez et al, 1999). Findings 
from these studies and the present study do not suggest a consistent pattern of change 
for either antioxidants or oxidative-damage-related parameters with age. In this 
study, a higher level of DNA damage was found in the healthy younger group. In 
contrast, age was found to have no effect on lipid peroxidation. Moreover, the 
antioxidant defence system investigated in this work was found to be unaffected by 
age. Similarly, oxidative damage and antioxidant defence have previously been 
studied in AD patients (Volicer and Crino, 1990; Zaman et al, 1992; Marcus et al, 
1998). Increased peroxidation, reduced antioxidant enzyme activity and lowered 
antioxidant levels have been reported. Findings from the present study are consistent 
with these previous studies, as lipid peroxidation and GSSG level were found to be 
higher in AD patients. However, AD was shown to have no effect on cellular DNA 
damage and total antioxidant capacity in plasma. The role of HO-1 expression in 
ageing and AD has yet to be explored. In conclusion, findings from this study 
demonstrate the complexities inherent in the free radical theory of ageing, with some 
data supporting the theory and others contradicting it. The effect of age and AD on
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various parameters which measured either oxidative damage or antioxidant status 
varied and more work will have to be carried out to increase our understanding of the 
complex relationship of age and AD with oxidative stress.
8.2 Future work
Findings from this work are informative but by no means conclusive. Nevertheless, 
this work has provided a valuable insight into the possible relationships of age and 
AD with oxidative stress. Moreover, this study has emphasised the need for 
accurate, reliable and sophisticated techniques for oxidative-damage and antioxidant 
studies. For example, the sensitivity of the comet assay used to study oxidative 
damage to DNA could be improved by the inclusion of a digestion step with lesion- 
specific endonucleases. Moreover, combining the manual comet analysis method 
with sophisticated image analysis system and investigating different comet 
parameters can improve the accuracy of the assay (Section 3.3.5). Also, it would be 
interesting to investigate if HiCMnduced DNA damage is evenly distributed among 
all PBMCs, or limited to a functional subpopulation by measuring levels of 
glutathione peroxidase or catalase in different populations of cells. For the study of 
lipid peroxidation, it would be beneficial to measure different parameters using two 
or more methods since MDA is only one of the many by-products of lipid 
peroxidation (Section 4.3). Similarly, combining the fluorometric assay with the 
more reliable HPLC assay to determine glutathione may be useful in the future 
(Section 5.1). It would also be helpful to explore the identity and the proportion of
188
antioxidants that contribute to the plasma TAA. Also, a post addition assay 
described by Strube et al (1997) can be carried out to discriminate between the 
scavenging and the inhibitory effect of plasma antioxidants (Section 6.3). Lastly, the 
use of RT-PCR techniques to measure HO-1 expression has yet to be established and 
it would be prudent to consider different sets of primers, alternative methods or 
alternative sources of starting material for future studies (Section 7.3.1). It should be 
emphasised that the levels of parameters measured in blood plasma and PBMCs may 
or may not correlate with that obtained from other areas of the body. It would 
therefore be useful to compare these levels in different cell types e.g. AD brain cells 
or in different biological fluids e.g. serum. In addition, the limited availability of 
PBMCs can be overcome by using a cultured cell line, for example, fibroblasts 
which have been extensively used as a model for studying the process of cellular 
senescence. Fibroblasts can be passaged in culture over many generations and they 
eventually reach a stage at which they remain viable but are permanently unable to 
replicate and such cells are considered senescent. It should also be emphasised that 
all our observations are made using in vitro systems and they do not necessary reflect 
in vivo situations. Therefore, the physiological significance of the in vitro results 
should be confirmed by in vivo studies. Finally, a larger population size and more 
stringent selective criteria will improve the significance of this type of study. The 
power of a hypothesis test can be used to calculate the appropriate sample size for a 
study or clinical trial providing that the smallest true clinically valuable difference 
between the treatments can be specified. It is this requirement that is somewhat 
artificial and difficult to define and this has to be established by general consent of
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scientists in the area of research. Data from this study form a good base for the 
determination of sample size for similar future studies.
Whatever the eventual consensus on the cause(s) of the ageing process, attempts to 
minimise free radical reaction damage in humans are likely to increase the functional 
life-span. It is reasonable to expect the application of the free radical theory of 
ageing will decrease the morbidity and mortality due to degenerative diseases and 
non-specific age changes and possibly also slow down ageing. Slower ageing will 
benefit society since the additional years of use of the skills gained over a lifetime 
should increase productivity. More importantly, slower ageing will help to fulfill 
man’s natural desire for a longer healthy life.
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APPENDIX I
INFORMATION SHEET AND CONSENT FORM
FREE RADICALS & AGEING STUDY
INFORMATION SHEET
RESEARCH
Free radicals are chemical entities produced in the body which can cause tissue and 
cell damage by attacking cell proteins, DNA and lipids by the process of oxidation. 
They are implicated in causing various diseases including cancers, Alzheimer’s 
disease, etc. They are also thought to be involved in the ageing process. These 
entities are produced as a result of normal body function but they can also be 
produced when the body is exposed to sunlight, radiation and certain chemicals such 
as hydrogen peroxide.
The body has many defence systems, which can deactivate free radicals. Some 
people believe we can obtain a certain degree of protection through a healthy diet and 
by taking vitamin supplements. The body also has repair mechanisms to repair the 
damages caused by these free radicals.
We propose to study these oxidative damages and defence systems in the body in 
people of different age groups to see if they vary with age or disease.
HOW YOU CAN HELP
We would be grateful if you would donate a small amount of your blood (45 ml) to 
assist us in this research. The blood will be collected at the Research Institute for the 
Care of Elderly at St. Martin’s Hospital, Bath. The Bath Local Ethics Committee has 
approved this research. Please fill in the consent form enclosed if you can help.
Your help would be very much appreciated.




Free radicals and ageing study consent form
Have you read the information sheet? Yes No
Have you had any opportunity to discuss this and ask questions?
Yes No
Have you received satisfactory answers to all your questions?
Yes No
Have you received enough information about the study?
Yes No
Do you understand that you are free to refuse to participate or change your 
mind at any time without giving any reason?
Yes No
Do you agree to take part in this study by donating 45 ml blood?
Yes No
VOLUNTEER














Are you a vegetarian? Yes No
How many portions of vegetables do you have daily? _______________
Smoking:
Do you smoke? Yes No
If Yes, how many cigarettes do you smoke daily?
Exercise: (1 session = 30 minutes, includes walking, gardening, aerobics, etc.) 
None
Low (at least 1 session a week)
Moderate (at least 2 sessions a week)
High (at least 3 sessions a week)
Medical History:
Do you have any known medical condition(s)? Yes No




Are you currently taking any drugs (prescribed drugs or over the counter drugs 
such as aspirin, paracetamol, etc.)?
Yes No
If Yes, please give details: ________________________________________
Do you take vitamins or mineral supplements regularly? Yes No
If Yes, please give details: ________________________________________
Would you like to participate in similar research in the future?
Yes No
If Yes, please give us your contact details:
Address: _____________________________________________________
Telephone: _____________________________________________________
All information will be treated as confidential.
Thank you for your participation in this research.
Peggy Ho MRPharmS 
PhD Research Student
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APPENDIX III SUMMARY OF INFORMATION ON ALL VOLUNTEERS
Abbreviations applied to Appendix III
Y -  Yes N -  No
VB -  Vitamin B VC -  Vitamin C VE -  Vitamin E MV -  Multivitamins
Ca -  Calcium Mg -  Magnesium MM -  Multi-minerals CLO -  Cod liver oil
EPO -  Evening primrose oil GP -  Garlic oil HO -  Halibut oil Q 10 -  Coenzyme Q 10
C -  Contraceptive pills GTN -  Glyceral trinitrate HRT -  Hormone replacement therapy
NSAIDs -  Non-steroidal anti-inflammatory drugs Do -  Donepezil Dop -  Placebo for Donepezil 
trial
Ga -  Galanthamine Pr -  Propentofylline T-588 -  active drug for Toyama trial
T-588P -  Placebo for Toyama trial AD -  Alzheimer’s disease MI -  Myocardial
infarction .








1 N N N N N
2 N N N N N
3 Y N N Paroxetine, 
illegal drug use
Depression
4 N MV N N N
5 N N N N Asthma, eczema
6 N N N N N
7 ■N N N N N
8 Y N N N N
9 N N N Salbutamol Asthma
10 N N N N N
11 N . N N Ibuprofen N
12 N N N N N










13 N N N N N
14 N MV N C N
15 N N N N N
16 Y N N C Irritable bowel 
syndrome
17 N VC N N N
18 N N N N N
19 N N N C N
20 N N N N N
21 N N N N N
22 N N N N N
23 N N EPO C N
24 N N Iron C N
25 N VC N N N










1 N N N Aspirin Angina
2 N N N N N
3 N N N N N
4 N N N N Padget’s disease
5 N MV MM N Diabetic
6 N N N N N
7 N MV N Perindopril HC, HT










8 N N N N N
9 N N CLO N HH
10 N N N N N
11 N N CLO Terbinafine N
12 Y VC CLO N N
13 N N N Ibuprofen Osteoarthritis, 
thrombosis, HH









16 N N N Aspirin Kidney stone
17 N N N N HH
18 N N CLO N N
19 N N N Analgesics,
NSAIDs
Arthritis
20 N VE CLO Aspirin,
bendrofluazide
HT







22 Y MV HO Thyroxine,
HRT
N
23 N N N N N
24 N N CLO, GO N N
25 N N N N N














2 N N N Oxybutanin, Ga Adeno­
carcinoma, AD
3 N N N Do AD
4 N N N T-588p AD





6 N N N Do AD
7 N N N T-588p AD
















11 N N N Beconase,
T-588
AD










12 N N N T-588 AD
13 N N N Do AD




15 N N Iron, Ca T-588p Arthritis, 
spondylitis, AD
16 N N CLO Aspirin, Do AD
17 N N N Terbutaline, Pr AD
18 N N N Aspirin, 
paracetamol, Do
Migraine, AD




20 N VB N Aspirin, 
omeprazole, 
fluoxetine, P r? .
AD, HH
21 N N N Do AD
22 N N Gingko-bilboa Quinine, Do AD







24 N N N Paracetamol,
Do
Arthritis, AD
25 N N N Do AD
F. Summary of information on 14 female Alzheimer’s volunteers age > 60.
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